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ABSTRACT
Protein Kinase C (PKC) family of isoenzymes are critical players in signal 
transduction at the membrane surface.  Its aberrant activity has been associated with 
Alzheimer’s disease, cancer, and mood disorders.  Significant efforts have been made to 
understand how PKC is regulated in order to design drugs to modulate activity.  This has 
proved challenging due to the dynamic nature of PKCs. 
The key event in PKC activation is the translocation of its regulatory region to 
anionic membranes in response to second messengers.  This region in conventional 
isozymes contains three peripheral membrane binding modules:  twin C1 domains that 
penetrate the membrane in response to diacylglycerol and a C2 domain that binds to 
anionic lipids upon association with up to three Ca2+ions.  The objective of this 
dissertation is to provide mechanistic insight into PKC activation by probing the 
regulatory region’s structure, function, and interactions with toxic substances. 
Paramagnetic solution NMR revealed that the C1B-C2 region from PKC 
primarily samples open conformations, with both membrane binding sites exposed.  In 
several of these conformations, the membrane binding loops of C1B and C2 are in 
relative orientations that are compatible with simultaneous membrane insertion. This 
suggested that C1 and C2 domains coordinate membrane binding.  Consistent with this, 
functional studies showed that C1 ligands lowered the amount of Ca2+ needed to traffic 
C2 to membrane mimics. 
iii
Studies with membrane mimics revealed that the regulatory region responded 
differently to C1 ligands, diacylglycerol and tumor-promoting phorbol ester, PDBu.  
Preliminary data indicated that diacylglycerol drives the C1 domain deeper into the 
bilayer.  Furthermore, the presence of the low abundance signaling lipid, 
phosphatidylinositol 4,5-bisphosphate, was required for bivalent binding of C1 and C2 in 
the presence of diacylglycerol but not PDBu.
Finally, previous studies have shown that PKCs are targeted by xenobiotic metal 
ions, Pb2+ and Cd2+.  This work shows that both metals drive self-assembly of the C1B-
C2 regulatory region into large oligomers, enhancing membrane binding functionality.  
A new mode of Pb2+ and Cd2+ binding is identified.  Both bind opportunistically to the 
linker region and C-terminal helix.  Collectively this work adds to the understanding of 
PKC activation and its interactions with toxic substances.
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IMAC Immobilized metal affinity chromatography
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LB Luria-Bertani
LRC lysine rich cluster
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PKC protein kinase C
PMA phorbol 12-myristate 13-acetate
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PRE paramagnetic relaxation enhancement
PS phosphatidylserine
RDC residual dipolar couplings
SAXS small angle x-ray scattering
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis
SEP solubility enhancement peptide
SUMO small ubiquitin-like modifier
Syt I synaptotagmin I
TCEP tris(2-carboxyethyl)phosphine
TFA trifluoroacetic acid
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TROSY transverse relaxation-optimized spectroscopy
xTABLE OF CONTENTS
Page
ABSTRACT .......................................................................................................................ii
ACKNOWLEDGEMENTS ..............................................................................................iv
CONTRIBUTORS AND FUNDING SOURCES..............................................................v
NOMENCLATURE..........................................................................................................vi
TABLE OF CONTENTS ...................................................................................................x
LIST OF FIGURES.........................................................................................................xiv
LIST OF TABLES .........................................................................................................xvii
CHAPTER I INTRODUCTION ........................................................................................1
PKC Isoforms and Substructure .....................................................................................3
C1 domains .................................................................................................................5
C2 domains .................................................................................................................7
PKC Regulation..............................................................................................................9
Intramolecular Interactions.........................................................................................9
PKC self-association.................................................................................................11
Foreign Substances Modulate PKC Activity................................................................12
Toxic Metal Ions.......................................................................................................13
Phorbol Esters...........................................................................................................13
Challenges associated with structural studies on PKC.................................................14
CHAPTER II EXPRESSION AND PURIFICATION OF THE N-TERMINAL 
REGULATORY DOMAIN OF PROTEIN KINASE C FOR BIOPHYSICAL 
STUDIES..........................................................................................................................16
Background ..................................................................................................................16
Materials and methods..................................................................................................19
Cloning and site-directed mutagenesis .....................................................................19
Induction and solubility tests ....................................................................................20
Protein expression.....................................................................................................21
Protein purification ...................................................................................................22
Analytical gel-filtration ............................................................................................23
xi
Mass-spectrometry....................................................................................................24
Sample preparation and Nuclear Magnetic Resonance (NMR) experiments...........24
Results ..........................................................................................................................25
Construction of chimeric protein enables expression of the tag-free soluble N-
terminal regulatory region from conventional PKC .................................................25
Expression of soluble N-terminal regulatory region is exquisitely sensitive to 
experimental conditions............................................................................................27
Tag-free C1C2c and C2C1 can be obtained with moderate-to-high yields............29
Preparation of samples for NMR studies..................................................................30
C1C2c: improvement of solubility and stability.......................................................32
C2C1: improvement of solubility ...........................................................................34
Conclusion....................................................................................................................37
CHAPTER III OPPORTUNISTIC CD(II) AND PB(II) BINDING TRIGGERS 
THE SELF-ASSOCIATION OF PERIPHERAL MEMBRANE BINDING 
DOMAINS FROM PROTEIN KINASE C......................................................................39
Background ..................................................................................................................39
Methods ........................................................................................................................43
Buffer and metal ion solutions..................................................................................43
Protein purification ...................................................................................................43
Analytical gel-filtration ............................................................................................45
UV-vis spectroscopy.................................................................................................46
C1B refolding ...........................................................................................................46
NMR spectroscopy ...................................................................................................47
Small-angle X-ray scattering (SAXS) data collection..............................................48
Small Angle X-ray Scattering (SAXS) measurements: buffer conditions and 
data analysis procedures ...........................................................................................49
Analytical gel-filtration and sedimentation experiments..........................................50
Electron microscopy .................................................................................................51
Protein-to-membrane FRET .....................................................................................52
Estimation of the relative affinities for Cd2+ and Zn2+ to C1B.................................52
Results ..........................................................................................................................56
Pb2+ and Cd2+ promote self-assembly of the regulatory region................................56
Characterization of Pb2+- and Cd2+-containing C1B-C2 oligomers .........................58
Mechanism of Cd2+- and Pb2+ induced self-association............................................63
C1B: Cd2+ displaces Zn2+ to form a functional “Cd finger”.....................................63
C1B: Pb2+ coordinates Cys residues but can neither displace Zn2+ nor support 
the treble-clef fold ....................................................................................................69
C2: Cd2+ and Pb2+ drive the association of C1B-C2 oligomers with acidic 
membranes................................................................................................................72
Linker region connecting the domains is involved in self-association.....................74
Known metal binding sites do not significantly contribute to self-association........76
Discussion ....................................................................................................................82
xii
Toxic metal ions serve as ionic mimics for Zn2+ and Ca2+.......................................82
Opportunistic metal binding drives self-association of C1B-C2 region...................85
CHAPTER IV PARAMAGNETIC AGENTS REVEAL THE 
CONFORMATIONAL SPACE SAMPLED WITHIN THE C1B-C2 
REGULATORY REGION...............................................................................................90
Background ..................................................................................................................90
Experimental Procedures..............................................................................................91
C1B-C2 Purification .................................................................................................91
Buffers/Metal ion solutions ......................................................................................93
Small-angle X-ray scattering (SAXS) ......................................................................93
UV-vis spectroscopy.................................................................................................94
NMR spectroscopy ...................................................................................................94
PCS Restraints ..........................................................................................................96
Determining Intra-PCS .............................................................................................98
Measurement of intermolecular 1H PRE rates........................................................100
Maximum Occurrence Calculations .......................................................................101
Results ........................................................................................................................103
C1B-C2 crystallizes in a compact conformation....................................................103
C1B-C2 is partially flexible in solution..................................................................105
Conformationally averaged restraints.....................................................................109
C1B-C2 samples primarily open conformations ....................................................113
C1B-C2 samples “open” conformations, poised for membrane insertion..............116
C1B-C2 transiently self-associates .........................................................................120
Discussion ..................................................................................................................123
CHAPTER V MULTIVALENT INTERACTIONS OF THE C1B-C2 
REGULATORY REGION WITH MEMBRANE MIMETICS AND FUTURE 
DIRECTIONS ................................................................................................................126
Background ................................................................................................................126
Experimental Procedures............................................................................................128
C1Bα Purification...................................................................................................128
C1B-C2 Purification and sample preparation.........................................................129
Preparation of bicelles ............................................................................................129
Measurement of 1H Paramagnetic Relaxation Enhancement .................................130
Measurement of PCSs and RDCs...........................................................................130
Assignment of C1B methyl region .........................................................................131
Protein-to-membrane FRET ...................................................................................131
C1B binding to DAG probed by ultracentrifugation ..............................................133
Turbidity Assay ......................................................................................................134
Diffusion-ordered spectroscopy .............................................................................134
Results ........................................................................................................................135
xiii
Ligands do not perturb isotropic bicelles ...............................................................135
C1B transiently associates with bicelles in the absence of ligands ........................138
34 loop of C1B partitions deeper into the bilayer in the presence of phorbol 
esters .......................................................................................................................140
Proline-linker variant decreases conformational variability of C1B-C2 ................146
PIP2 is required to achieve maximum coupling between C1 and C2 ligands........150
Discussion and future directions ................................................................................154
CHAPTER VI SUMMARY AND FUTURE DIRECTIONS ........................................163
REFERENCES ...............................................................................................................174
xiv
LIST OF FIGURES
Page
Figure I.1  Current model for the activation of the conventional isoform PKC. .............3
Figure I.2 Linear diagrams illustrating the multimodular structure of PKC isoforms. ......4
Figure I.3 C1 domain architecture and ligand-binding. .....................................................6
Figure I.4 C2 domain architecture and ligand-binding. .....................................................9
Figure I.5  Intramolecular interactions stabilize the latent form of PKC. ........................11
Figure II.1 Regulatory regions purified in this Chapter. ..................................................18
Figure II.2  The C1A domain from PKC has a high sequence identity to C1A...........27
Figure II.3  Regulatory region preparations are mono-disperse.......................................30
Figure II.4  Use of osmolytes, SEP, and targeted mutations improves the quality of 
NMR spectra of N-terminal regulatory regions of PKCs. ................................36
Figure II.5  Individual domain resonances are present in the 15N-1H HSQC spectrum 
of F83S C1C2c..................................................................................................37
Figure III.1 Modular structure and peripheral domains of conventional PKC 
isoenzymes. .......................................................................................................42
Figure III.2  Treatment of PKC regulatory region with Cd2+ or Pb2+ results in self-
association, loss of conformational flexibility, and formation of globular 
species. ..............................................................................................................57
Figure III.3 C1B-C2 forms spherical oligomers in the presence of Cd2+ and Pb2+. .........59
Figure III.4 Pb2+ causes aggregation of C1B-C2 over time. ............................................60
Figure III.5 Cd2+-mediated self-association of C1B-C2 is reversible and pH-
dependent. .........................................................................................................61
Figure III.6  More self-association is observed at physiological pH with Cd2+. ..............63
Figure III.7 Cd2+ replaces Zn2+ in the C1B domain without loss of fold and function. ...65
Figure III.8  Cd2+ replaces Zn2+ in C1B-C2. ....................................................................67
xv
Figure III.9 Cd2+ binds to the loop regions of the C2 domains and the structural Zn-
sites of the C1B-C2...........................................................................................67
Figure III.10 Four distinct C1B species form upon treatment with Cd2+. ........................68
Figure III.11 Pb2+ coordinates C1B cysteines but does not cause Zn2+ release from 
C1B-C2. ............................................................................................................70
Figure III.12 Pb2+ interactions with isolated C1B..........................................................72
Figure III.13 Pb2+ and Cd2+ support the interactions of C1B-C2 domain with 
membranes. .......................................................................................................73
Figure III.14  Toxic heavy metals perturb the linker and c-terminal helix of C2. ...........75
Figure III.15 Canonical metal binding sites do not contribute to Cd2+ mediated self-
association.........................................................................................................78
Figure III.16  LH variant does not perturb the structure of C1B-C2................................79
Figure III.17  Self-association is mediated by linker and C-terminal helix. ....................81
Figure III.18 Model describing the interactions of Pb2+ and Cd2+ with the C1B-C2 
regulatory region. ..............................................................................................88
Figure IV.1  Agreement of PCS for tensor determination................................................98
Figure IV.2  NMR experimental set up designed to separate intra- and inter-PCS. .......99
Figure IV.3  C1B-C2 crystallizes in a compact conformation. ......................................104
Figure IV.4  C1B-C2 is partially flexible. ......................................................................107
Figure IV.5  Intramolecular PCS for C1B-C2 bound to Ln3+ at 800 MHz. ...................111
Figure IV.6  SAXS data for C1B-C2 in the apo and Ca2+- bound forms. ......................112
Figure IV.7  Comparison of the experimental PCS and SAXS curves with the 
averaged data from the best fit ensemble chosen by MaxOcc........................113
Figure IV.8  Conformational analysis of C1B-C2..........................................................114
Figure IV.9 C1B-C2 samples a narrow region of the allowed conformation space.......116
Figure IV.10  C1B-C2 samples mostly “open” conformations. .....................................117
xvi
Figure IV.11  Compact conformations score low in MaxOcc analysis..........................119
Figure IV.12  C1B-C2 samples “open” conformation in solution. ................................120
Figure IV.13  C1B-C2 has propensity to self-associate in a manner that is unique 
from the isolated C2 domain...........................................................................122
Figure V.1 C1B transiently associates with isotropically tumbling bicelles. ..............139
Figure V.2 PDBu binding recovers exchange broadened C1B residues in the presence 
of bicelles. .......................................................................................................141
Figure V.3 1H R2 increases upon bicelle and PDBu addition.........................................142
Figure V.4  The 34 loop of C1B is inserted deeper into the membrane with PDBu....143
Figure V.5 PDBu and PMA generate identical PRE profiles on C1B. ..........................144
Figure V.6 DOG drives C1B deeper into the membrane.............................................146
Figure V.7 Proline-linker rigidifies C1B-C2..................................................................147
Figure V.8 The C1B-C2 linker region tunes avidity. .....................................................150
Figure V.9 C1B-C2 binds DAG and has the potential to tether liposomes....................153
Figure V.10 Assigned methyl spectra of C1B................................................................156
Figure V.11 Multi-component isotropic bicelle enables acquisition of high quality 
NMR spectra in the presence of Ca2+ and PDBu. ...........................................157
Figure VI.1 Ca2+ breaks up an intermolecular interaction between C1B and C2. .........166
xvii
LIST OF TABLES
Page
Table II-1. NMR buffers used for PKC constructs.  Reprinted with permission from 
ref 97. .................................................................................................................25
Table II-2. Properties of N-terminal PKC constructs. Reprinted with permission from 
ref 97. .................................................................................................................32
Table III-1. Sample conditions for SAXS experiments....................................................50
Table III-2.  Fractional populations of each C1B species in solution for a 0.1 mM 
C1B sample with 0.1 mM Cd2+.........................................................................56
Table III-3. Relative affinities of Cd2+ to each C1Ba Zn-site. .........................................69
Table III-4.  Summary of the C1B-C2 variants. ...............................................................76
Table IV-1.  Magnetic Susceptibility Tensor parameters determined for C2. .................97
Table IV-2. Median R1, R2, and NOE values for C1B-C2 in the different metal-ligated 
states................................................................................................................109
Table IV-3. Rotational correlation times predicted from ROTDIF 3.1 (C1B-C2) and 
from ref 103 and 183 for isolated C1B and C2 respectively. .............................109
Table V-1. Ligands do not perturb bicelle morphology.  Translational diffusion 
coefficients (Dt) determined from DOSY experiments at 500 MHz. .............136
Table V-2.  Ligands do not perturb bicelle morphology. ...............................................138
Table V-3. PIP2 is required to maximize interactions of C1B-C2 with membranes. ....151
1CHAPTER I 
INTRODUCTION 
Protein Kinase C comprises a family of Ser/Thr kinases that participate in 
cellular signaling at the membrane surface.  PKCs are members of the AGC (PKA, PKG, 
PKC) family of kinases.  It was first discovered in 1977 as “PKM”, a cyclic nucleotide-
independent protein kinase produced by a proteolytic reaction.1,2  Later studies 
determined that full-length PKC is activated by Ca2+ and phospholipids.3  The field of 
research on PKC exploded when PKCs were discovered as receptors for tumor-
promoting phorbol esters.4,5  PKC isoenzymes are ubiquitously expressed in many 
different tissues (reviewed in 6) and have been implicated in many human diseases such 
as heart disease7,8, Alzheimer’s disease9, cancer 10-14, and mood disorders.15  In addition, 
PKC has been identified as a player in heavy metal toxicity.16-19
PKC isoenzymes serve as integral components in multiple cellular processes 
such as cell proliferation, migration, and apoptosis.20-22  Studies have shown that 
different PKC isoforms often play opposing roles in both diseased states and normal 
function.6  Their role in disease sparked the interest in finding modulators of PKC 
activity.  However, to design these, structural information is needed for different stages 
in the activation pathway.  Mature PKC exists in the cytosol in a compact, latent form 
(Figure I.1). In this form, an N-terminal pseudosubstrate region is bound to the active 
site of the kinase domain.  This region is designed to mimic targets of PKC23,24, with an 
alanine residue instead of Ser/Thr at the phospho-acceptor site.25  When an extracellular 
signal binds to a G-protein coupled receptor, phospholipase C is activated and 
2hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) to generate diacylglycerol 
(DAG) and inositol 1,4,5-trisphosphate (IP3).  DAG remains in the membrane while IP3 
goes on to the endoplasmic reticulum to release Ca2+.  The hallmark of PKC activation is 
the recruitment of the PKC regulatory domain to the plasma membrane by these two 
second messengers (DAG and Ca2+).  The resulting conformational rearrangements 
mediate the expulsion of the pseudo substrate region from the active site (Figure I.1), 
generating a fully active kinase.  Currently, there is no structural information available 
for the latent nor the membrane-bound enzyme, despite over forty years passing since 
the discovery of PKC.  This is largely in part due to the nature of PKC.  PKCs are multi-
modular, flexible, and hydrophobic, all traits which present challenges for conventional 
biophysical techniques.  Herein lies the primary motivation for this work:  to overcome 
these challenges and increase the understanding of the structure of the PKC regulatory 
region during activation.  Furthermore, toxic metal ions and phorbol esters have been 
shown to interfere with the normal activation pathway.  Additional work presented is 
aimed at understanding the mechanisms for this.  The following subsections will provide 
an introduction to the existing knowledge in the field about PKC structure, function, 
activation, and the foreign substances that interfere with them.
3Figure I.1  Current model for the activation of the conventional isoform 
PKC.Second messengers Ca and diacylglycerol (DAG) target the PKC regulatory 
domains (C2, C1A, and C1B) to the cell membrane.
PKC Isoforms and Substructure   
PKC isoenzymes are divided into three subgroups based on their activation 
requirements:  conventional, novel, and atypical.  Conventional isozymes (, , II, and 
) are activated by both diacylglycerol and Ca2+.  Novel isoforms (ε, δ, θ, and η) are 
activated by DAG only and atypical isoforms (ζ and ι/λ) do not require either second 
messenger to be activated.  All three subgroups have a regulatory domain and a catalytic 
domain connected by a proteolytically-sensitive hinge.  Figure I.2 shows the 
multimodular structure of each region.
4Figure I.2 Linear diagrams illustrating the multimodular structure of PKC 
isoforms.
All subgroups have a conserved kinase domain with N- and C-terminal lobes and 
an intrinsically disordered variable 5 domain at the C-termini.  All isoforms have the 
pseudosubstrate region within their regulatory domains that binds to the active site of the 
kinase in the latent form, although its placement within the regulatory domain varies.  
Structural differences are found in the regulatory regions, variable linkers, and the C-
terminal tail, making these regions attractive targets for isoform-specific modulators.
The regulatory region of conventional isoforms contains twin C1 domains that 
bind to membrane-embedded diacylglycerol and a C2 domain that associates with 
anionic membranes upon sensing its cofactor, Ca2+.  Novel isoforms have 
diacylglycerol-binding, twin C1 domains following a C2-like domain that lacks the 
residues needed for Ca2+ coordination.  Finally, atypical PKCs have only one atypical C1 
domain that does not have diacyglycerol binding ability and instead binds to ceramide or 
phosphatidylinositol (3,4,5)-trisphosphate (PIP3) and a protein-protein interaction box, 
PB1.  Each of the individual regulatory domains is functionally autonomous.  The hinge 
between the regulatory domains is sensitive to proteases26,27 and cleavage at this site 
5generates a constitutively active kinase for some isoforms.28  The majority of this work 
focuses on the regulatory regions of conventional isoform,  and Chapter 2 also focuses 
on novel isoform, .  Therefore, the remainder of the introduction will focus on these 
isoforms.
C1 domains
Structure
Both novel and conventional isoforms have two conserved homology 1 (C1) 
domains that bind to DAG and biologically active forms of phorbol esters, phorbol 12-
myristate 13-acetate (PMA) and phorbol 12,13-dibutyrate (PDBu).  Although these 
domains were originally identified in PKC, they exist in other signaling proteins such as 
Munc-13 isoforms and chimaerins (reviewed in 29).  The primary structure of these 
domains contains the sequence motif: His-X12-Cis-X2-Cis-X(13 or 14)-Cis-X2-Cis-X4-His-
X2-Cis-X7-Cis, where X can be any residue.  Two structural Zn2+ ions are coordinated by 
the six cysteines and two histidines and are essential to the proper folding of C1 
domains.30  A reactive cysteine (C151) was discovered for C1B of PKC, an uncommon 
feature for structural Zn-sites.31  It is unknown if other C1 domains feature this trait.  
Crystal structures and solution Nuclear Magnetic Resonance (NMR) structures exist for 
the C1 domains of isoforms 30, 32, 33, and   These structures reveal that C1 
domains adopt the canonic treble-clef fold common to Zn-finger proteins, with two 
“unzipped” -sheets and a C-terminal -helix.  The tops of C1 domains are very 
hydrophobic and insert into the membrane. The crystal structure of PKC in the 
presence of a phorbol ester showed that ligands bind in a pocket of the two loops (Figure 
6I.3), serving to cap hydrophilic residues in the ligand-binding loops and completing the 
hydrophobic surface that facilitates membrane penetration.  The middle of C1 domains 
has positively charged residues that mediate interactions with anionic phospholipids, 
with some isoforms having a preference for phosphatidylserine.35
Figure I.3 C1 domain architecture and ligand-binding.  Crystal structure of C1B 
domain from PKC in complex with phorbol 13-acetate (1PTR).
Membrane Interactions
Despite high sequence identities (36-46% within the folded core), C1 domains 
have varying affinities for DAG and phorbol esters, even within the same isoform.36-38  
7Studies have shown that the C1A domains of both PKC and PKC have high affinities 
for DAG and play a primary role in DAG-mediated activation of PKC.37,39  Within the 
same isoforms, C1B domains have low affinities for DAG and are implicated in phorbol 
ester-mediated activation of their full-length counterparts, with high affinities.38  The 
affinities of C1 domains to diacylglycerol have been found to correlate with the identity 
of a single residue in the loop region that is a Tyr in C1 domains with low affinity to 
DAG and Trp in C1 domains with high affinity for DAG.40  The high-affinity 
interactions of C1 domains in novel isoforms stabilize the membrane-bound form in the 
absence of a membrane-binding C2 domain.41 
C2 domains
Like C1 domains, conserved homology 2 domains serve as one of the building 
blocks of many different proteins including synaptotagmins42, involved in synaptic 
vesicle exocytosis; phospholipase C, another key player in signal transduction; and 
Munc 13, also involved in exocytosis.  C2 domains were first discovered in PKC 
isozymes as ~130 amino acid long Ca2+ and phospholipid binding motifs.43-45  Their 
ability to bind Ca2+ and phospholipids was first discovered in Synaptotagmin I.46  The 
basic structure of C2 domains consists of eight, conserved, anti-parallel -strands 
connected by more variable loop regions.47  Structural and functional studies on PKC 
found that 2 or 3 Ca2+ ions bind cooperatively to highly conserved aspartic acid residues 
in the Ca2+ metal-binding loops that connect the -sheets.48 In conventional isoforms, 
Ca2+ -binding and subsequent trafficking of PKC to the membrane serve as the first step 
of activation.49  Ca2+ binding is proposed to serve three purposes in modulating C2 
8affinity for membranes: (1) contributing to the change of electrostatic potential of C2, 
(2) coordinating the head groups of anionic lipids with a preference for 
phosphatidylserine (PS), and (3) contributing to interdomain rearrangements in the 
regulatory region that primes the enzyme for membrane association.44  In addition to 
Ca2+, C2 domains have been shown to be targeted by toxic metal ions with varying 
consequences for function.  While Pb2+ was able to drive the membrane association of 
C2 almost as effectively as Ca2+50, Cd2+ binding to the loops of the C2 domain 
completely abolished membrane association.51
C2 domains from conventional isoforms also bind to PIP2 through a positive 
patch on the -strands 3 and 4 called the lysine-rich cluster (LRC) (Figure I.4).  PIP2 
binding to the LRC has been shown to change the membrane binding geometry of C2 
domains 52 and significantly lowers the Ca2+-requirements for membrane recruitment of 
C2.53-55  In contrast to the C2 domains of conventional isoforms, C2 domains of novel 
isoform,  do not bind to Ca2+ and do not traffic the parent enzyme to membranes.41  
Instead, the relatively high affinity of the PKC C1 domains compensate for the lack of 
membrane binding C2 domain.41
9Figure I.4 C2 domain architecture and ligand-binding.  Ribbon diagram showing the 
structure of C2 domain from PKC in complex with PS (1DSY).  The coordinates for 
PtdIns(4,5)P2 (PIP2) were taken from 3GPE.
PKC Regulation
Intramolecular Interactions
The hallmark of PKC activation is translocation of the regulatory region to 
membranes.  This process is regulated by ligands (Ca2+ and DAG), phosphorylation, 
protein-protein interactions, and intramolecular interactions.  A host of intermolecular 
interactions that stabilize the latent form of PKC are summarized in Figure I.5.  It has 
been shown that the ligand binding sites of C1A and C1B domains of conventional 
isoforms PKCII and PKC were masked in the mature enzyme.56 One interaction that 
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stabilizes the latent form of PKC is between the pseudosubstrate region and the kinase 
domain24, however, several intermolecular interactions involving C1 and C2 domains are 
also important.  The most notable of these interactions is the proposed autoinhibitory 
interaction between C1A and C2 of PKC57,58  Evidence for this interaction comes from 
mutagenesis and docking studies that identified three interacting pairs of residues 
between the C1A and C2 domains57:  Asp55-Arg252, Arg42-Glu282, and Phe72-
Phe255.  Furthermore, a surface plasmon resonance study showed that the C2 domain 
from PKC bound to a construct containing the PKC C1A and C1B domains.58  The 
same study concluded that fusion proteins containing C1 domains from isoform  and 
novel isoform  were able to activate the full-length enzyme of the corresponding 
isoform, indicating their abilities to compete for the intermolecular interaction sites.58  
Additionally, the C2 domain from PKC has also been shown to interact with the C-
terminal tail of the kinase domain.59,60  This interaction is proposed to serve two 
purposes:  to maintain the auto-inhibited form of PKC and to sensitize the C2 domain to 
intracellular Ca2+ levels.59 
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Figure I.5  Intramolecular interactions stabilize the latent form of PKC.  Proposed 
intramolecular interactions indicated on the linear diagram for conventional PKC 
isozymes: (1) pseudosubstrate region and the active site of the kinase domain, (2) C1A 
and C2 (3) C2/V5 (4) C1B/kinase domain. 
    
A partial crystal structure of PKC II revealed a “C1B clamp” consisting of 
interactions between the C1B domain, N-lobe of the kinase domain, and the variable 5 
(V5) domain.61  This interaction involves the side chains of Leu125 and Ile126 which are 
involved in membrane binding.  Furthermore, it blocks the DAG binding site, pointing to 
the autoinhibitory nature of the interaction.  Mutations designed to destabilize this 
interface lowered the concentration of PMA needed for membrane translocation of full-
length PKCII.61
PKC self-association
An additional layer of regulation is thought to come through self-association.  
PKC activity was found to be concentration dependent, consistent with 
oligomerization.58  A peptide containing the C1A and C1B domains from PKC was 
found to be able to activate the corresponding parent enzyme in the presence of phorbol 
ester.58  Furthermore, the maximum specific activity of PKC in the presence of its own 
C1A-C1B peptide was equivalent to the activity in the presence of saturating activators:  
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phospholipids, phorbol esters, and Ca2+, which indicates that self-association is potent in 
activation.  Crosslinking studies found that conventional PKCs form homodimers in the 
presence of activators, phospholipids and Ca2+, with phosphatidylserine having the most 
profound effect.62  This was found to occur independently of the substrate binding site 
and in parallel with activation, likely due to exposure of interfaces masked in the latent 
form.
More recent studies using intermolecular Förster resonance energy transfer 
(FRET) pairs suggest that homodimerization serves to regulate PKC activity by 
sequestering intramolecular interaction sites.63  Furthermore, this study identifies the 
regulatory domain in addition to the V5 domain as the sites of interaction in the 
homodimer.  Yet another study found that Ca2+ was minimally sufficient for PKC to 
self-associate in vitro and that the clustered state of PKC depends on which ligands are 
used to stimulate oligomerization.64  Despite accumulating evidence of PKC 
dimerization, further investigation is needed to understand the molecular details of the 
interactions.
Foreign Substances Modulate PKC Activity
Foreign substances interfere with the physiological activity of PKC with adverse 
effects on human health.  This work deals with two types of these: toxic metal ions and 
tumor-promoting phorbol esters.  An introduction to the consequences of PKC exposure 
to both is given below.   
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Toxic Metal Ions
Heavy metals are naturally occurring in trace amounts but become enriched in 
our environment through industrial, technological, and agricultural applications.65,66 
Human exposure to these metals, even in small amounts has been shown to cause cancer, 
neurological defects, and other health problems.65-70  PKC is a known player in heavy 
metal toxicity.  Pb2+ has been shown to activate PKC at low concentrations and inhibit 
PKC at higher concentrations.71,72  Cu2+, Cd2+, Mn2+, Zn2+, and Hg2+ were all shown to 
inhibit phorbol ester binding.73,74  Cd2+ has been shown to interfere with multiple cellular 
processes through PKC signal transduction pathways.18,75  Due to the dependence of 
PKC activity on Ca2+ which can be mimicked by divalent toxic metals, studies on PKC 
and heavy metals have focused on the C2 domain.  Pb2+, for example, was found to be as 
effective as Ca2+ in driving the C2 domain to the membrane.50  In stark contrast, Cd2+ 
treatment of C2 abolished binding to anionic membranes.51  Despite the lack of C2-
membrane binding in the presence of Cd2+, it was shown to activate nuclear PKC.17          
Phorbol Esters
Phorbol esters refer to a class of compounds naturally occurring in croton oil and 
plants from the family Euphorbiaceae.76  Phorbol esters can make their way into our diet 
through the consumption of animals that are exposed to the plants.  It was found that 
treatment of mice with phorbol esters promoted the formation of skin tumors, making 
them the focus of intensive research.77  PKCs are the primary target for tumor-promoting 
phorbol esters although other receptors have been identified.  For example, Munc 13-1, a 
regulator in synaptic function in mammals, is a well-established phorbol ester receptor.78  
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The discovery that PKCs were receptors for phorbol-esters was the initial motivation for 
intense studying of PKCs.79  The cocarcinogenic effect comes from PKCs involvement 
in cell growth and proliferation.  The potency of the response of PKC to phorbol esters is 
due to the high affinity to C1 domains and the inability of phorbol esters to be 
metabolized by the cell like it’s native agonist, DAG, rendering PKC constitutively 
active. 
Challenges associated with structural studies on PKC
To date, there is no mechanistic understanding of PKC activation.  This is largely 
due to the challenges associated with studying PKCs.  The full-length enzyme is ~80 
kDa, large for solution structural studies by NMR and adding in membrane mimetics to 
study the membrane-associated form only increases the effective size and makes 
studying PKC more difficult.  X-ray crystallography has been indispensable in obtaining 
information about the isolated regulatory domains. However, the multi-modular structure 
and dynamic nature of PKC, while essential to function, have prevented attainment of a 
full-length crystal structure.  Only one partial crystal structure of PKC exists.61  In this 
structure of PKC II, the C1A domain is completely missing and although Ca2+ is bound 
to the C2 domain, the kinase is in an inactive conformation, indicating that the 
conformation represents an intermediate along the activation pathway.  In particular, the 
peripheral membrane binding domains of the regulatory region present challenges in 
obtaining concentrations high enough for biophysical studies.  C1A domains are 
notoriously insoluble and have a propensity to aggregate.80,81  A common approach in 
studying PKC isozymes is to express C1-containing constructs as fusion partners with 
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highly soluble tags such as maltose binding protein (MBP) or glutathione S-transferase 
(GST) and retain the tag after purification.58,81,82  However, large tags can influence the 
native conformation and behavior of the protein of interest and these tags often add a 
considerable amount of molecular weight to the constructs.  This approach is not viable 
for structural studies by NMR due to the increase in the molecular tumbling time and the 
line broadening that occurs as a result. 83  The work presented in this thesis is largely 
aimed at overcoming these challenges to gain insight into the structure and function of 
the regulatory region during different steps of the activation process.        
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CHAPTER II 
EXPRESSION AND PURIFICATION OF THE N-TERMINAL REGULATORY 
DOMAIN OF PROTEIN KINASE C FOR BIOPHYSICAL STUDIES*
Background
This chapter details efforts towards obtaining full-length PKC regulatory region 
constructs suitable for biophysical studies.  Given the pivotal role of PKCs in signal 
transduction and human disease, significant efforts have been directed at altering their 
activity in therapeutically productive ways (reviewed in 84).  Structural information is 
needed for this but has eluded scientists for decades.
The hallmark of PKC activation is their translocation to lipid membranes in 
response to second messengers that are generated in the upstream signaling event.  
Conventional PKC isozymes (, I, II, and ) translocate to membranes in response to 
both diacylglycerol (DAG) and Ca2+, while novel PKC isozymes (, , , and ) respond 
to DAG only.  The membrane-binding functionality of conventional and novel PKCs 
resides on their N-terminal regulatory region that has a multi-modular structure.  This 
region contains tandem C1 domains, C1A and C1B, which target PKCs to DAG-
containing membranes.  Another membrane-targeting domain of conventional PKCs, 
C2, binds anionic phospholipids – with high specificity towards phosphatidylserine – in 
* Reprinted with permission from Cole, T.R., and Igumenova, T.I. (2015) Expression and 
purification of the N-terminal regulatory domain of Protein Kinase C for biophysical studies, 
Protein Expr Purif 110, 14-21. doi: 10.1016/j.pep.2014.12.018.
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a Ca2+-dependent manner.  In novel PKC isozymes, the C2-like domains lack the 
residues required for Ca2+/membrane association and serve as protein interaction 
modules.85,86  All C1 and C2 domains are independently folded protein modules that 
preserve their functional properties when expressed in the isolated form.
The membrane-binding step relieves the auto-inhibitory interaction between a short 
pseudosubstrate region (black bars in Figure II.1A) and the active site of the C-terminal 
catalytic domain. 87-90  The structural basis of the membrane association step, which 
includes the rearrangement within the N-terminal regulatory domain followed by 
membrane insertion, remains poorly understood.  The functional autonomy of the N-
terminal region 91-93 makes it an attractive candidate for structural studies of the 
membrane association process, including the domain rearrangement that accompanies 
insertion and the geometry of protein-membrane interactions.
Liquid-state Nuclear Magnetic Resonance (NMR) techniques are ideally suited to 
probe the structure and dynamics of inherently dynamic multi-modular systems, such as 
the N-terminal regulatory region.  An additional advantage of NMR methods is that they 
can provide access to both, solution and membrane-bound states of the N-terminal 
regulatory region, the latter through incorporation of membrane mimics and hydrophobic 
ligands.  The objective of this work was to develop a robust and cost-effective protocol 
that would enable the generation of sufficient protein quantities for future NMR studies.   
Analysis of the existing literature revealed that large-scale preparation of these proteins 
is challenging.  The C1A domain from conventional isozymes, PKCI/II has been 
referred to as “notoriously insoluble”. 80 This finding was subsequently extended to the 
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C1A domain from PKC. 94  Because of the low solubility of C1A domains from  and 
I/II isozymes, they are targeted to inclusion bodies during heterologous over-
expression in E. coli; this requires implementation of purification protocols that include 
a protein-refolding step in the presence of Zn2+. 95  When placed in the context of its 
primary structure neighbors, such as C1B, the C1A domain imposes its unfavorable 
solubility properties on the entire construct. 96
Figure II.1 Regulatory regions purified in this Chapter.  (A) Linear diagram 
illustrating the multi-modular structure of conventional and novel PKC isoforms.  Black 
bar indicates a short pseudo-substrate region.  (B) Schematic view of the purification 
procedures used in this study.  *Reused with proper permission from ref97.
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For the biochemical studies of PKC, fusing the N-terminal regulatory region and 
its individual domains to glutathione S-transferase (GST) and maltose binding protein 
(MBP) results in high expression of soluble proteins and facilitates the purification.  
Moreover, the GST and MBP tags are almost always retained after purification to 
improve the solubility and stability of the proteins. 36,58,81,82  These tags add a 
considerable amount of molecular mass to the target proteins, ≥100 % in the case of ~30 
kDa N-terminal regulatory domains.  This presents challenges for NMR spectroscopy 
because the increase in the rotational diffusion coefficient and number of amino acids in 
the fusion protein diminishes the resolution and signal-to-noise ratios of the spectra.  In 
this chapter, the expression and purification protocols for two N-terminal regulatory 
domain constructs suitable for NMR studies are reported:  C2-C1A-C1B from the novel 
isozyme PKC (C2C1) and the chimeric C1A-(C1B-C2) (C1C2c, where “c” stands 
for conventional PKC isozymes).
Materials and methods
Cloning and site-directed mutagenesis
The cDNA of PKC (R. norvegicus), PKC (M. musculus), and PKC (R. 
norvegicus) was purchased from Open Biosystems/GE Healthcare.  The amino acid 
sequences of PKC from M. musculus and R. norvegicus are identical.  pET-SUMO 
plasmid (Novagen) was used as the expression vector for all PKC constructs.  The 
cloning strategy involved inserting the target gene downstream from SUMO, thereby 
placing the expression of the fusion protein gene under the control of an inducible T7 
promoter.
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The regulatory region, C2C1, comprising residues 1-285 of PKC was cloned 
into pET-SUMO using the In-Fusion PCR Cloning Kit (Clontech), according to the 
manufacturer’s instructions.  The cloning of C1C2c that comprises the C1A domain 
from PKC (residues 27-98) and the C1B-C2 domain from PKC (residues 100-293) 
into pET-SUMO was outsourced to GenScript.  The F83S mutation was introduced into 
C1C2c using a QuikChange® Site-Directed Mutagenesis kit (Stratagene) with the 
appropriate primers.  Using the same procedure, a positively charged amino acid tag, 
G(K)6, was added to the C-terminus of C2C1 to generate the C2C1-G(K)6 variant.  
The sequences of all constructs were verified by DNA sequencing.
Induction and solubility tests
A single colony was picked from a transformation plate of the appropriate PKC 
plasmid and used to inoculate 5 mL of LB broth supplemented with 50 g/mL 
kanamycin.  For the pLysS and Rosetta cell lines, chloramphenicol was added to a final 
concentration of 34 g/mL to maintain the pLysS and pRARE plasmids, respectively.  
Cultures were grown to an OD600=0.6 at 37 °C, followed by incubation at the appropriate 
temperature for 15 minutes and subsequent induction of protein expression with 
isopropyl -D-thiogalactoside (IPTG).  Samples of cell culture were taken pre- and post-
induction.  Cells were harvested at the end of the induction period by centrifugation at 
3,400 g for 10 minutes.  Cell pellets were re-suspended and lysed at room temperature 
with 0.3 mL of B-PER protein extraction reagent (Thermo Scientific).  Soluble and 
insoluble fractions were separated by centrifugation at 13,520 g for 5 minutes.  12% 
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SDS-PAGE was used to assess the amount of total PKC fusion proteins pre- and post-
induction, and the amount of soluble protein after lysis.
Protein expression
RosettaTM 2(DE3)pLysS competent cells (Novagen) were used as the E. coli 
expression strain.  All cell cultures were supplemented with 50 g/mL kanamycin and 
34 g/mL chloramphenicol and grown with shaking at 250 rpm.  For natural abundance 
protein preparations, 5 mL starter cultures in LB broth (Fisher Scientific) were grown at 
37 °C to reach an O.D.600=0.6.  The starter cultures were subsequently transferred to 30 
mL of fresh LB medium and grown to an OD600=0.8-1 at 30 °C.  As a final step, 30 mL 
cultures were transferred to 1 L of fresh LB medium and grown to an OD600=0.4.  The 
temperature was then reduced to 20 °C, to allow 1 L cell cultures to equilibrate at a 
lower temperature and reach O.D.600=0.6.  The expression of fusion protein was induced 
with IPTG at a final concentration of 0.5 mM for 16 hours at 20°C.  Immediately prior to 
induction, 100 M ZnSO4 was added to the growth medium to facilitate the proper 
folding of C1 domains.
For the preparation of 15N-enriched proteins, the 5 mL starter LB cultures were 
spun down and re-suspended in 30 mL of M9 medium containing 1 g/L of ammonium 
chloride (15N, 99 %)(Cambridge Isotopes) and 3 g/L D-glucose (Macron Chemicals) as 
nitrogen and carbon sources, respectively.  The growth medium was supplemented with 
Kao and Michayluk Vitamin Solution (Sigma-Aldrich), 100 M ZnSO4, and 1 g/L of 
ISOGRO-15N Powder-Growth Medium (15N, 98 %)(Sigma-Aldrich).  The cell culture 
growth and induction of protein expression was conducted as described for the natural-
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abundance preparation.  Cells were harvested by centrifugation at 4000 g for 30 min at 4 
°C.  Cell pellets were stored at -20 °C.
Protein purification
Cell pellets were re-suspended in ice-cold lysis buffer containing 20 mM Tris-
HCl at pH 7.5, 10% (w/v) sucrose, 50 M ZnSO4, 5 mM -mercaptoethanol (-ME), 
and 1 M NaCl.  For the C1C2c construct and its F83S variant, 50 M CaCl2 was added 
to stabilize the C2 domain.  The cells were disrupted with a Microfluidizer processor 
(Microfluidics Corporation) pre-packed with ice and equilibrated for 30 minutes.  The 
lysate was clarified by centrifugation at 15,300 g for 30 minutes at 4 °C.
All preparative and analytical chromatography experiments were carried out 
using an ÄKTA FPLC system and appropriate columns (GE Healthcare Life Sciences).  
For IMAC chromatography, the composition of loading/wash Buffer A was 20 mM Tris-
HCl at pH 7.5, 0.5 M NaCl, 5 mM -ME, and 5 mM imidazole.  The composition of 
Buffer B was identical except for the addition of 1 M imidazole.  The SUMO fusion 
protein carrying the N-terminal histidine tag was purified from cell lysate on a 2 x 5 mL 
HisTrap™ HP Ni2+ affinity column, using a 0-50 % gradient of Buffer B over 15 column 
volumes (Figure II.1B).
Fractions containing the fusion protein were pooled, concentrated to 10 mL using 
a 10 kDa cutoff Vivaspin 15R concentrator (VIVAproducts), and diluted 5 times with 
Buffer A to reduce the imidazole concentration.  The SUMO fusion tag was cleaved 
from the target protein using 170 nM histidine-tagged SUMO protease at 25°C in the 
presence of 10 mM -ME.  To follow the progress of the reaction, small-volume aliquots 
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of the reaction mixture were taken at specific times and quenched by mixing with the 
SDS-PAGE loading buffer and subsequent freezing.  The aliquots were run on a 12% 
SDS-PAGE gel to assess the amount of cleaved protein.  Cleavage was > 90% complete 
after 3 hours for all constructs.  The products of the SUMO protease cleavage reaction 
were separated on a 2 x 5 mL HisTrap™ HP Ni2+ affinity column.  The target proteins 
were collected in the flow through, while His-tagged SUMO protease and SUMO were 
retained on the column.  The SDS-PAGE analysis of concentrated C2C1 and its serial 
dilutions showed that the purity of the target protein is > 95%, which is suitable for 
NMR work.  The conventional PKC constructs, C1C2c and its F83S variant, required an 
additional purification step (Figure II.1B).  Gel-filtration chromatography was carried 
out using a HiLoad 16/600 Superdex 200 gel filtration column (GE Healthcare Life 
Sciences), in 20 mM Tris-HCl at pH 7.5, 0.5 M NaCl, 5 mM -ME, and 100 M CaCl2.  
The purity of the C1C2c and its F83S variant was >95%, as determined by the SDS-
PAGE.
Analytical gel-filtration
Analytical gel-filtration was carried out for all PKC constructs using a Superdex 
75 10/300 GL column (GE Healthcare Life Sciences).  The column was calibrated with 
protein standards from the Gel Filtration LMW Calibration Kit (GE Healthcare/Life 
Sciences) according to the manufacturer’s protocol.  100 l of 0.1-0.2 mM protein 
sample was loaded onto the column that was run with a flow rate of 0.5 mL/min.  The 
composition of the gel-filtration buffer for C2C1 was 20 mM Imidazole, 500 mM KCl, 
and 5 mM -ME and 20 mM NaH2PO4, 150 mM L-arginine and L-glutamate, 10 M 
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ZnSO4, and 5 mM -ME for C2C1-G(K)6.  C1C2c and its F83S variant showed strong 
interactions with the gel-filtration resin at low salt concentrations.  A high-salt buffer 
containing 20 mM Tris-HCl at pH 7.5, 0.5 M NaCl, 100 M CaCl2, and 5 mM -ME 
was used for these samples.
Mass-spectrometry
MALDI-TOF experiments were carried out using a Shimadzu/Kratos MALDI-
TOF mass spectrometer in linear mode at the Protein Chemistry Laboratory (Texas 
A&M University).  Samples were concentrated to > 2mg/mL and processed with a 
ZipTip® pipette tip (Millipore) to remove excess salt.  The ZipTip® was washed with 
acetonitrile (ACN) and equilibrated with 0.1% trifluoroacetic acid (TFA).  10 L of 
concentrated sample was bound to the ZipTip® and eluted with a 20 mg/mL solution of 
sinapic acid (Sigma-Aldrich) in 50/50 0.1% TFA/ACN.  The instrument was calibrated 
with either cytochrome c or a mixture of cytochrome c/aldolase, both from Sigma-
Aldrich.
Sample preparation and Nuclear Magnetic Resonance (NMR) experiments
To prepare NMR samples, all proteins were concentrated and buffer exchanged 
using 10 kDa cutoff Vivaspin 15R concentrators (VIVAproducts).  The buffers used 
for NMR experiments are listed in Table II.1.  The experiments were carried out on 
Avance III HD NMR spectrometers (Bruker Biospin) operating at the 1H Larmor 
frequencies of 800 (18.8 Tesla) and 600 MHz (14.1 Tesla).  The 800 and 600 MHz 
systems were equipped with a cryogenically cooled and room temperature probes, 
respectively.  The temperature was calibrated using deuterated (D4, 98%) and protonated 
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methanol samples.  The 15N-1H chemical shift correlation spectra were collected using 
the fHSQC method. 98
Table II-1. NMR buffers used for PKC constructs.  Reprinted with permission from 
ref 97.  
NMR buffer PKC construct pH Composition
N1 C2C1 6.5
20 mM Imidazole (D4, 98%), 500 mM KCl, 70 M ZnSO4, 1 
mM TCEP, 8% D2O, and 0.02% NaN3
N2 C2C1-G(K)6 6.3
20 mM NaH2PO4, 150 mM L-arginine and L-glutamate, 10 M 
ZnSO4, 1 mM TCEP, 8% D2O, and 0.02% NaN3
N3 C1C2c 6.0
10 mM MES, 150 mM KCl, 1 mM TCEP, 8% D2O, and 0.02% 
NaN3
N4 F83S C1C2c 7.0
1 M glycine (D5, 98%), 2 mM CaCl2, 1 mM TCEP, 8% D2O, 
and 0.02% NaN3
Results
Construction of chimeric protein enables expression of the tag-free soluble N-terminal 
regulatory region from conventional PKC
In conventional PKC isoenzymes the C1A domain is the least soluble of the three 
peripheral membrane modules that comprise the N-terminal regulatory region.  
Inspection of the primary structures reveals an unusually high content of Phe residues – 
10, or 20%, in the 50-residue folded core of C1A domain from  (C1A) and I/II 
(C1A) isoenzymes.  Recently, the structure of C1A from human PKC (C1A, PDB ID: 
2E73, identical to the R. norvegicus C1A) was determined using solution NMR 
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methods by the RIKEN Structural Genomics/Proteomics Initiative in Japan (Figure II.2 
A).  Although the experimental protocol has not been published, the header of the PDB 
file indicates that the isotopically enriched protein was generated using cell-free 
synthesis rather than heterologous expression in E. coli.  Comparison of the primary 
structures of C1A and C1A shows that only 6 amino acid residues are different in the 
domain core (Figure II.2B).  Based on these data, it was concluded that the construction 
of chimeric proteins is a viable approach to overcome the detrimental effect of C1A on 
the expression and solubility behavior of the N-terminal regulatory region from 
conventional isoenzymes.  In this work, the expression and purification of the chimeric 
C1C2c, which is a fusion of C1A with the (C1B-C2), and its F83S variant (Figure 
II.1A) that has superior solubility properties is reported.  The N-terminal regulatory 
region of PKC, C2C1, was cloned “as is”.  SUMO was chosen as a fusion partner for 
all PKC constructs because of the high expression yields of fusion proteins and the 
specificity of the SUMO protease cleavage reaction.
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Figure II.2  The C1A domain from PKC has a high sequence identity to C1A.  
(A) NMR structure of C1A from H. sapiens (PDB ID: 2E73).  The first structure of the 
ensemble is shown.  Diacylglycerol and phorbol esters bind in the cleft formed by the 
two ligand-binding loops.  There are two structural Zn2+ that stabilize the structure.  (B) 
Alignment of the C1A primary structures from  and  PKC isoenzymes from R. 
norvegicus.  Zn2+-coordinating residues and residues that are different between the 
isoenzymes are highlighted with yellow and gray, respectively.
 
Expression of soluble N-terminal regulatory region is exquisitely sensitive to 
experimental conditions
Expression and lysis of C1C2c required optimization of several parameters, as 
only a very narrow set of conditions yielded soluble protein in sufficient quantities for 
NMR work.  These parameters include the expression cell line, Zn2+ supplementation of 
the growth medium, temperature of induction, and cell disruption method.
The induction and solubility tests were conducted at 4 temperatures: 37 °C (4 hours), 30 
°C (6 hours), 24 °C (16 hours), and 15 °C (16 hours) in the following 5 cell lines: 
BL21(DE3), BL21 (DE3)pLysS, RosettaTM, RosettaTM (DE3)pLysS, and RosettaTM 
2(DE3)pLysS.  In previous experiments with isolated C1A, it was found that 
supplementation of growth medium with Zn2+ was essential for maximizing the amount 
of soluble protein.  Therefore, the concentration of ZnSO4 was varied in the range from 
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10 to 1000 M using a set of small-volume LB cell cultures expressing C1A.  While the 
overall induction levels remained approximately the same, even small amounts of Zn2+ 
resulted in significant increase of the soluble protein yield. The intermediate value of 
100 M Zn2+ was chosen for inducing the expression of both isolated C1A and the N-
terminal regulatory domains.  The appropriately buffered solution of ZnSO4 was added 
to the growth medium immediately prior to induction.
The expression level of SUMO-C1C2c fusion protein was high at 37°C for all 
cell lines, but most of the protein was insoluble.  Induction tests at 15 °C resulted in very 
low overall expression.  At intermediate temperatures, only pLysS strains produced 
significant amounts of soluble fusion protein, approximately 50% of the total at 30 °C 
and 80-90% of the total at 24°C.  The optimum temperature range for a balance between 
expression and solubility was determined to be 20-24°C.  Ultimately, the RosettaTM 
2(DE3)pLysS cell line was chosen for further experiments because of its slightly higher 
levels of protein expression compared to other pLysS strains.
While B-PER lysis reagent worked well for the small-scale C1C2c tests, upon 
scaling up to larger cell cultures, cell disruption with a Microfluidizer processor led to 
higher yields of soluble protein.  B-PER was effective in lysing the cells expressing 
C2C1, but the protein began to precipitate out of solution within 10 minutes after lysis.  
Therefore, the Microfluidizer processor was used to disrupt cells expressing all PKC 
constructs.
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Tag-free C1C2c and C2C1 can be obtained with moderate-to-high yields
The SDS-PAGE gels illustrating the expression and purification for the 
conventional and novel PKC constructs are shown in Figures II.3A and II.3B, 
respectively.  The corresponding SUMO fusion proteins were highly soluble illustrating 
the applicability of the SUMO system 99 to the expression of regulatory regions from 
PKCs.  The highly specific SUMO protease cleavage reaction proceeded to completion 
in a matter of hours.  The yields from the protein preparations that were carried out in 
this study are summarized in Table II.2.  For the C2C1 variants, 17-18 mg of > 95% 
pure protein were obtained per 1 liter of LB broth.  For the C1C2c variants, the yields 
were ~3-4-fold lower at 5-6 mg of > 95% pure protein per 1 liter of LB broth.
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Figure II.3  Regulatory region preparations are mono-disperse.  SDS-PAGE gels 
illustrating expression and purification of (A) C1C2c and (B) C2C1.  The gel labels 
correspond to: (1) induced cells; (2) cell lysate; (3) supernatant; (4) pellet; (5) flow-
through of the first Ni2+ affinity column; (6-9) eluted fusion proteins; (10) molecular 
weight marker (five bottom bands are: 6.5, 14.4, 21.5, 31, and 45 kDa); (11) SUMO 
protease cleavage reaction; (12) elution from the gel-filtration column (A) and flow-
through of the second Ni2+ affinity column (B); and (13) concentrated protein sample to 
show purity.  (C)  Elution profiles of four PKC constructs that illustrate mono-dispersity 
of the samples.  Inset: calibration of the analytical Superdex 75 10/300 column using 
standard proteins: APR, aprotinin, 6.5 kDa; R, ribonuclease A, 13.7 kDa; CA, carbonic 
anhydrase, 29.0 kDa; and C, conalbumin, 75.0 kDa.  Reprinted with permission from ref 
97.  
For all constructs, milligram quantities of soluble proteins that are free of bulky 
solubility tags were obtained.
Preparation of samples for NMR studies
NMR experiments typically require milligram quantities of isotopically enriched 
proteins that are soluble to > 100 M.  The isotope enrichment is usually carried out in 
the M9 minimal medium, where the 15N-enriched ammonium chloride and 13C-enriched 
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D-glucose serve as sole nitrogen and carbon sources, respectively.  However, the 
maximum attainable cell mass and protein expression yields are lower in M9 compared 
to the rich medium such as LB broth.  This problem can be alleviated by re-suspension 
of LB-grown cultures at high cell densities in M9 with subsequent induction of 
expression100; the use of algal lysate-derived complex labeling medium such as 
ISOGRO (Sigma-Aldrich) or BioExpress 1000 (Cambridge Isotope Laboratories); 
and the supplementation of M9 medium with either ISOGRO or BioExpress 1000.  
For the preparation of uniformly 15N-enriched N-terminal regulatory regions of PKCs, it 
was found that 10% (w/v) supplementation of M9 with ISOGRO resulted in the final 
cell mass and protein yields that are comparable to those obtained in LB broth (Table II-
2).  This provides a cost-effective method to produce isotopically enriched domains of 
PKC.
Protein aggregation is problematic for biophysical studies in general and NMR in 
particular.  To assess the oligomerization state of the PKC samples, analytical gel 
filtration experiments were conducted using a size-exclusion column with a fractionation 
range between 3 and 60 kDa (Figure II.3C).  The concentration of analyzed samples was 
between 100 and 200 M, which are within the range suitable for NMR spectroscopy.  
All protein species eluted in a single peak, indicating the mono-dispersity of the samples.  
The calibration of the gel-filtration column with globular protein standards enabled 
evaluation of the apparent molecular mass of the PKC constructs, which was similar to 
the theoretical values for the C2C1 variants.  However, C1C2c and its F83S variant 
have larger than expected retention volumes with apparent molecular masses of 15.8 
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kDa and 19.7 kDa, respectively.  This behavior can be attributed to the interactions of 
proteins with the column matrix.  Consistent with this, the elution volume increased even 
further upon omitting salt in the running buffer and substituting with 1 M glycine.  
Given the propensity of the PKC regulatory domain to interact with the column matrix, 
definitive information about their Stokes radii will have to await detailed biophysical 
studies.
Table II-2. Properties of N-terminal PKC constructs. Reprinted with permission from 
ref 97.  
PKC construct pI
Mol. mass 
(calc., Da)
Mol. mass 
(exp., Da)
Yield,
mg/(1L of LB)
Yield,
mg/(1L of M9)
C2C1 8.9 32,664 32,725 17-18 18
[U-15N] C2C1-GK6 9.2 33,902 33,888 17-18 18
C1C2c F83S 8.8 30,517 30,547 5-6 4
C1C2c 8.8 30,577 30,595 5-6 4
C1C2c: improvement of solubility and stability
Proper folding of the PKC N-terminal regulatory regions was evaluated using 
NMR spectroscopy.  The 15N-1H chemical shift correlation spectra of [U-15N] C1C2c 
contained regions with poor chemical shift dispersion that may indicate partial 
misfolding of the protein (Figure II.4A).  A comparison of the C1C2c NMR spectra with 
that of a well-behaved C1B-C2 construct revealed that the C1A domain is the likely 
“problem site” of this three-domain protein.  In previous work on isolated C1A 
(unpublished), it was found that addition of glycine, a naturally occurring osmolyte 101, 
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stabilizes the domain and results in well-dispersed NMR spectra.  It was previously 
shown that addition of up to 2 M glycine enhances protein folding and stability, without 
significant perturbations to the native fold and function.102  Therefore it was incorporated 
at 1 M into the NMR buffer N4 (Table II-1).
To further improve the solubility properties of the C1C2c construct, the 
differences between the C1A domains and highly soluble C1B domains from 
conventional PKC isoforms were investigated.  The main difference is the phenylalanine 
content, a total of 8-10 in C1A and only 2 in C1B.  A surface-exposed phenylalanine at 
position 83 (Figure II.2), which is close to the linker region and away from the ligand-
binding loops, is a conserved serine in C1B domains.  To decrease the hydrophobicity of 
the C1A domain in C1C2c, this phenylalanine at position 83 was mutated to a serine.  
Because this residue is not a part of any secondary structure element and is not involved 
in ligand/membrane interactions in homologous C1 domains103,104, its mutation to a 
hydrophilic residue is unlikely to affect the fold of C1A.  A combination of 1 M glycine 
and the F83S mutation significantly improved the quality of NMR spectra (Figure 
II.4B), as evidenced by the number of cross-peaks and their dispersion.  The 1H cross-
sections taken at the 15N chemical shifts of 116.4 ppm (C1C2c) and 116.2 ppm (F83S) 
illustrate the differences in signal intensity and the number of cross-peaks between the 
two spectra.  The data were scaled to account for the differences in protein 
concentration, receiver gain, and the number of points in the direct and indirect 
dimensions.  While the exact quantitative comparison is not feasible due to a rather 
drastic change in protein state and buffer conditions, the improvement of data quality 
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due to the F83S mutation and glycine are evident.  The use of glycine also enabled 
acquiring data at an increased sample temperature of 35 °C.  Higher temperatures are 
beneficial for protein NMR experiments due to the reduction of the rotational correlation 
time of the molecule with the concomitant reduction in the line-widths.
An overlay of the F83S C1C2c NMR spectrum with those of the individual 
components, C1B-C2 and C1A, shows the general similarity of the chemical shift 
patterns (Figure II.5).  This indicates that individual domains are properly folded in the 
full-length construct of the regulatory domain.
C2C1: improvement of solubility
Compared to the C1C2c variants, C2C1 has more favorable solubility properties 
albeit under high salt conditions,  0.5 M.  The 15N-1H chemical shift correlation 
spectrum of C2C1 in high-salt buffer N1 (Table II-1), collected using the room-
temperature NMR probe showed good chemical shift dispersion indicative of a fully 
folded protein (Figure II.4C).  However, to take full advantage of the sensitivity 
enhancement afforded by the cryogenically cooled NMR probes, the concentration of 
salt in the sample needed to be reduced.
For this, two strategies were implemented: introduction of a solubility 
enhancement peptide (SEP) tag and incorporation of osmolytes in the NMR buffer.  SEP 
tags comprising short stretches of either negatively105 or positively106 charged amino 
acids were shown to improve protein solubility.  Taking into consideration the “basic” 
isoelectric point of C2C1, the C2C1-G(K)6 construct was generated by adding six 
lysines to the C-terminus.  The effect of glycine on the solubility of C1C2-G(K)6 was 
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investigated.  Addition of  0.5 M glycine to the NMR buffer resulted in protein 
precipitation.  In contrast, a buffer additive comprising a mixture of 150 mM L-
glutamate and L-arginine enabled the reduction of the salt concentration to 150 mM 
NaCl (Table II.1, buffer N2), while maintaining the protein concentration at 0.2 mM for 
NMR measurements.  To prepare the NMR sample, buffer N2 was added to the protein 
sample under dilute conditions and not directly to the concentrated sample, as prescribed 
by Golovanov et al. 107  This step was crucial to achieving the maximum benefits 
afforded by the Arg/Glu mixture.  However, both the Arg/Glu osmolytes as well as the 
SEP were needed to improve the behavior of the  regulatory region.  A combination of 
SEP with L-arginine/L-glutamate and moderate concentrations of salt enabled 
acquisition of a high-quality 800 MHz NMR spectrum with a cryogenically cooled probe 
(Figure II.4D). 
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Figure II.4  Use of osmolytes, SEP, and targeted mutations improves the quality of 
NMR spectra of N-terminal regulatory regions of PKCs.  15N-1H HSQC spectra of 
(A) C1C2c in buffer N3, 25°C, 18.8 Tesla; (B) F83S C1C2c in buffer N4, 35°C, 18.8 
Tesla; (C) C2C1 in buffer N1, 25°C, 14.1 Tesla; (D) C1C2-G(K)6 in buffer N2, 25°C, 
18.8 Tesla.  The buffer compositions are given in Table II.1.  The 1D 1H cross-sections 
were taken at the 15N chemical shift positions indicated with dashed lines.  The chosen 
cross-sections go through at least one cross peak whose (1H, 15N) position is similar in 
the pair of spectra being compared. Reprinted with permission from ref 97.  
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Figure II.5  Individual domain resonances are present in the 15N-1H HSQC 
spectrum of F83S C1C2c.  This is demonstrated by its overlays with the spectra of 
C1A (A) and (B) C1BC2.  The data for individual domains were collected under 
buffer conditions that matched those of F83S C1C2c (Tables II-1 and II-2), except that 
the C1A spectrum was collected at 25° C. Reprinted with permission from ref 97.  
Conclusion 
This chapter describes the expression, purification, and NMR characterization of 
the N-terminal regulatory regions from PKC isozymes.  Challenges associated with 
purification of these regions were overcome by optimization of expression, purification, 
and buffer conditions as well as carefully designed modifications to the regions.  
Although the modifications are not expected to interfere with function, future work is 
needed to determine the effect of these mutations.  These represent the first fusion-
partner-free full-length regulatory domains of PKC to be purified in sufficient quantities 
for structural and biophysical studies.  The successful purification of these proteins will 
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enable scientists to gain insight into the tertiary structure of the regulatory domains and 
evaluate the structural changes that they undergo upon association with membranes.  The 
NMR spectra of the N-terminal regulatory regions are indicative of fully folded protein 
species.  It is worth noting that the quality of the NMR spectra can be improved even 
further by using deuteration and implementation of transverse-relaxation optimized 
NMR techniques. 
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CHAPTER III 
OPPORTUNISTIC CD(II) AND PB(II) BINDING TRIGGERS THE SELF-
ASSOCIATION OF PERIPHERAL MEMBRANE BINDING DOMAINS FROM 
PROTEIN KINASE C†
Background
This chapter describes the structural and functional consequences of the exposure 
of the PKC regulatory region to xenobiotic metal ions, Cd(II) and Pb(II).  Cd(II) and 
Pb(II) are potent environmental toxins that have elevated levels in the environment due 
to human activity.  Cd(II) is a known carcinogen, with its chronic exposure leading to 
kidney damage66-69 and lead has adverse effects on all organs in the body and is 
associated with long-term effects on the ability to learn in children.65,70  These 
deleterious effects are compounded by the relatively long half-lives of both metals in the 
human body. 66,108,109  Despite this, the molecular mechanisms of toxicity remain poorly 
understood, although it is well documented that divalent Pb2+ and Cd2+ can mimic native 
metal ions in the cell.  For example, Cd2+ and Pb2+ ions have been shown to replace Ca2+ 
in many different proteins with various structural and functional consequences.  In 
studies with calmodulin, Pb2+ was as effective as Ca2+ in binding and activation while 
Cd2+ was much less potent. 110,111  In contrast,  while Pb2+ was able to bind with higher 
† Portions of this chapter are adapted with permission from Cole, T.R., Erickson, S.G., et al. 
(2019) Cd(II)- and Pb(II)-Induced Self-Assembly of Peripheral Membrane Domains from 
Protein Kinase C, Biochemistry 58, 509-513. Copyright 2019 American Chemical Society.
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affinity than Ca2+ and drive phospholipid association of Synaptotagmin I (Syt I), it was 
unable to support interactions with its binding partner, Syntaxin. 112
Toxic metal ions can also target Zn-finger proteins resulting in diverging impacts 
on structure and function. 113-115  Due to the high affinity of Cd2+ for thiol groups, it 
readily replaces Zn2+ in structural Zn-sites.  While in most systems Cd2+ supports the 
global fold, it does not always preserve the function of Zn-finger containing proteins114 
and due to the larger ionic radius, has been shown to cause reorientation of secondary 
structural elements and side chains. 116  Pb2+ also has high affinity for cysteine residues 
in structural Zn2+ sites but in most cases cannot support the fold or function.117 The 
diversity of protein-responses to non-essential metal ions highlights the need for system 
specific studies on their molecular targets.
Protein Kinase C is a well-documented target of both Pb2+ and Cd2+. 118-120 While 
it has been shown that Pb2+ and Cd2+ can have both activating and inhibitory effects on 
PKCs17,18,118,121, the molecular details are not well understood.   
PKCs have a multi-modular structure with a conserved kinase domain and 
membrane-binding regulatory domain.  The key step in PKC activation is translocation 
of the regulatory domains to anionic membranes upon sensing its ligands, Ca2+ and 
diacylglycerol embedded in the membrane.  This region of PKC relies on divalent metal 
ions, Zn2+ and Ca2+ for structure and function of the regulatory domain122,123 and 
previous studies have shown that the regulatory domain of protein kinase C  is targeted 
by toxic metal ions such as Pb2+ and Cd2+. 17,120,124-126 The objective of this chapter is to 
illustrate the effect of toxic metal ions Pb2+ and Cd2+ on the structure and function of the 
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membrane-binding regulatory region of PKC and investigate their ability to replace Zn2+ 
and Ca2+.  
Efforts were focused on a regulatory domain construct from PKC, consisting of 
two, independently folded and functionally autonomous peripheral membrane-binding 
domains, C1B and C2 (Figure III.1).  These domains represent the minimal machinery of 
the PKC region needed to bind both lipid and metal ligands and fully activate the 
parent enzyme.  The conventional, full-length regulatory region construct from Chapter 
II was used to ensure that the behavior of C1B-C2 is a faithful representation of the 
behavior of the full-region.  The structure and function of this region relies on divalent 
metal ions.  C1A and C1B both require two structural Zn2+ ions, each with a Cys(3)His 
coordination sphere to properly fold and bind diacylglycerol embedded in the 
membrane.  The C2 domain binds up to three Ca2+ ions and interacts with anionic lipids.  
An understanding of how metal ions affect this region is needed to understand the 
mechanism of toxicity.  In addition, C1 and C2 motifs are the basic building blocks of 
many proteins in the cell and the knowledge gained from this study can be applied to 
other C1 and C2 containing proteins, leading to a more complete understanding of heavy 
metal toxicity. 127-129
42
Figure III.1 Modular structure and peripheral domains of conventional PKC 
isoenzymes. Shown is the linear diagram of conventional PKCs (A) and ribbon 
representation of C1B (NMR structure, 2ELI) with highlighted structural Zn2+ sites, and 
C2 (crystal structure, 1DSY) in complex with Ca2+ and phosphatidylserine analogue, 
PSF (B). DAG stands for diacylglycerol.
Using solution nuclear magnetic resonance (NMR) spectroscopy, it is shown that 
Cd2+, but not Pb2+ is able to spontaneously replace Zn2+ in the C1B domain.  
Additionally, it is demonstrated that opportunistic binding of Cd2+ and Pb2+ leads to the 
self-association of C1B-C2 which has a profound impact on its membrane binding 
functionality.  This work indicates that ionic mimicry is insufficient to explain the 
interactions of Pb2+ and Cd2+ with PKC and demonstrates the potential diversity of 
responses of signaling proteins to toxic metal ions.
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Methods
Buffer and metal ion solutions
For the majority of experiments reported in this work, “MES buffer” was used 
and prepared in HPLC-grade water (Avantor) and comprising 10 mM 2-(N-
morpholino)ethanesulfonic acid (MES) at pH 6.0, 150 mM KCl, and 1 mM tris(2-
carboxyethyl)phosphine (TCEP).  The pH was chosen to minimize (i) the formation of 
Pb(II) hydroxides that becomes prominent at higher pH values; and (ii) the broadening 
of amide hydrogen cross-peaks in the NMR spectra due to exchange with water.  In 
addition, several Cd2+ experiments were conducted in the “HEPES buffer” comprising 
10 mM HEPES at pH 7.4, 100 mM KCl, and 1 mM TCEP.  The buffer solutions were 
passed through the Chelex 100 (Sigma-Aldrich) column to remove residual divalent 
metal ions.  The stock solutions of metal ions were prepared by dissolving either 
Cd(NO3)2·4H2O (>99% purity, Sigma-Aldrich) in the appropriate buffer or 
Pb(CH3CO2)2·3H2O (99.999% purity, Sigma-Aldrich) in the HPLC-grade water.
Protein purification  
The DNA sequence encoding residues 100-293 of PKC (M. musculus) was 
amplified by PCR using the cDNA clone of PKC (Open Biosystems) as a template and 
cloned into the pET-SUMO vector (Invitrogen).  Protein expression was carried out in E. 
coli BL21(DE3) cells.  Cell cultures were grown to an OD600 of 0.6 and induced with 
0.5 mM Isopropyl β-D-1-thiogalactopyranoside (FisherBioreagents) for 16 hours at 15 
°C, with 10 M ZnCl2 added to the growth medium prior to induction.  For the 
preparation of 15N-enriched proteins, 5 mL starter LB cultures were spun down and re-
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suspended in 1 L of M9 medium containing 1 g/L of ammonium chloride (15N, 99%) 
(Cambridge Isotopes) and 3 g/L d-glucose (Macron Chemicals) as nitrogen and carbon 
sources, respectively.  The growth medium was supplemented with Kao and Michayluk 
Vitamin Solution (Sigma–Aldrich), 100 μM ZnSO4, and 1 g/L of ISOGRO®-15N 
Powder-Growth Medium (15N, 98%) (Sigma–Aldrich).  The cell culture growth and 
induction of protein expression were conducted as described for the natural-abundance 
preparation.  The re-suspension method of Marley et al130 was used to generate [U-
13C,15N, 55%-2H] C1B-C2 sample for resonance assignment experiments.  Cells were 
harvested by centrifugation at 4,000 g for 30 min at 4 °C and stored at −20 °C.  Cell 
pellets were re-suspended in B-PER™ Bacterial Protein Extraction Reagent (Thermo-
Fisher Scientific) supplemented with Halt™ Protease Inhibitor Cocktail (Thermo-Fisher 
Scientific) and 0.25 mg/mL lysozyme.  The lysate was clarified by centrifugation at 
15,300 g for 30 min at 4 °C.  The histidine-tagged SUMO-C1B-C2 fusion protein was 
purified using a HisTrapTM HP Ni2+ affinity column (GE Healthcare Life Sciences).  
Fractions containing fusion protein were desalted on a HiPrep 26/10 column (GE 
Healthcare Life Sciences).  C1B-C2 was obtained by cleaving the fusion protein for 1 
hour with histidine-tagged SUMO protease at room temperature, followed by another 
Ni2+ affinity purification step to remove the histidine-tagged SUMO and SUMO 
protease.  The final purification step was cation-exchange chromatography on a Source 
15S column (GE Healthcare Life Sciences), carried out in 10 mM 2-(N-
morpholino)ethanesulfonic acid (MES) buffer at pH 6.5, 0.1 mM CaCl2, and 1 mM 
tris(2-carboxyethyl)phosphine (TCEP) with a linear concentration gradient of NaCl.  The 
45
purity of C1B-C2 was evaluated using SDS-PAGE.  The molecular weight was verified 
by MALDI-TOF mass spectrometry.  Fractions containing C1B-C2 were transferred to a 
10 kDa VivaSpin 15R spin concentrator (Sartorius) where C1B-C2 decalcification was 
carried out.  A total of 3 washes with 10 M EGTA containing buffer (10 mM MES pH 
6.0, 150 mM KCl, 1 mM TCEP, and 10 M EGTA), followed by 3 washes into the final, 
EGTA-free buffer.  C1B-C2 variants were generated either using the QuikChange 
(Agilent) or Q5 (NEB) mutagenesis kits.  Full regulatory region of PKC (C1C2c, 
comprising C1A/C1B/C2 domains harboring the F83S stabilizing mutation) and 
isolated C1B and C2 were expressed and purified as described previously97,103,126 and as 
described in Chapter II.
Analytical gel-filtration 
Superdex 75 10/300 GL column (GE Healthcare Life Sciences) and Superdex 
200 Increase 10/300 GL column were calibrated with protein standards from the Gel 
Filtration LMW Calibration Kit (GE Healthcare/Life Sciences), supplemented with 
alcohol dehydrogenase and apo ferritin (Sigma-Aldrich) for the Superdex 200 
calibration.  150-200 M C1B-C2 samples were dialyzed overnight against the Cd2+-
containing MES or HEPES buffers to ensure removal of displaced Zn2+.  Pb2+/C1B-C2 
samples were prepared by adding up to 2 mM Pb(Ac)2 from a concentrated stock 
solution to 0.3 mM [U-15N] C1B-C2 and diluting the sample to 150 M just prior to 
injection.  The gel-filtration buffers were supplemented with 2% glycerol to prevent non-
specific interactions with the column, and either 1 mM Cd2+, 1 mM Ca2+, or 0.5 mM 
Pb2+.  Typically, 100 l of 100-150 M protein sample was loaded onto the column that 
46
was run with a flow rate of 0.5 mL/min; proteins were eluted with 1.5 column volumes 
of buffer.
UV-vis spectroscopy
UV-vis spectra were collected on a Beckman DU 640 spectrophotometer. 25 M 
protein (C1B-C2, C2, or C1B) solution or “MES buffer” (for metal ion-only reference 
experiments) were placed in the sample cuvette; the reference cuvette always contained 
metal ion-free MES buffer.  Pb2+ or Cd2+ were added stepwise from the corresponding 
stock solutions to the sample cuvette.  The samples were incubated for 5 minutes prior to 
the start of the measurements for Pb2+ experiments and 1 hour for Cd2+ experiments.  
The post-acquisition processing included the subtraction of the spectra of free Pb2+ and 
Cd2+ from the spectra of protein-containing samples.  The difference spectra were 
obtained by subtracting the spectrum of the apo protein from the spectra of the metal ion 
containing protein.  All spectra were corrected for dilution prior to subtraction.
C1B refolding
[U-15N]-enriched C1B was dissolved in 6 M guanidine hydrochloride (Acros 
Organics) and the “refolding buffer” comprising 20 mM MES at pH 6.0 and 1 mM 
TCEP.  The final protein concentration was between 15 M and 35 M during the 
denaturation step.  The refolding was conducted in three dialysis steps, all of them 
carried out in the refolding buffer: (1) against 8 M urea at room temperature, for 8 hours; 
(2) against 1.5 M urea and 100 M of either Cd(II) nitrate or Pb(II) acetate at 4 °C, 
overnight; and (3) against urea-free buffer at 4 °C, for 3 days to ensure complete 
removal of all urea.  The refolded protein was concentrated in a spin concentrator with a 
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3 kDa cutoff and subsequently exchanged into an NMR buffer (10 mM MES pH 6.0, 
150 mM KCl, 1 mM TCEP, 0.02% NaN3, and 8% D2O (Cambridge Isotopes)) using a 
Midi-Trap G25 desalting column (GE Healthcare).  Successful refolding of the protein 
was achieved in the presence of Cd2+ only.
NMR spectroscopy  
All proteins were concentrated and buffer exchanged using 10 kDa (C1B-C2), 3 
kDa (C1B) and 5 kDa (C2) cutoff Vivaspin 15R concentrators into an MES buffer 
containing 0.02% (w/v) NaN3, and 8% (v/v) D2O.  The experiments were carried out on 
Avance III HD NMR spectrometers (Bruker Biospin), operating at the 1H Larmor 
frequencies of 800 (18.8 Tesla) and 600 MHz (14.1 Tesla) equipped with cryogenically 
cooled probes, and 500 MHz (11.7 Tesla) equipped with a room temperature probe.  The 
temperature was calibrated using deuterated (D4, 98%) methanol for cryogenically 
cooled probes and protonated methanol for the room temperature probe.  Spectra were 
processed using nmrPipe.131 The cross-peak intensities were obtained using Sparky.132  
Sequence-specific assignments of the 1H and 15N resonances for apo C1BC2 were 
obtained using 2H-decoupled 3D HN(CA)CB, HNCA(CB), HN(COCA)CB, and 
HN(CO)CA133 experiments on a [U-13C,15N; 55%-2H] C1B-C2 sample.  Assignments for 
Cd2+-substituted C1B (C1BCd) were transferred from the native Zn2+-containing protein 
(C1BZn) and verified using 3D CBCA(CO)NH and HNCACB134 spectra collected at 14.1 
Tesla.  Assignments for Cd2+-bound C1B-C2 were transferred from the isolated C1B and 
C2124 domains.  Chemical shift perturbations  between Cd2+-free and Cd2+-containing 
C1B-C2 were calculated according to the following equation:
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Equation 1
  H2  (0.152N )2
where ΔδH and ΔδN are residue-specific 1HN and 15N chemical shift differences.
For NMR-detected binding experiments, the C1B ligand phorbol-12,13-dibutyrate 
(PDBu, Sigma-Aldrich) was dissolved in [2H6] DMSO (Cambridge Isotopes) and added 
to the sample containing 94 M of [U-15N] enriched C1BCd in the presence of 10 mM 
mixed micelles.  Mixed micelles comprising [2H38] dodecylphosphocholine, (DPC, 
Cambridge Isotopes) and 2-dihexanoyl-sn-glycero-3-[phospho-l-serine] (DPS, Avanti 
Polar Lipids) at a molar ratio of 7 to 3 were prepared as previously described.103  The 
final concentration of PDBu in the NMR sample was 100 M.
Small-angle X-ray scattering (SAXS) data collection
 SAXS experiments were conducted on the SIBYLS135 beamline at the Advanced 
Light Source synchrotron at the Lawrence Berkeley National Laboratory.  Full 
regulatory region of PKC (C1C2c97, comprising C1A-C1B-C2 domains) and C1B-C2 
were concentrated and dialyzed against the appropriate metal-ion containing buffer 
(Table III-1) for 48 hours.  24 L of protein solution at three different concentrations (1, 
2.5, and 4.5 mg/mL) was placed in a 96-well plate (Axygen).  SAXS data were collected 
continuously with q ranging from 0.013 to 0.328 with exposures of 0.5, 1, 2, and 5 s.  
Buffer blanks were performed both before and after each sample exposure and 
subtracted from the sample signal for each condition tested.  Data analysis was carried 
out using ScÅtter.
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Small Angle X-ray Scattering (SAXS) measurements: buffer conditions and data analysis 
procedures
The scattering curves I(q) were examined for signatures of aggregation, 
concentration dependence, and radiation damage.  Data sets that were free from radiation 
damage and concentration dependence were merged using the software package ScÅtter.  
For conditions that had greater than 5 data sets that could be merged the median value 
was taken to avoid bias from outliers.  Conditions with less than 5 data sets that could be 
merged were averaged.  The pair-distance distribution function, P(r); the “real space” 
radius of gyration, Rg; and maximum particle dimension, Dmax, were obtained from I(q) 
using Indirect Fourier transform, as implemented in ScÅtter.  The molecular mass for 
each sample was estimated using the method of Rambo and Tainer.136  For the analysis 
of protein flexibility and shape, the dimensionless Kratky plots, (qRg)2I(q)/I(0) versus 
(qRg), were constructed as described by Durand et al.137
In contrast to the data obtained on the full-length regulatory region C1C2c (see 
Table III-1), the Pb2+/C1B-C2 data were not useable for quantitative analysis because of 
aggregation and severe signs of inter-particle interference.  It is assumed that that the 
SAXS experiments on the Pb2+-containing sample of C1C2c were successful because 
glycine was used as a buffer.  1 M glycine serves not only as an osmolyte that is required 
to stabilize the C1C2c structure,97 but also as a ligand that can sequester excess Pb2+ 138 
and thereby prevent the formation of high-molecular-weight aggregates.
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Table III-1. Sample conditions for SAXS experiments.
Metal ion/protein pH Buffer Components Merged data sets/method
Ca2+/C1B-C2 6.0 10 mM MES, 150 mM KCl, 1 mM TCEP, 
2% glycerol, 0.02 % NaN3, 2 mM CaCl2
4.5 mg/mL; exposure 0.5 and 1 s;
2.5 mg/mL; exposure 0.5, 1, and 2 s;
1.0 mg/mL; exposure 2 and 5 s;
median
Cd2+/C1B-C2 6.0 10 mM MES, 150 mM KCl, 1 mM TCEP, 
2% glycerol, 0.02% NaN3, 1 mM 
Cd(NO3)2
4.5 mg/mL; exposure 0.5 and 1 s;
2.5 mg/mL; exposure 0.5, 1, and 2 s;
median
Pb2+/C1B-C2 6.0 10 mM MES, 150 mM KCl, 1 mM TCEP, 
2% glycerol, 0.02% NaN3, 1 mM Pb(Ac)2
Not useable for analysis due to 
aggregation and inter-particle 
interference
Ca2+/C1A-C1B-C2 7.0 1 M Glycine, 1 mM TCEP, 2% Glycerol, 
0.02% NaN3, 2 mM CaCl2
4.5 mg/mL; exposure 0.5, 1, and 2 s;
2.5 mg/mL; exposure 0.5, 1, and 2 s;
median
Cd2+/C1A-C1B-C2 7.0 1 M Glycine, 1 mM TCEP, 2% Glycerol, 
0.02% NaN3, 1 mM Cd(NO3)2
2.5 mg/mL; exposure 0.5, 1, and 2 s;
average
Pb2+/C1A-C1B-C2 7.0 1 M Glycine, 1 mM TCEP, 2% Glycerol, 
0.02% NaN3, 1 mM Pb(Ac)2
1.0 mg/mL 0.5, 1, 2, and 5 s;
average
 Analytical gel-filtration and sedimentation experiments  
Analytical gel-filtration experiments were carried out on a Superdex 75 10/300 or 
a Superdex 200 Increase 10/300 GL columns as described in the SI.  Sedimentation 
velocity experiments on Cd2+-complexed and Pb2+-complexed C1B-C2 were conducted 
at the Center for Analytical Ultracentrifugation of Macromolecular Assemblies at the 
University of Texas Health Science Center at San Antonio.  The experiments with Cd2+ 
were conducted at pH 6.0 and 7.4 for two C1B-C2 samples with 1 mM Cd2+ containing 
buffer: a “low” concentration sample, 7 M/OD280=0.3, and a “high” concentration 
sample, 23 M/OD280=0.9.  Samples were centrifuged for 12 hours 27 minutes and 13 
seconds at 25,000 rpm at 20 °C in a Beckman Optima analytical ultracentrifuge.  
Experiments in the presence of 0.1 mM Pb2+ were conducted in MES buffer with 7 
M/OD280=0.3, and a “high” concentration sample, 23 M/OD280=0.9.  Pb2+ 
concentrations were limited by the strong absorbance of Pb[Cl3]- and Pb[Cl4]2- species at 
51
280 nm. 139  The data were analyzed using the van-Holde Weischet method140 for 
heterogeneous systems, as implemented in the UltraScan software package.141
Electron microscopy  
Cd2+/C1B-C2 samples were prepared as described for SAXS measurements and 
then passed through the Superdex 200 GL 10/300 column to isolate the oligomer 
fraction.  The Pb2+/C1BC2 oligomers were prepared by incubation of 150 M C1B-C2 
with 1 mM Pb2+ in the MES buffer supplemented with 2% glycerol.  The concentration 
of Pb2+/C1BC2 oligomers in the gel-filtration fraction was not high enough to observe 
them in the EM experiments; the appropriate dilution of the pre-incubated protein-metal 
ion mixture was used instead.  The C1B-C2 oligomers were negatively stained according 
to Valentine et al.142  Specimens were observed in a JEOL 1200 EX transmission 
electron microscope operated at an acceleration voltage of 100 kV.  Electron 
micrographs were recorded at a calibrated magnification of ×50,000 using a 3k slow-
scan CCD camera (model 15C, SIA) resulting in 5.1 Å/pixel at the specimen level.  The 
images were processed using the EMAN single particle analysis package.  Class 
averages were obtained using reference-free classification with a box size of 32.6 nm for 
Cd2+ (1834 particles) and 22.4 nm for Pb2+ (2903 particles).  Averages were low-pass 
filtered to 11 Å.  The maximum particle dimensions were estimated using ImageJ.  
Histograms of Feret diameters were constructed using 24,237 (Pb2+) and 25,289 (Cd2+) 
C1B-C2 particles. 
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Protein-to-membrane FRET 
Large unilamellar vesicles (LUVs) were prepared as previously described126 
using 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-
sn-glycero-3-phospho-L-serine (POPS), and 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-(5-dimethylamino-1-naphthalenesulfonyl) (dansyl-PE), all 
from Avanti Polar Lipids.  The composition of LUVs was POPC:POPS:dansyl-PE=(73-
75):20:(7-5) molar %.  FRET experiments using Trp residues in C1B-C2 as a donor and 
dansyl-PE as an acceptor were conducted as previously described, with excitation at 295 
nm.124  FRET experiments were carried out on an ISS PC1 fluorometer (ISS, 
Champaign, IL) at 25 °C.  Cd2+ or Pb2+ from the respective concentrated stock solutions 
were added to 0.5 μM protein (C1B-C2 or C2) pre-incubated with 150 μM LUVs.  The 
cuvettes were coated with Sigmacote® (Sigma Aldrich) siliconizing reagent to prevent 
protein adsorption on the cuvette walls.
Estimation of the relative affinities for Cd2+ and Zn2+ to C1B
Three residues (I145, V147, and H140) in both the C1B (Figure III.10) and C1B-
C2 (Figure III.7C, expansions shown for I145 and V147) regions had four exchange 
peaks associated with each residue. These correspond to four distinct species that coexist 
in solution: Zn(1,2), Zn(1)Cd(2), Cd(1)Zn(2), and Cd(1,2).  The intensity of the Cd(1,2) 
exchange peak increased, while the Zn(1,2) crosspeak intensity decreased, as more Cd2+ 
was added.    The relative populations of each species were used, determined from the 
intensities of the corresponding crosspeaks, to obtain the affinity of each site for Cd2+ 
relative to Zn2+.  Consistent with Cd2+ binding to the loops of C2124, C2 residues in C1B-
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C2 also shifted in response to Cd2+ addition (Figure III.9) indicating Cd2+ is 
simultaneously populating both the loops of C2 and the Zn-sites of C1B.  Therefore, for 
the analysis, the isolated C1B domain was used which is only affected by Cd2+ replacing 
Zn2+.
For any given concentration of Cd2+ the fractional populations, , are defined by:𝑓
Equation 2
fZn(1,2)  IZn(1,2) , fPZn(1)Cd (2) 
IZn(1)Cd (2)
 , fPCd (1)Zn(2) 
ICd (1)Zn(2)
 , fCd (1,2) 
ICd (1,2)

  IZn(1,2)  IZn(1)Cd (2)  ICd (1)Zn(2)  ICd (1,2)
where I is the intensity of the corresponding species identified in Figure III.10 in Cd2+ 
containing 15N-1H HSQC for H140, I145, and V147.
The concentrations of free Cd2+ and Zn2+ are estimated from the fractional 
populations assuming a starting stoichiometry of 2 Zn2+ per C1B domain:
Equation 3
[Cd 2 ]0
P0
 [Cd
2 ]
P0
 2 fPCd (1,2)  fPZn(1)Cd (2)  fPCd (1)Zn(2)
Equation 4
2  [Zn
2 ]
P0
 2 fPZn(1,2)  fPZn(1)Cd (2)  fPCd (1)Zn(2)
where P0 is the total protein concentration and [Cd2+]0 is the total Cd2+ concentration.
In the presence of Cd2+, each site exists in an equilibrium between free, Zn-
coordinated, and Cd-coordinated:  
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The binding equilibria in terms of fractional population are described by:
Equation 5
Equation 6
Equation 7
Equation 8
and the relative affinity of Cd2+ and Zn2+ to each site can be estimated by taking the ratio 
of association constants for each site:
Equation 9
KaCd(1)
KaZn(1)
 [Zn
2 ] fCd (1)Zn(2)
[Cd 2 ] fZn(1,2)
Equation 10
KaCd(2)
KaZn(2)
 [Zn
2 ] fZn(1)Cd (2)
[Cd 2 ] fZn(1,2)
In addition, Cd2+ and Zn2+ can bind to one site of a C1B molecule that is already 
populated by Cd2+ at the other site:
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and the relative affinity to each site when Cd2+ is bound at the other site can be estimated 
by:
Equation 11
KaCd(1)
KaZn(1)
 [Zn
2 ] fCd (1,2)
[Cd 2 ] fZn(1)Cd (2)
Equation 12
KaCd(2)
KaZn(2)
 [Zn
2 ] fCd (1,2)
[Cd 2 ] fCd (1)Zn(2)
These values describe how population at one structural site influences the 
population of the other site.
For a 0.1 mM sample of isolated C1B with 0.1 mM Cd2+ equilibrated overnight, 
the fractional populations of each species and the concentrations of free Cd2+ and Zn2+ 
were determined in solution for all residues that showed four exchange peaks (Table III-
2).
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Table III-2.  Fractional populations of each C1B species in solution for a 0.1 mM 
C1B sample with 0.1 mM Cd2+.
Residue fPZn2 fPZnCd fPCdZn fPCd2 [Zn
2+], M [Cd2+], M
H140 0.387 0.205 0.271 0.138 75.1 24.9
I145 0.400 0.215 0.247 0.138 73.8 26.2
V147 0.389 0.211 0.264 0.136 74.6 25.4
Average 0.392± 0.007 0.210± 0.005 0.260± 0.012 0.137± 0.001 74.5± 0.7 25.5± 0.7
Results
Pb2+ and Cd2+ promote self-assembly of the regulatory region
Two divalent metal ions, Zn2+ and Ca2+, are essential components of the 
membrane-binding regulatory region of PKC.  Zn2+ is required for the proper folding 
and structural integrity of the C1 domains, C1A and C1B.  Ca2+ is not needed for the C2 
domain folding but is essential for its association with acidic phospholipids.  In fully 
activated PKC, the interaction of both C2 and C1 domains with membranes, 
schematically illustrated in Figure III.1, is required for full activation of the enzyme.143 
Therefore, while only Zn2+ plays a structural role in PKC, both metal ions are absolutely 
essential for the PKC function.  For the majority of the work reported here, a two-
domain C1B-C2 membrane-binding region was used (Figure III.1) that faithfully 
reproduces the behavior of the full-length region.
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Figure III.2  Treatment of PKC regulatory region with Cd2+ or Pb2+ results in self-
association, loss of conformational flexibility, and formation of globular species.  
(A) SAXS scattering curves of the 2- and 3-domain regulatory regions showing the 
differences between Ca2+ and Cd2+/Pb2+-bound proteins.  The changes in size and 
flexibility/shape caused by Cd2+ and Pb2+ are evident from the comparison of pair-
distance distribution functions P(r) (B) and dimensionless Kratky plots (C), respectively.
To determine how toxic metal ions influence the shape and size of the 
membrane-binding regulatory region of PKC, SAXS experiments were conducted on 
the C1B-C2 and the full regulatory region C1C2c that additionally contains the C1A 
domain.97 Three metal ions: Cd2+, Pb2+, and native cofactor Ca2+ were introduced into 
protein solutions via dialysis during the SAXS sample preparation procedure (see Table 
III-1 for the composition of all samples).  A comparison of the scattering curves 
illustrates that the morphology of the protein species in the presence of Cd2+ and Pb2+ is 
drastically different from that of the Ca2+-complexed proteins that are monomeric 
(Figure III.2A).  Surprisingly, the scattering curves of Cd2+/C1C2s and Pb2+/C1C2s are 
similar, indicating that these metal ions interact with the regulatory region in a similar 
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manner.  The Pb2+/C1B-C2 scattering curves showed signs of aggregation and inter-
particle repulsion and were not used for quantitative analysis (see Methods for details).
Analysis of the pair-distance distribution functions P(r) revealed that interactions 
with Cd2+ and Pb2+ promote self-association of the regulatory regions (Figure III.2B).  
The radii of gyration, Rg, of the Cd2+ complexes exceeded those of the Ca2+-bound 
species ~2-fold.  The maximum distance present in the scattering particle, Dmax, 
increased 1.9- and 2.7-fold for the C1B-C2 and C1C2c, respectively.  The behavior of 
Pb2+-bound C1C2c sample closely mirrored that of the Cd2+-complexed species.
Dimensionless Kratky plots137 were constructed to evaluate the flexibility and 
shape of the protein complexes.  The plots of globular proteins converge to zero at high 
scattering angles and have a maximum of 1.1 at qRg = √3.  Ca2+-complexed C1B-C2 and 
C1C2c lack these features and have a plateau-like region at high qRg that is typical of 
flexible multi-domain proteins (Figure III.2C).  In contrast, all Cd2+ and Pb2+ plots have 
maxima at (√3, 1.1) and show a significant decrease in intensity at high qRg values.  It’s 
conclude that Ca2+-complexed regulatory region behaves as a flexible monomer in 
solution, as one would expect based on its modular structure with unstructured linkers.  
Interactions with Cd2+ and Pb2+ result in formation of oligomeric species that are more 
globular in shape, with attenuated mobility of the linker regions.
Characterization of Pb2+- and Cd2+-containing C1B-C2 oligomers
Negative-stain electron microscopy experiments were conducted to visualize the 
oligomers (Figure III.3).  The overall globular shape of Cd2+- and Pb2+-containing C1B-
C2 oligomers is evident from the inspection of characteristic class averages (bottom 
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panel of Figure III.3).  The maximum dimension of Cd2+-containing particles is 15-18 
nm.  They appear to be composed of 4 spherical densities, each with an estimated 
molecular mass of 80 kDa.  Given that the molecular mass of the monomer is 22.34 kDa, 
this would correspond to a 320 kDa oligomer consisting of ~16 monomers.  Pb2+-
containing particles are smaller.  Their footprint appears as two parallel ellipsoids, with 
each ellipsoid having an estimated molecular mass of ~40 kDa.  This arrangement would 
produce an 80 kDa tetramer. In addition to large particles that were used to generate the 
class-averages, a sub-population of smaller particles were observed that could be 
dissociation products of the oligomeric species. The overall distributions of particle sizes 
are centered at ∼12.5 and ∼15.0 nm for the Pb2+- and Cd2+-containing particles, 
respectively (Figure III.3C).
 
Figure III.3 C1B-C2 forms spherical oligomers in the presence of Cd2+ and Pb2+.  
Electron micrographs and class averages of (A) Cd2+- and (B) Pb2+-complexed C1B–C2. 
(C) Distribution of Feret diameters in Cd2+- and Pb2+-complexed C1B–C2.  The data 
were obtained at pH 7.4 (Cd2+) and 6.0 (Pb2+).
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To characterize the distribution of oligomeric species in solution, sedimentation 
velocity experiments were conducted on C1B-C2 in the presence of Cd2+ and Pb2+.  The 
conditions of sedimentation experiments did not favor the formation of Pb2+-containing 
C1B-C2 oligomers (Figure III.4), presumably due to lower protein and Pb2+ 
concentration than those used for preparation of EM samples.  After one day of 
incubation, the majority of C1B-C2 in the presence of Pb2+ has sedimentation 
coefficients consistent with monomeric C1B-C2. With two additional days of incubation, 
15-20% of the boundary has significantly larger sedimentation coefficients, which 
indicates the formation of large aggregates over time.   
   
Figure III.4 Pb2+ causes aggregation of C1B-C2 over time.  Distribution of 
sedimentation coefficients determined from van-Holde Weischet analysis of 
sedimentation velocity experiments of C1B-C2 in the presence of 0.1 mM Pb2+ at pH 
6.0.  The increase in the size of aggregated particles over time is indicated with an arrow.
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In contrast, Cd2+ caused the formation of oligomeric C1B-C2 species in a process 
that is reversible and pH-dependent (Figure III.5).  The sedimentation data are presented 
in two ways: as integral distribution of s20,w, and as the envelopes of the s20,w frequency 
histograms (Figure III.5).  Two distinct populations of oligomeric species are observed.  
Changing the total protein concentration causes the redistribution of populations, 
indicating that: (i) Cd2+-dependent oligomerization process is reversible; and (ii) the 
apparent dissociation constant Kd is in the range of protein concentrations tested, 723 
M, at pH 6.0, and is < 7 M at pH 7.4.
Figure III.5 Cd2+-mediated self-association of C1B-C2 is reversible and pH-
dependent.  (A)  Distribution of sedimentation coefficients determined from the van-
Holde Weischet analysis of sedimentation velocity experiments at pH 6.0 (top) and pH 
7.4 (bottom).  Black symbols represent the integral distribution of s20,w; purple lines 
represent the envelopes of the frequency histograms (B).  The shift towards larger 
sedimentation coefficients upon increasing protein concentration from 7 to 23 M is 
indicated with an arrow.
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The slow-sedimenting population with s20,w values in the 2-5 S range contains a 
monomer and lower-order oligomers, potentially up to a tetramer.  The fast-sedimenting 
population showed broad distributions centered at ~14 S (pH 6.0) and ~19 S (pH 7.4), 
consistent with at least >10 monomers per oligomer.  Higher pH value resulted in the 
shift towards higher molecular mass species. This was also evident in analytical gel-
filtration experiments (Figure III.6).  Analytical gel filtration data were collected for two, 
identically prepared C1B-C2 samples at pH 6.0 in MES buffer and pH 7.4 in HEPES 
buffer with Cd2+.   For both conditions, C1B-C2 elutes in two peaks corresponding to 
monomeric C1B-C2 and high molecular weight oligomers.  Changes in the elution 
profiles at different pH are consistent with size and apparent affinity changes observed in 
sedimentation velocity experiments.  The amount of monomer that elutes from the 
column decreases with increasing pH (Figure III.6).  Furthermore, the retention volume 
of the oligomer peak decreased at higher pH, which is consistent with the formation of 
larger species and a higher affinity for oligomer formation at physiological pH.
63
Figure III.6  More self-association is observed at physiological pH with Cd2+.  100 
M C1B-C2 analytical gel filtration profiles on a Superdex 200 10/300 size exclusion 
column in the presence of 1 mM Cd2+ in MES buffer at pH 6.0 and HEPES buffer at pH 
7.4.  Red arrows indicate the changes in the elution profile under the different 
conditions.
Mechanism of Cd2+- and Pb2+ induced self-association
The next set of experiments was designed to determine: (i) which regions of 
C1B-C2 interact with Cd2+ and Pb2+, and (ii) how these interactions contribute to self-
association.  From previous studies, it is known that isolated C2 domain binds Pb2+ 50 
and Cd2+ 124 through its calcium-binding loops; there is an additional weak Cd2+ site that 
is formed by the N- and C-terminal residues.  Neither binding event causes the self-
association of the isolated C2.  Therefore, the goal was to determine how C1B and C2 
domains interact with Cd2+ and Pb2+ in the context of the regulatory region.
C1B: Cd2+ displaces Zn2+ to form a functional “Cd finger” 
Addition of Cd2+ to the C1B-C2 domain resulted in the appearance of the 
absorption shoulder near =270 nm (Figure III.7A).  The wavelength range is consistent 
64
with the position of thiolate-Cd2+ charge transfer bands observed in other studies.144 C2 
domain is cysteine-free and therefore does not contribute to the difference absorption 
spectrum.  Based on this information and previous studies of Zn2+-containing proteins 
with Cys-rich sites, it was concluded that Cd2+ forms coordination bonds with the 
cysteine residues of the C1B domain.  Two modes of coordination are possible:  
peripheral, shared coordination with Zn2+ or replacement of Zn2+. To determine if Cys 
coordination by Cd2+ is accompanied by the ejection of Zn2+ from the protein, 4 molar 
equivalents of Cd2+ were added to the C1B-C2 domain in the presence of a highly 
selective Zn2+ fluorophore, FluoZin-3.  A steady increase in the fluorescence intensity at 
516 nm was observed, indicating that Zn2+ is being displaced from the protein as a result 
of Cd2+ treatment (Figure III.7B).
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Figure III.7 Cd2+ replaces Zn2+ in the C1B domain without loss of fold and function. (A) Difference UV-vis absorption 
spectra of C1B-C2 with increasing molar equivalents of Cd2+.  (B) Cd2+-stimulated Zn2+ release from the C1B-C2 domain 
monitored using fluorescence intensity of FluoZin-3 at 516 nm (red).  No-Cd2+ control is shown in gray.  (C) Expansions of the 
15N-1H HSQC spectra of native (black) and Cd2+-treated C1B-C2 (blue).  The N-H cross-peaks of Cd2+- and Zn2+ containing 
species are connected with red lines.  Ile145 and V147 have 4 distinct cross-peaks corresponding to the Zn(1,2), Zn(1)Cd(2), 
Cd(1)Zn(2), and Cd(1,2) C1B-C2 species.  (D) Expansions of the 15N-1H HSQC spectra of isolated native C1B domain (black), 
C1B “Cd finger” (purple), and “Cd finger” complexed to PDBu and mixed micelles.
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NMR experiments conducted on the C1B-C2 and the isolated C1B domain 
revealed that the replacement of Zn2+ with Cd2+ occurs at both sites 1 and 2 (see Figure 
III.1 for the site definitions) without the loss of secondary structure.  The expansions of 
the 2D 15N-1H HSQC spectra illustrate the appearance of a new subset of well-dispersed 
C1B cross-peaks upon addition of Cd2+ to C1B-C2 (Figure III.7C).  The same chemical 
shift pattern was observed in the isolated C1B (Figure III.8), which was used to assign 
the cross-peaks of the Cd2+-containing protein species.  The N-H groups of many 
residues, including those coordinating Zn1 and Zn2 experience large chemical shift 
perturbations compared to the native Zn2+-containing protein (Figure III.9).  While the 
majority of the N-H groups had two sets of cross-peaks, there were three residues: 
His140, Ile145, and Val147, whose N-H groups had four cross-peaks (expansion of 
Ile145 and Val147 in Figure III.7B; also Figure III.10).  This means that all four possible 
Cd/Zn protein species coexist in solution: Zn(1,2), Zn(1)Cd(2), Cd(1)Zn(2), and Cd(1,2), 
where “1” and “2” denote the structural zinc sites.  The ability to detect distinct Cd2+- 
and Zn2+-containing protein populations indicates that they interconvert on a timescale 
that is slow on the NMR chemical shift scale.
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Figure III.8  Cd2+ replaces Zn2+ in C1B-C2.  15N- 1H HSQC of 0.1 mM [U-15N] C1B 
in apo state and in the presence of 2 molar-equivalents of Cd2+.  The same signatures of 
Cd2+ replacement at structural Zn-sites are observed for isolated C1B.
Figure III.9 Cd2+ binds to the loop regions of the C2 domains and the structural 
Zn-sites of the C1B-C2. Chemical shift perturbation (CSP) from 15N-1H HSQC in the 
presence and absence of Cd2+ for C1B-C2 (black) and isolated C1B (red). Inset: 
Correlation of the CSPs for C1B residues in the C1B-C2 region versus the isolated C1B 
domain.  
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Based on the relative cross-peak intensities and the peak positions in the refolded 
Cd(1,2) C1B (Table III-2), all four cross-peaks were assigned to specific Cd/Zn C1B 
species.  The relative intensities of the four cross-peaks enabled determination of the 
ratio of the association constants for Zn2+ and Cd2+ binding to the C1B domain. Cd2+ has 
a 1.9-fold higher affinity to site 1 and 1.5-fold higher affinity to site 2 on C1B (Table III-
3); these values are independent of the metal ion identity that occupied the other site.
Figure III.10 Four distinct C1B species form upon treatment with Cd2+.  Expansions 
of 15N-1H HSQC for three residues in isolated C1B that have 4 exchange peaks in the 
presence of Cd2+.
A potent activator of PKC, phorbol ester PDBu, was used to test if the C1B “Cd 
finger” is functional.  C1B was successfully refolded in the presence of Cd2+, as 
evidenced by large chemical shift dispersion observed in the NMR spectrum of the 
resulting “Cd finger” (Figure III.7D).   Upon addition of PDBu and mixed micelles as a 
membrane mimic, the loop residues of C1B experienced significant chemical shift 
69
perturbations that were essentially identical to those previously reported for the native 
Zn(1,2) protein.  It is concluded that Cd(1,2) C1B interacts with PDBu and partitions 
into micelles in a manner identical to that of the native C1B.  Taken together, these 
results demonstrate that Cd2+ is able to replace Zn2+ at both structural sites and thereby 
support the fold and function of C1B.  The presence of the second domain, C2, has little 
influence on this process.
Table III-3. Relative affinities of Cd2+ to each C1Ba Zn-site.  Error is reported as the 
standard deviation of all three residues.
Residue
KaCd(1)
KaZn(1)
KaCd(2)
KaZn(2)
KaCd(1)
KaZn(1)
KaCd(2)
KaZn(2)
H140 2.11 1.59 2.02 1.53
I145 1.74 1.51 1.81 1.57
V147 1.99 1.60 1.89 1.52
Average 1.94± 0.19 1.57± 0.05 1.91± 0.11 1.54± 0.03
C1B: Pb2+ coordinates Cys residues but can neither displace Zn2+ nor support the 
treble-clef fold
UV-vis absorption spectroscopy was used to monitor Pb2+ interactions with C1B-
C2.  Addition of Pb2+ to the C1B-C2 domain resulted in the appearance of absorption 
bands at 245 and 330 nm (Figure III.11A).  To attribute these spectral changes to 
individual domains, Pb2+-binding experiments were conducted on isolated C1B and C2.  
Addition of Pb2+ to C2 resulted in the increase of absorbance at 245 nm (Figure III.11B), 
which is consistent with the formation of Pb-O coordination bonds.145  This observation 
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is in agreement with previous structural work showing that Pb2+ populates two sites on 
the C2 domain – one high- and one low-affinity, both having an all-oxygen coordination 
environment.126  Addition of Pb2+ to the isolated C1B domain resulted in the appearance 
of two bands at 245 nm and 330 nm (Figure III.11C).  These represent lead-thiolate 
charge-transfer bands that were previously detected upon treating Zn2+-binding peptides 
with Pb2+.146  Therefore, the C1B-C2 data reflect two types of Pb2+ binding events: one 
to the loop region of C2, and the other one to the cysteine residues of C1B.
Figure III.11 Pb2+ coordinates C1B cysteines but does not cause Zn2+ release from 
C1B-C2.  (A) Difference UV-vis absorption spectra of C1B-C2 obtained at increasing 
molar equivalents of Pb2+.  The position of the absorption bands at 245 and 330 nm is 
consistent with the formation of Cd2+-thiolate bonds.  (B,C) Difference UV-vis 
absorption spectra that show the response of isolated C2 (C) and C1B (D) to Pb2+ 
binding.  (D) Treatment with Pb2+ does not cause Zn2+ release from the C1B-C2 domain, 
evidenced by unchanged fluorescence intensity of FluoZin-3 at 516 nm (red). No-Pb2+ 
control is shown in gray.
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Unlike Cd2+, Pb2+ did not cause the release of Zn2+ from the structural C1B sites.  
No increase in FluoZin-3 fluorescence was observed upon treating the protein with 4 
molar equivalents of Pb2+ (Figure III.11D).  Attempts to refold the C1B domain in the 
presence of Pb2+ were unsuccessful, indicating that Pb2+ is unable to support the treble-
clef fold of C1B.  Therefore, the observed changes in the UV-VIS spectra have to come 
from external coordination of cysteines by Pb2+, without displacement of Zn2+.  Because 
C1B relies on Zn2+ for the proper fold, cysteine residues cannot be altered without 
disturbing the fold.  Therefore, to determine how the individual residues of C1B respond 
to interactions with Pb2+, a series of 15N-1H HSQC NMR experiments were recorded on 
isolated C1B in the presence of increasing molar equivalents of Pb2+.  While little 
chemical shift perturbation was observed in the spectra, there was a significant decrease 
in peak intensities, accompanied by modest line broadening, upon increasing Pb2+ 
concentration (Figure III.12).  The peak intensities are fully recovered upon EGTA 
treatment.  This behavior is consistent with the reversible formation of high-molecular 
weight C1B oligomers that are not detectable in NMR spectra due to extreme line 
broadening.  It is concluded that Pb2+ promotes self-association of C1B domains through 
coordination of surface-exposed cysteine residues, with Zn2+ structural sites remaining 
intact. The most likely candidates are Cys132, Cys143, and Cys151 (see Figure III.1B); 
it was recently demonstrated that the backbone amides of cysteines at equivalent 
positions are highly solvent exposed in the C1B domain from PKC.147
72
Figure III.12 Pb2+ interactions with isolated C1B.  Expansions of 15N-1H HSQC for 
0.1 mM [U-15N] isolated C1B in the presence of increasing molar equivalents of Pb2+.
C2: Cd2+ and Pb2+ drive the association of C1B-C2 oligomers with acidic membranes  
Ca2+ binding to the C2 domain is a prerequisite for its association with 
phosphatidylserine-containing membranes.  The C2 domain binds Pb2+ and Cd2+ through 
its loop regions; however, in the isolated C2 domain only Pb2+126 but not Cd2+124 can act 
as a functional Ca2+ mimic and support the membrane interactions.
Protein-to-membrane FRET was used to determine how self-association of the 
regulatory region influences its membrane binding-properties.  The tryptophan residues 
of the C2 domains served as a donor, while the dansyl-labeled lipid incorporated into 
large unilamellar vesicles served as an acceptor (Figure III.13A).  Upon addition of Pb2+ 
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to the C1B-C2 pre-incubated with LUVs, an appearance of dansyl emission peak was 
observed due to protein-membrane FRET (Figure III.13B).  The Trp emission peak also 
decreased in intensity due to the combined effect of metal ion binding and resonance 
energy transfer to dansyl group.  Addition of EGTA eliminated the dansyl emission peak 
indicating that the protein dissociated from the membrane upon sequestration of Pb2+ 
ions.  The intensity of the Trp peak did not fully recover upon EGTA treatment because 
C2 domain has one high-affinity Pb2+ site126 that remains populated even after EGTA 
treatment.
Figure III.13 Pb2+ and Cd2+ support the interactions of C1B-C2 domain with 
membranes.  (A) Schematic representation of FRET experiments.  (B,C) Fluorescence 
emission spectra of C1B-C2 conducted in the presence of LUVs as a membrane mimic. 
FRET is manifested as the appearance of the dansyl emission peak and concomitant 
decrease of the Trp emission peak.  The inset in (C) represents the spectra collected on 
the isolated C2 domain in the presence of LUVs and Cd2+.
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It was previously demonstrated that isolated C2, despite binding a full 
complement of Cd2+ ions, does not appreciably associate with membranes.124  This is 
illustrated by a lack of the dansyl emission peak in the control experiment that was 
conducted on the isolated C2 domain under the same set of conditions as C1B-C2 (inset 
of Figure III.13C).  It is concluded that making loop regions of C2 more electropositive 
is not sufficient to drive membrane binding and speculated that Cd2+, unlike Ca2+ and 
Pb2+, cannot effectively coordinate lipid headgroups.124  It was therefore surprising to 
find that Cd2+ supported the membrane association of C1B-C2 (Figure III.13C).  This 
can be attributed this phenomenon to the increase in local concentration of C2 membrane 
binding functionalities provided by the formation of oligomeric species.  The 
contribution of general electrostatics, which is too weak in the isolated domain, becomes 
significant enough in the oligomers to support their membrane interactions.  Treatment 
with EGTA resulted in protein dissociation from the membrane and completely reversed 
the Trp fluorescence, consistent with the low micromolar affinity of Cd2+ to the loop 
regions of C2.
Linker region connecting the domains is involved in self-association 
Having characterized the interactions of metal ions with C1B and C2, NMR 
experiments were conducted to determine the effect of Cd2+ and Pb2+ ions on the linker 
region.  The 15N-1H HSQC spectra showed two signatures: (i) a decrease in cross-peaks 
intensities that affected the majority of N-H groups uniformly; and (ii) selective 
broadening of a subset of N-H cross-peaks (Figure III.14).  Addition of EGTA reversed 
both the uniform and selective broadening (Figure III.14A).  Furthermore, Cd2+ 
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occupying the Zn-sites on C1B was chelated by EGTA and replaced by the previously 
displaced Zn2+.  This indicates that both metal dependent self-association and Zn-
displacement is reversible.  Selective broadening occurred within the inter-domain linker 
region and the C-terminal -helix.  While this suggests that these regions undergo an 
additional process, it is not direct evidence that they mediate self-association.  Therefore, 
a mutagenesis approach was developed to elucidate the mechanism of oligomerization.
Figure III.14  Toxic heavy metals perturb the linker and c-terminal helix of C2. 
Peak intensity as a function of primary structure from 15N-1H HSQC spectra of C1B-C2 
with 2-fold and 4-fold excess Pb2+ (A) and Cd2+ (B) normalized to peak intensity in the 
absence of Pb2+ and Cd2+.  Structural features are highlighted in grey on the plots.  (C)   
Expansions of an overlay 15N-1H HSQC spectra of native (black), M2+-treated C1B-C2 
(gold and magenta), and after treatment with EGTA (cyan).
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Known metal binding sites do not significantly contribute to self-association
Mutants were designed to disrupt Cd2+ and Pb2+ binding the CMBLs, linker 
region, and C-terminal -helix (Table III-4, Figure III.15).   The effect that these 
variants have on self-association was evaluated using size exclusion chromatography 
(Figure III.15A,C,D).  Wild-type C1B-C2 in the presence of Ca2+ elutes in a single peak 
on an analytical gel filtration column (Figure III.15A).  In the presence of Cd2+, C1B-C2 
elutes in two peaks, one corresponding to monomeric C1B-C2 and one corresponding to 
higher molecular weight oligomers (Figure III.15A).  Interactions with the resin 
prevented exact determination of the molecular weight. Furthermore, resin interactions 
were stronger in the presence of Pb2+.  Therefore, the elution profiles of each variant 
compared with wild-type protein were used to qualitatively evaluate the relative amounts 
of monomer and oligomer (Figure III.15A-C).
 
 
Table III-4.  Summary of the C1B-C2 variants.
Variant Mutation Location Rationale
L3 D246N C2 domain, loop 3 Disruption of M2+ binding to loop region
L1 D187N/D193N C2 domain, loop 1 Disruption of M2+ binding to loop region
H1 E282K C-terminal -helix Charge reversal of Cd3 ligand
tetraMut D154K/H155G
E157K/E282K
Linker and -helix Elimination of potential M2+ ligands in the 
linker/charge reversal of Cd3 ligands
GL 153-158Gly6 -helix Full linker replacement with Gly
LH 153-158Gly6
E281K/E282K/E284K
Linker and -helix Full linker replacement with Gly and charge 
reversal of -helix 
Variants that were previously shown to disrupt metal binding to the loops of C2, 
D246N (L3) and D187/193N (L1), had little effect on the amount of monomer that 
eluted from the analytical gel filtration column—although the L3 mutant had slightly 
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more monomer elute from the column than wild-type or the L1 mutant (Figure III.15B).  
From this it was concluded that Cd2+ and Pb2+ binding to the CMBLs does not contribute 
significantly to self-association. The charge reversal variant of Cd3 ligand, E282K, also 
had little effect on self-association (Figure III.15C).  Collectively, this suggests that toxic 
metals binding to known metal binding sites doesn’t significantly contribute to self-
association.  A variant was designed to eliminate residues that could potentially 
coordinate both Pb2+ and Cd2+ in the linker region combined with H1 mutation 
(tetraMut) (Table III-4).  This variant had the largest effect on self-association, with 
significantly more monomer eluting from the column compared to wild-type (Figure 
III.15C).  However, this still did not completely abolish oligomer formation, suggesting 
other ligands/regions that mediate self-association exist.
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Figure III.15 Canonical metal binding sites do not contribute to Cd2+ mediated self-
association.  C1BC2 analytical gel filtration profiles for C1B-C2 variants compared 
with wt on (A) a Superdex 75 GL and (B-C) a Superdex 200 Increase 10/300 column at 
pH 7.4 in the presence of 1mM Cd2+.  (D) residues mutated are highlighted on ribbon 
diagrams of C1B (NMR structure, 2ELI) and C2 (crystal structure, 4L1L) with a 
modeled linker region.
Two, more extensive variants were designed that abolish all residues that could 
potentially coordinate Cd2+ and Pb2+ in the linker region and C-terminal helix.  The GL 
variant targets the entire linker, replacing it with glycine (Table III-4).  The LH variant 
combines the glycine linker with a charge reversal for all negatively charged residues in 
the C-terminal helix (Table III-4).  A comparison of the 15N-1H HSQC spectra for wild-
type C1B-C2 and the LH mutant assured that these mutations did not disrupt the fold of 
C1B-C2 (Figure III.16).
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Figure III.16  LH variant does not perturb the structure of C1B-C2.  Overlay of 
15N-1H HSQC of 0.3 mM [U-15N] C1B-C2 LH and wild-type in the metal-free state. 
  
The relative extent of self-association was evaluated using 15N-filtered 1H-
detected 1D NMR spectra in the presence of increasing amounts of Pb2+ and Cd2+ 
(Figure III.17A-B) for both variants.  Wild-type C1B-C2 showed a 35% decrease in the 
integrated intensity in the presence of 4-molar equivalents of Pb2+ and 52% with the 
same ratio of Cd2+ as a result of oligomerization.  The GL variant attenuated this 
intensity drop, with only an 18% decrease for the same concentration of Pb2+ and a 15% 
decrease for an equivalent concentration of Cd2+.  The largest attenuation of self-
association was achieved by eliminating all potential coordinating residues in both the 
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linker region and C-terminal helix.  The LH variant only had a 2-3% decrease in 
intensity in the presence of both Cd2+ and Pb2+(Figure III.17A-B). The LH variants were 
visualized using negative stain EM in the presence of Pb2+ and Cd2+. No oligomers were 
observed in the presence of Pb2+ although some oligomers (fewer than wild-type) were 
observed in the presence of Cd2+.  Despite this, there were no detectable oligomers that 
eluted from the analytical gel filtration column in the presence of either metal ion 
(Figure III.17C).  It is worth noting that both of these regions are highly conserved in 
conventional PKC isozymes (Figure III.17E).
    
81
Figure III.17  Self-association is mediated by linker and C-terminal helix.  15N-
filtered 1H-detected 1D NMR spectra in the presence of increasing amounts of (A) Pb2+ 
and (B) Cd2+ for Gly6-linker mutant (GL), linker-helix mutant (LH), and wild-type C1B-
C2.  The decreases in the integrated intensity in the presence of 4-molar equivalents of 
metal relative to the metal-free spectra are indicated in orange.
Collectively, these data indicate that both the interdomain linker and C-terminal 
-helix are crucial for Pb2+ and Cd2+ mediated self-association.  This likely occurs 
through direct, shared coordination between ligands in these regions on opposite 
molecules.  Since Ca2+ does not bind to these regions and regions known to bind Ca2+ do 
not contribute to self-association, it is clear that opportunistic binding and not ionic 
mimicry drives oligomerization.  It is worth noting that these regions are highly 
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conserved within conventional isozymes (Figure III.17E).  Therefore, it is plausible that 
this metal-induced self-association could occur in other conventional isozymes. 
Discussion
The goal of this study was to investigate the interactions of toxic metal ions, Pb2+ 
and Cd2+, with two, independently folded peripheral membrane binding modules from 
the regulatory region of PKC.  Cd2+ has been shown to activate nuclear PKC17 and Pb2+ 
has been shown to have both activating16 and inhibitory effects on PKC.19,148  While both 
Pb2+ and Cd2+ have been previously shown to displace Ca2+ from the CMBLs of the C2 
domain of PKC124,126, ionic mimicry alone is not enough to explain these toxic effects. 
The picture that emerges from this study reveals that Pb2+ and Cd2+ influence the 
regulatory region through by mimicking both Zn2+ and Ca2+ and opportunistic binding to 
regions outside of the known metal ion binding sites. Both metal ions had distinct 
influences on structure and function, unique from native metal ion cofactors, Zn2+ and 
Ca2+.   Cd2+ was able to spontaneously replace Zn2+ in the C1B domain, while Pb2+ was 
able to coordinate cysteines in structural Zn2+ sites without ejecting Zn2+.  Cd2+ and Pb2+ 
both bind opportunistically to other sites on C1B-C2 leading to self-association. 
Collectively, this work illustrates that the consequences of toxic metal ion encounters are 
complex and that even within proteins that are known to bind divalent native metal ions, 
the effects of toxic metals extend beyond ionic mimicry.
Toxic metal ions serve as ionic mimics for Zn2+ and Ca2+
Pb2+ and Cd2+ had different abilities to serve as ionic mimics for Zn2+ and Ca2+.  
Cd2+ is able to displace both Ca2+ and Zn2+.  While Cd2+ was able to support the fold and 
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function of the C1B domain it did not support the function of the isolated C2 domain.  In 
contrast, Pb2+ was found only to serve as an ionic mimic for Ca2+ and was unable to 
replace Zn2+ or support the fold of the C1B domain.  The proper folding of the C1B 
domain depends on two structural Zn2+ sites coordinated by the three cysteines and one 
histidine each with the motif, HX12CX2CXnCX2CX4HX2CX7C (where n is 13 or 14 and 
X is any amino acid), in a tetrahedral geometry.149  Zn2+ and Cd2+ both have a preference 
for tetrahedral geometry when bound to cysteine/histidine ligands whereas Pb2+ has a 
preference for trigonal pyramidal geometry when bound to cysteines.150 Despite this, 
Pb2+ is still able to displace Zn2+ in several Zn-binding proteins, often resulting in 
misfolding.115,117,146 A study done by Godwin et al. using peptides that mimic Zn2+ 
coordination sites, found that the relative position of cysteines in the coordination sites 
governed the relative affinities of Zn2+ and Pb2+ to the sites.150  Constructs with only two 
residues between the coordinating cysteines had insufficient separation of coordinating 
cysteines in the primary structure and disfavored the trigonal pyramidal geometry 
needed for Pb-S complexes, destabilizing the complex and resulting in a lower affinity 
of Pb2+ relative to Zn2+. 150  In both Zn2+ sites of C1B, two of the coordinating cysteines 
are separated by only two amino acids in the primary structure (C115 and C118 in Zn(1) 
site and C132 and C135 in Zn(2) site) positioned to support a tetrahedral coordination 
geometry with Zn2+.  Therefore, it is concluded that Pb2+ has a lower affinity than Zn2+ 
due to the lack of three cysteines in favorable positions to coordinate Pb2+ in a trigonal 
pyramidal geometry.  As a result, Pb2+ does not efficiently replace Zn2+.  Cd2+, however, 
can adopt a tetrahedral geometry when coordinated by cysteines and histidines151, which 
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is compatible with the geometry of both of the Zn2+ sites in C1Ballowing for 
efficient replacement. 
Pb2+ and Cd2+ also differed in their abilities to mimic Ca2+.  Despite literature 
showing that Pb2+ enhances the aggregation of other proteins with inhibitory effects on 
function,132,152 this study finds that, consistent with previous work, Pb2+ was able to both 
bind to the CMBLs in the C2 domain and drive membrane association. 
Cd2+ was also able to bind to the CMBLs but was unable to drive membrane 
binding of isolated C2 domain, consistent with previous work.  C1B-C2, in contrast, was 
able to bind to anionic membranes in the presence of Cd2+ due to the induced self-
association.  The avidity of the interactions of multiple membrane binding domains from 
the same oligomer associating with the membrane compensates for the weak interaction 
of Cd2+ bound C2 with phosphatidylserine.  There is a precedence for this in FYVE 
domains153 and Syt I.154  FYVE domains rely on the avidity of multiple weak 
interactions with membranes through dimerization to efficiently bind membrane 
embedded ligands.  Isolated C2A and C2B domains from SytI show extremely weak 
binding to anionic membranes in the presence of Cd2+, but Cd2+ is able to drive 
membrane binding of the intact two-domain region.  Thus the ability of Cd2+ to drive 
membrane binding is dependent on both ionic mimicry in the loops and opportunistic 
binding to other sites on C1B-C2. While it has been shown that Cd2+ stimulates activity 
of PKC, the mechanisms are unclear.  This work illustrates the potential for Cd2+ to 
activate PKC through self-association and enhancement of the membrane binding 
properties of the regulatory region.  Furthermore, it has been suggested that conventional 
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PKCs exist as multimers and oligomerization regulates and enhances activity.63,155  This 
work shows that self-association of the regulatory region enhances interactions with 
membranes, suggesting one possible explanation for increased activity of PKC when 
present as an oligomer.
Opportunistic metal binding drives self-association of C1B-C2 region
Through analysis of existing structures, studies have shown that Pb2+ and Cd2+ 
can bind to protein regions not normally occupied by native metal ions because of more 
variability in coordination numbers and differences in ligand preferences.151,156  This 
study found that, in addition to serving as ionic mimics for Zn2+ and Ca2+, both Cd2+ and 
Pb2+ mediate self-association of the C1B-C2 regulatory region through opportunistic 
binding to sites outside of the physiological metal binding sites.  Several studies have 
illustrated the propensity of PKC to self-associate through the regulatory region in the 
presence of activators:   Ca2+, phorbol esters, or phosphatidylserine.58,62-64,157  In the 
experiments in this chapter, significant self-association of C1B-C2 or C1C2c  in the 
presence of Ca2+ only was not observed.  However, at identical concentrations of Cd2+ 
and Pb2+, both regions were found to self-assemble into higher order oligomers in the 
absence of other PKC activators. Variants that abolished metal binding to known Ca2+-
binding sites had very little effect on Cd-mediated self-association while multiple lines 
of evidence implicate the linker and C-terminal helix, regions where Ca2+ does not bind 
but contain multiple potential ligands that could coordinate Cd2+ and Pb2+.  Substituting 
these residues for residues that are unable to coordinate Cd2+ and Pb2+ significantly 
lowered the apparent affinity for self-association, indicating that opportunistic binding of 
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Pb2+ and Cd2+ to the linker and C-terminal helix of C2 mediate intermolecular contacts 
that stabilize the C1B-C2 oligomers. It is worth noting that while the C-terminal helix of 
C2 was found to be important for self-association, the isolated C2 domain does not self-
associate.  A study done on SytII found a similar phenomenon.158  The isolated C2A and 
C2B domains were not found to self-associate.  However, the intact C2A-C2B region 
was found to form dimers at low Pb2+ concentrations and oligomers at higher 
concentrations of Pb2+. The multimers were thought to be mediated through either an 
intact linker or the combination of multiple weak interactions that were insufficient to 
drive self-association of the isolated domains.  In C1B-C2 either the C2 domain does not 
associate with itself or that more than one type of interaction is needed to stabilize the 
oligomer and the avidity of multiple weak binding sites results in self-association.   
CaM has been shown to interact with Pb2+ outside of the primary metal binding 
sites.159  Pb2+ binding opportunistically to secondary sites on CaM resulted in a 
decreased flexibility of the linker. SAXS data in this study showed a decrease in 
flexibility of the linker region in response to Pb2+ and Cd2+.  Along with mutagenesis and 
NMR this highlights the importance of the linker in mediating self-association and the 
changes that occur in response to binding in this region.  Variants that abolished ligands 
in the linker and C-terminal helix significantly lowered the apparent affinity of the 
oligomers, although some self-association was still observed in negative-stain EM 
images (although to a much lesser extent than wild-type). This indicates that at least one 
other site is intact and able to mediate self-association. There is evidence in the literature 
for a third Cd2+ binding site on C1B. Electrospray ionization mass spectrometry of a 
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C1B peptide with two native Zn-binding sites, after treatment with Cd2+ showed a 
significant population of peptide coordinated to three Cd2+ ions.121  This was not 
observed after Zn-treatment.  The third ion disappeared after treatment with EDTA, 
suggesting that the third site has a lower affinity than the two structural sites.121 
Another potential interaction mode could be through intermolecular coordination 
of cysteines on C1B. UV-VIS data showed the potential for Pb2+ to externally coordinate 
cysteines on C1B.  The propensity for Pb2+ to share coordination of cysteines with 
another metal is illustrated with homo-octomeric ALAD in the presence of Pb2+.156,160  In 
addition to Pb2+ replacement of Zn2+ in the binding pocket, a second Pb2+ ion shares 
coordination with one of the cysteine ligands already coordinated to the first Pb2+.  With 
C1B-C2, metal charge transfer bands appear at sub-saturating concentrations for the low 
affinity Pb2+ site on C2 with micromolar affinity indicating Pb2+ coordinates cysteines in 
C1B before the C2 loops are fully populated and cysteines in C1B can compete with 
CMBLs for Pb2+. The most likely candidates for coordination are C132, C143, and C151 
which have been shown to be the most solvent exposed.147   
Including the potential of C1B to play an active role in self-association, there 
are five possible types of interactions that can be formed and it is likely that different 
combinations of these interactions exist in the oligomers.  The different modes of 
interactions are likely favored by the flexibility of the C1B-C2 region that allows it to 
adopt different conformations.
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Figure III.18 Model describing the interactions of Pb2+ and Cd2+ with the C1B-C2 
regulatory region.  Pink stars indicate sites where native metal ions can be displaced by 
Pb2+ or Cd2+. Cyan stars indicate opportunistic binding sites that promote self-
association.  Black boxes indicate sites within each possible dimer that are available to 
interact with Cd2+ or Pb2+ and facilitate interactions with neighboring dimers and the 
formation of higher order oligomers.  
Based on the data presented in this chapter as well as previous work from the 
lab,124,126 a model has been constructed to explain interactions of Pb2+ and Cd2+ with 
C1B-C2 regulatory region of PKC (figure III.18).  When Cd2+ encounters C1B-C2, it 
distributes between the loops of C2 and the structural Zn2+ sites in C1B, displacing and 
serving as an ionic mimic of Zn2+.  Pb2+, however, populates the high affinity binding 
site in the loops of C2, and then targets cysteines without displacing Zn2+ at metal-to-
protein ratios >1.  With increasing concentrations, both Pb2+ and Cd2+ bind 
opportunistically to sites outside of known metal binding sites including the linker, C-
terminal helix of C2, and an anionic patch near the bottom of C1B (cyan stars), 
mediating self-association and the formation of higher order oligomers. There are five 
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types of dimers that can be formed through interactions with Pb2+ and Cd2+ that stabilize 
the C1B-C2 oligomers: C2 to linker, C1B to linker, linker to linker, C1B to C1B, and 
C1B to C2.  Each mode of interaction within C1B-C2 dimers leaves free sites (black 
boxes) that, along with additional Cd2+ or Pb2+ ions, bridge interactions with other 
dimers and mediate the formation of higher order oligomers. 
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CHAPTER IV 
PARAMAGNETIC AGENTS REVEAL THE CONFORMATIONAL SPACE 
SAMPLED WITHIN THE C1B-C2 REGULATORY REGION
Background
Dynamic proteins and complexes play a role in all cellular processes and signal 
transduction cascades.  It is essential to understand the dynamics and conformational 
landscapes of these systems in order to understand their functions.  Therefore, an 
increasing amount of research is being dedicated to extracting protein ensembles from 
limited data sets 161-163 and even designing drugs to modulate them based on the resulting 
ensembles. 164-166 
Protein Kinase Cs (PKCs) are flexible isoenzymes that are integral components 
of cellular signaling processes that occur at the membrane surface.167  Despite significant 
efforts aimed at gaining structural information on full-length PKC, this has eluded 
scientists for decades.  This is in part due to its multi-modular structure, amphipathic 
nature, and inherent flexibility, that, while essential for function, provide significant 
challenges 97 for structural biologists.  
The N-terminal regulatory region of PKCs is trafficked to anionic membranes 
upon sensing its ligands, which generates the necessary conformational rearrangements 
needed to pull the pseudosubstrate region from the active site of the kinase domain.
  No information is available about the conformational changes that occur within 
the regulatory region during activation.  Only one multi-domain crystal structure exists 61 
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and most of the structural information for this region is primarily for the functionally 
autonomous isolated domains. This chapter details the steps taken towards assembling 
structural information on the full regulatory region by focusing on a multi-domain 
construct that comprises the C1B and C2 domains from the conventional isoform, , 
representing the minimum machinery needed by PKC to bind both lipid and metal 
activators.  To overcome the challenges presented by the flexibility of this region, 
paramagnetic lanthanides were used in combination with solution nuclear magnetic 
resonance (NMR) spectroscopy to obtain structural information that reports on the 
ensemble of conformations that C1B-C2 samples.  Furthermore, a transient 
intermolecular interaction between C1B and C2 domains of neighboring molecules is 
identified.  
Experimental Procedures
C1B-C2 Purification
The C1B-C2 region from 100-293 of PKC (M. musculus) and isolated C2 
domain of PKCα from Rattus norvegicus (residues 155–293) were cloned as described 
previously. 50,168  All proteins were expressed in E. coli BL21(DE3) cells.  5mL 
overnight cultures were grown from a fresh transformation of the appropriate plasmid 
and transferred to 1 L flasks of Luria-Bertani broth (FisherBioreagents) and grown to an 
OD600 of 0.6 and subsequently induced with 0.5 mM Isopropyl β-D-1-
thiogalactopyranoside (FisherBioreagents) for 16 hours at 15 °C.  For C1B-C2 which 
contains two structural-Zn2+ sites, 10 M ZnCl2 was added to the growth medium just 
prior to induction to ensure proper folding of the C1 domain.  For the preparation of U-
92
15N, [U-13C,15N, 55%-2H], and [U-13C,15N ] proteins, the re-suspension method of 
Marley et al 130 was used.  The M9 minimal medium contained 1 g/L of ammonium 
chloride (15N, 99%) (Cambridge Isotopes) and either 3 g/L d-glucose (Macron 
Chemicals) or 2 g/L d-glucose (13C, 99%) (Cambridge Isotopes) as nitrogen and carbon 
sources, respectively. Induction of protein expression was conducted as described for the 
natural-abundance preparation. After induction cells were harvested by centrifugation at 
4,000 g for 30 min at 4 °C and stored at −20 °C.  
All C2 and C1B-C2 purification steps were carried out using an ÄKTA FPLC 
system (GE Healthcare Life Sciences).  For C1B-C2, cells were lysed using B-PER™ 
Lysis reagent (Thermo-Scientific).  The lysate was clarified by spinning down at 13,000 
RPM for 30 minutes and passed over a HisTrap HP Ni affinity column (GE Healthcare 
Life Sciences) and eluted with a linear gradient of 1 M imidazole (ACROS Organics).  
C1B-C2 was cleaved from its SUMO fusion partner using SUMO protease for 1 hr.  
SDS-PAGE gel was used to assess the completion of the reaction.  The cleavage solution 
was then passed back over the Ni affinity column.  Tag-free C1B-C2 eluted in the flow 
through fractions while histidine-tagged SUMO and SUMO protease bound to the 
column.  As a final polishing step, a cation exchange column (SOURCE 15S) was run in 
the presence of 0.1 mM CaCl2.  Purified C1B-C2 was then transferred to a 10 kDa 
VivaSpin 15R spin concentrator (Sartorius) for decalcification with three washes of 10 
M ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA) and 
buffer exchange into the final buffer.  The isolated C2 domain was expressed and 
purified as previously described. 50  
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Buffers/Metal ion solutions
All buffers were prepared using HPLC grade water (Macron) and trace amounts 
of metal ions were removed using Chelex® 100 resin (Sigma).  For all C1B-C2 
experiments the protein was exchanged into “MES buffer” containing 10 mM MES pH 
6.0, 150 mM KCl, 1 mM Tris(2-carboxyethyl)phosphine hydrochloride (TCEP). For 
NMR experiments 8% D2O (Cambridge Isotopes) and 0.02% NaN3 were added to the 
buffers.  For SAXS experiments 2% glycerol was added to prevent radiation damage.  
Ln2+ stocks were prepared by dissolving Dysprosium (III) Chloride, Thullium (III) 
Chloride, Terbium (III) Chloride, and Lanthanum (III) Chloride (Sigma) in HPLC grade 
water.
Small-angle X-ray scattering (SAXS)
 SAXS experiments were conducted on the SIBYLS 135 beamline at the Advanced 
Light Source synchrotron at the Lawrence Berkeley National Laboratory. Samples of 
200-300 M C1B-C2 were dialyzed against “MES buffer” for 48 hours in the presence 
or absence of 2 mM CaCl2.  Data was collected for a range of concentrations (1, 2.5, and 
4.5 mg/mL) of C1B-C2 in a 96-well plate (Axygen).  SAXS data were collected 
continuously with q ranging from 0.013 to 0.328 with exposures of 0.5, 1, 2, and 5 s.  
Buffer blanks taken before and after each sample exposure were subtracted from the 
sample signal for each concentration.  Data sets free of signs of aggregation/radiation 
damage were merged using the median method in ScÅtter.  For both apo and Ca2+-bound 
94
SAXS data this corresponded to 7 data sets.  SAXS curves collected for both Ca2+-bound 
C1B-C2 and apo C1B-C2 were almost super-imposable, indicating that there are no 
major metal-dependent conformational changes.  Going forward the data for Ca2+-bound 
C1B-C2 was used in the calculations to represent the metal bound state since lanthanides 
were used to extract PCS.  SAXS data were re-binned to match the scattering angles 
calculated by RANCH for individual conformations using a set of scripts provided by 
Dr. Enrico Ravera.
UV-vis spectroscopy
UV-vis spectra were collected on a Beckman DU 640 spectrophotometer. 25 M 
protein (C1B-C2, C2, or C1B) solution or “MES buffer” (for metal ion-only reference 
experiments) were placed in the sample cuvette; the reference cuvette contained metal 
ion-free MES buffer.  Pb2+ was added stepwise from the corresponding stock solutions 
prepared in HPLC water to the sample and reference cuvettes.  The samples were 
incubated for 5 minutes prior to the start of the measurements.  The post-acquisition 
processing included the subtraction of the spectra of free Pb2+ from the spectra of 
protein-containing samples.  The difference spectra were obtained by subtracting the 
spectrum of the apo protein from the spectra of the metal ion containing protein.  All 
spectra were except for apo spectra that was not diluted were corrected for dilution prior 
to subtraction.
NMR spectroscopy
NMR experiments were carried out at 25 °C on a Bruker Avance III system 
equipped with a cryo-probe operating at 1H Larmor frequency of 800 MHz (18.8 Tesla).  
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Temperature was calibrated using deuterated methanol (methanol- d4).169 Sequence-
specific assignments of the 1H, 13Cα, 13Cβ, and 15N resonances for the apo and Ca2+-
bound C1B-C2 were obtained using 2H-decoupled three-dimensional HN(CA)CB, 
HNCA(CB), HN(COCA)CB, and HN(CO)CA experiments on a [U-13C,15N; 55%-2H] 
C1B-C2 sample. 133 Assignments experiments were carried out in the presence of “MES 
buffer” with 50 mM KCl and transferred to 0, 100, and 150 mM KCl conditions.
For 1H-15N relaxation measurements, C1B-C2 was concentrated to 0.3 mM in 
“MES buffer” for NMR. Relaxation parameter sets were measured for all spectrally 
resolved 15N-1H backbone residues for C1B-C2 in the apo and Ca2+-bound states 
containing 6 mM Ca2+  comprising the longitudinal relaxation rate constant (R1), 
transverse relaxation rate constant (R2-CPMG), and 1H-15N nuclear Overhauser 
enhancement (NOE).170,171  The data were acquired in an interleaved manner. Delays 
used for R1 were: 0.080 s, 0.23 s, 0.42 s, 0.65 s, 0.91 s, 1.19 s, and 1.5 s.  Duplicates 
were collected for the 0.08 s, 1.5 s, and 0.65 s time points.  Delays used for R2 were:  
0.006 s, 0.016 s, 0.028 s, 0.044 s, 0.08 s, and 0.100 with duplicates collected for the 
0.006 s, 0.044 s, and 0.1 s time points.  For 1H-15N NOE experiments, a recycle delay of 
10 s was used for the reference experiment and the saturation period was 4 s. It has been 
shown that cross-correlated relaxation between 15N chemical shift anisotropy and 15N-1H 
dipolar coupling becomes significant at high magnetic fields, leading to an incorrect 
steady state. 172,173  This was corrected for by using repetions of [/2--/2], where  is a 
hard 180º 1H pulse and  is set to 22 ms, during the saturation period as described in ref 
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171.  Additionally, a water flip-back element was added to the reference experiment to 
suppress water.
Rotational correlation times were estimated for C1B and C2 as part of the C1B-
C2 construct using ROTDIF 174  assuming an axially symmetric model.  R1/R2/NOE 
values for all spectrally resolved residues were used, omitting residues with NOE values 
< 0.65 and exchange broadened residues 175, and the coordinates from the C1B-C2 
crystal structure.  Values were entered separately for the folded core of C1B and C2 to 
obtain rotational correlation times for each domain. 
HYDRONMR 176 was used to predict the rotational correlation time of the C1B-
C2 crystal structure using 0.0091 poise for the viscosity of water at 25 C and 3.3 Å for 
the effective radius of the atomic elements.  The value for the effective radius was 
chosen based on values used for similar sized multi-domain proteins. 177,178
PCS Restraints
Lanthanide-induced pseudocontact shifts (PCSs) were used to determine the 
conformational preferences of C1B-C2 in solution.  For fully paramagnetic samples, 
either 0.25 mM U-13C,15N C1B-C2 or U-15N C1B-C2 was mixed with equimolar 
amounts of LnCl3 (Ln = La, Tb, Tm, Dy) dissolved in HPLC water to generate a single 
Ln3+ bound to the C2 domain. PCS were measured using 15N-HSQC at 298K at 800MHz 
for C1B-C2 bound to each paramagnetic Ln3+ (Tm3+, Tb3+ and Dy3+) in reference to 
diamagnetic La3+.  Assignment of C2 residues was carried out as described previously. 59  
Assignment of C1B residues in C1B-C2 was done by comparison with the diamagnetic 
spectra.  Mixed experiments were conducted with 0.125 mM U-15N C1B-C2 D246N 
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mutant mixed with 0.125 mM of a 1:1 complex of natural abundance C1B-C2 wild-type 
protein bound to the appropriate Ln3+.
PCSs from the isolated C2 domain were used to determine the axial and rhombic 
components of the magnetic susceptibility tensor anisotropies, metal position, and Euler 
angles for each metal (Table IV-1) using FANTEN 179 and the coordinates for the C2 
domain were taken from the C1B-C2 crystal structure.  PCS for Tm3+ and Tb3+ were 
collected previously. 59 PCS for isolated C2 with Dy3+ were collected as described above 
for C1B-C2.  The correlation between the experimental and back calculated PCS is 
shown in figure IV.1.
Table IV-1.  Magnetic Susceptibility Tensor parameters determined for C2.
Ln3+
Ln3+ 
coord (x)
Ln3+ 
coord (y)
Ln3+ 
coord (z)
axial 
(12•10-6• Å3)
rhombic 
(12•10-6• Å3)
     
Tb3+ -7.8 16.8 18.4 12572.62 -2206.43 -71.9 -80.3 -76.9
Dy3+ -7.8 16.8 18.4 16355.03 -2793.516 -108.5 -76.9 -77.3
Tm3+ -7.8 16.8 18.4 -7192.59 2569.155 -109.4 -103.2 100.8
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Figure IV.1  Agreement of PCS for tensor determination.  Comparison between 
observed and back-calculated PCS from FANTEN tensor fitting.
Determining Intra-PCS
A transient intermolecular interaction that gives rise to PCS on C1B was detected 
for C1B-C2.  To disentangle the contributions from intra- and intermolecular PCS, a pair 
of NMR experiments were conducted for each Ln3+ (Figure IV.2). 
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Figure IV.2  NMR experimental set up designed to separate intra- and inter-PCS. 
Sample 1 contained 250 M of U-15N enriched C1B-C2 with a single lanthanide 
ion bound in the loops of C2 (prepared as described above). The PCS observed on C1B 
in 15N-HSQC have two contributions:  intramolecular PCS from its own C2 domain and 
intermolecular PCS from the interaction between neighboring C1B-C2 molecules.  The 
equation for the observed residue specific PCSs is therefore: 
Equation 13
  PCSobs,1 =  PCSintra + f𝐷 PCSinter 
where  is the fractional population of the C1B-C2 dimer.f𝐷
 Sample 2 contained 250 M of equimolar amounts of natural abundance, “NMR-
invisible” C1B-C2 bound to a lanthanide ion and U-15N enriched C1B-C2 D246N 
mutant.  This mutant disrupts a key metal binding residue in the loops of C2 and has 
been shown to abolish metal binding.  Therefore, the observed PCS only has one 
contribution from the intermolecular interaction between C1B-C2 molecules.  The 
equation for the residue specific observed PCSs is:
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Equation 14
  PCSobs,2 =  0.333 f𝐷 PCSinter 
There are three potential types of dimers in the mixed sample, only one of which 
gives rise to PCS.  Therefore, the 0.333 scaling factor comes from the fraction of the 
productive dimer.  Combining the above equations yields the equation for the 
intramolecular PCS:
Equation 15
  PCSintra =  PCSobs,1 ― PCSobs,20.333  
The above set of experiments were conducted with Dy3+, Tm3+, Tb3+, and La3+ 
and used to extract intramolecular PCS.  These PCS were then used for MaxOcc 
analysis. 
Measurement of intermolecular 1H PRE rates
3-(2-Iodoacetamido)-PROXYL was purchased from Sigma Aldrich.  Cysteines 
were substituted for lysines on C1B-C2 at positions 181/268 and 181 for C2 using a 
QuikChange® Site-Directed Mutagenesis kit (Stratagene). All cysteine variants were 
prepared without isotope labeling.  The cysteines were covalently modified with 3-(2-
Iodoacetamido)-PROXYL under the following conditions: 75 M protein, 6 x molar 
excess of PROXYL, and 20 mM TrisHCl buffer at pH 8.0 with 150mM KCl.  The 
reaction was allowed to proceed for 18 hours, in the dark under nitrogen.  Reducing 
reagent was removed just prior to modification with two rounds of desalting using PD-
10 desalting columns (GE).  The completeness of the reaction was assessed using mass-
spectrometry.  Excess of the labeling reagent was removed using VivaSpin 2 
centrifugal concentrators (Viva Products) with a molecular weight cutoff of 5 kDa for 
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C2a and 10 kDa for C1B-C2.  The modified proteins were exchanged into NMR buffer 
and used for the preparation of the paramagnetic and diamagnetic NMR samples.  The 
“paramagnetic” samples were generated by mixing equimolar amount of PROXYL-
tagged natural abundance K181C/K268C C1B-C2 and [U-15N] enriched wild-type 
protein. A diamagnetic variant of PROXYL was not commercially available so therefore 
the unmodified protein was used as a diamagnetic reference in the case of C1B-C2.  The 
total protein concentration was 0.3 mM in the C1B-C2 samples.  
The 1H paramagnetic relaxation enhancement (PRE) rates 2 are defined as the 
difference in the 1H transverse relaxation rate constants obtained for the diamagnetic and 
paramagnetic samples, R2,dia and R2,para:
Equation 16
2  R2,para  R2,dia
The measurements of the 1H R2 values were conducted on an 18.8 Tesla NMR 
instrument using the two-point acquisition scheme.180  The uncertainties in 2 values 
were estimated from the root-mean-square noise of the spectral planes, as described in 
ref 180.
Maximum Occurrence Calculations
Maximum occurrence (MO) calculations were employed to characterize the 
conformational space sampled by C1B-C2 using the MaxOcc software 181  kindly 
provided by Drs. Enrico Ravera and Witold Andralojc. Calculations were conducted on 
the Ada and Terra clusters of the Texas A&M High Performance Research Computing 
facility.  For these calculations, a large pool of conformations is needed to represent the 
102
conformational space that C1B-C2 can sample.  50,000 random conformations of C1B-
C2 as well as their scattering profiles were generated using RANCH 2.1 (from the 
Ensemble Optimization Method software suit developed by the European Molecular 
Biology Laboratory)  163 taking the starting coordinates from the C1B-C2 crystal 
structure.  The coordinates of C2 were held fixed and the coordinates of C1B were 
randomized by varying the dihedral angles of the linker residues (M153-K159) using 
angles typically found in intrinsically disordered proteins.  Pseudocontact shifts were 
then calculated for each of the 50,000 conformations using the program CALCALL (also 
provided by Drs. Enrico Ravera and Witold Andralojc 182) and the tensor parameters 
determined from isolated C2.  The MO values are determined individually for randomly 
selected conformations and represent the maximum population that each conformation 
can have in solution as part of an ensemble and still be compatible with experimental 
observables.  Conformations with high MO values are therefore more likely to be 
sampled. The MO values were calculated for 600 randomly selected structures, using the 
experimental SAXS data and PCS as restraints (weighted 0.05 and 1 respectively).  To 
determine the MO value, MaxOcc increases the weight of the selected conformation 
(and therefore its calculated PCS and SAXS) in combination with all other 
conformations in the pool until there is no longer agreement with the experimental 
observables. The top scoring structures with MO values above 0.4 as well as the bottom 
structures with MO values less than 0.1 were chosen for further analysis.  This resulted 
in 49 and 38 structures, respectively. 
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Results
C1B-C2 crystallizes in a compact conformation 
The crystal structure for C1B-C2 was previously determined by Dr. Krystal 
Morales in collaboration with Drs. Anup Aggarwal, Joseph Mire, and James Sacchettini 
(Figure IV.3).  While crystallization of both the apo and Ca2+-bound states were 
attempted, only the Pb2+-bound form of C1B-C2 would crystallize.  In the conformation 
that crystallized, there is an interaction between C1B and C2 mediated by a fourth Pb2+ 
ion that coordinates D254 in C2 and two cysteines, C118 and C143, that also coordinate 
a structural Zn2+ ion in the C1B domain.  A citrate molecule completes the coordination 
sphere of the fourth Pb2+ ion.  This interaction sequesters an area of 565 Å2 and forces 
C1B-C2 to adopt a compact conformation.  Electron density is completely missing for 
residues 154-156 and most of the side chain electron density is missing for 157-158, 
which suggests that despite the fixed orientation of C1B-C2 mediated by Pb2+, the linker 
region is flexible.  Compared to the isolated domains (C1B NMR structure, 2ELI and C2 
Pb2+-bound X-ray structure, 3TWY) the pairwise root-mean-square deviations for 
backbone atoms were 0.848 Å and 0.466 Å for C1B and C2 respectfully.  This indicates 
that connecting the two domains using their native linker does not significantly perturb 
their backbone conformations.  The conformation that crystallized is not compatible with 
the simultaneous membrane binding of C1B and C2.  As a result of Pb2+ serving as a 
cross linker, the C1B and C2 membrane binding loops point in different directions and a 
portion of CMBL1 is sequestered.  This mode of crosslinking comes from the unique 
properties of Pb2+.  As an intermediate Lewis acid, it can coordinate both oxygen and 
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sulfur ligands.  PKCs native ligand, Ca2+, is a hard Lewis acid that prefers all oxygen 
coordination spheres and could not coordinate both C1B and C2 in this manner.  
Therefore, while this structure provides information about domain structure of C1B-C2, 
it is unlikely that this is a major conformation in solution in the absence of Pb2+.  It was 
clear that crystallography is not a viable approach to structurally characterizing this 
region.  Therefore, going forward, a solution NMR approach was pursued. 
 
Figure IV.3  C1B-C2 crystallizes in a compact conformation.  Crystal structure of 
C1B-C2 showing the domain structure of C1B and C2 along with the details of Pb-
coordination and crosslinking between C1 and C2.  
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C1B-C2 is partially flexible in solution
As a first step to probing the behavior of C1B-C2 in solution, the rotational 
diffusion properties of C1B-C2 were evaluated.  R1, R2, and {1H}-15N nOe relaxation 
parameters were collected for the C1B-C2 backbone N-H groups in two metal-ligated 
states: apo and Ca2+-bound (Figure IV.4).  The objective of these experiments was two-
fold:  to characterize the C1B-C2 backbone sub-nanosecond motions and to determine if 
these motions are altered by Ca2+ binding.  Residues with a poor signal-to-noise ratio 
and poor resolution were omitted from the analysis.  This resulted in 134 backbone 
amide groups that were suitable for analysis of apo C1B-C2 and 135 residues that were 
suitable for analysis of Ca2+-bound C1B-C2.  Detailed inspection of the relaxation data 
indicated that the crystallized compact conformation of C1B-C2 is likely not a major 
conformation in solution.  The average R1 values of each of the three regions (C1B, 
linker, and C2) were different, which indicates that each region has a different mobility 
on the sub-nanosecond timescale.  Interestingly, there were also no differences in the 
average R1 values of each region upon the addition of Ca2+ consistent with no change in 
the picosecond to nanosecond motions of the C1B-C2 region upon Ca2+-binding.   The 
median R2 values, which are additionally sensitive to the overall molecular tumbling 
rate, were lower for C1B than C2 in both metal-bound states (Table IV-2), which 
indicates that the motions of the domains are at least partially uncoupled from one 
another.  This is echoed by the rotational correlation times that were estimated from the 
R1, R2, and NOE values (Table IV-3).  In the context of the two domain region, C1B and 
C2 have different correlation times compared to their isolated counterparts.  
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Furthermore, C1B’s rotational correlation time is lower than that predicted from the 
crystal structure using HYDRONMR.  This is consistent with an intermediate case of the 
domains neither tumbling completely dependent nor completely independent of one 
another.  There was a uniform elevation in the R2 rates (Figure IV.4) of the Ca2+-bound 
C1B-C2 compared to the apo.  Again, this was reflected in a uniform increase of the 
rotational correlation times for C1B and C2 in the Ca2+-bound state.  The most likely 
explanation for this is an increase in the apparent size due to either a small amount of 
aggregation in the presence of Ca2+ or transient self-association between neighboring 
C1B-C2 molecules.  Self-association has been observed previously in the isolated C2 
domain in the presence of Ca2+. 183  It is possible that C1B-C2 self-associates in the same 
manner upon addition of Ca2+.  Another explanation is that there is a transient interaction 
between neighboring C1B and C2 domains that mimics the proposed interaction between 
C1A and C2.    
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Figure IV.4  C1B-C2 is partially flexible.  (A-C) 15N C1B-C2 relaxation data 
comprising R1, R2, and NOE at 800 MHz.  
Several signatures indicate that the linker region between the C1B and C2 
domains is at least partially flexible.   The median R2 values of the linker region are 
lower in the apo form relative to C1B and C2, and the R1 values are elevated for the 
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linker region in both the apo and Ca2+ bound forms (Figure IV.4).  The NOE values of 
the linker region in both the apo and Ca2+-bound C1B-C2 are lower than the folded 
domains’ NOE values, indicating greater flexibility in this region.  
The detailed inspection of the properties of the individual residues revealed that 
the dynamic “QG” motif (Q128 and G129) in the C1B domain has elevated R2 values 
consistent with conformational exchange on the microsecond to millisecond times 
scales, which was observed with previous studies. 103  Therefore, the dynamics of the 
isolated C1B domain are preserved in the context of the two-domain construct.  In 
addition, elevated R2 values are observed for CMBL3 residues, D248 in the apo state, 
and T250 in the Ca2+-bound state.  The NOE values are also lower for this region (246-
253) in both the apo and Ca2+-bound states, which is again consistent with the behavior 
observed of the isolated C2 domain. 183  
Collectively, these data show that each domain retains its properties in the 
context of its neighbor and behaves as a flexible protein in solution, mediated by its 
dynamic inter-domain linker.  However, two things suggest that the domains are not 
tumbling randomly and independently of one another.  First, the NOE values for the 
linker region are higher than one would expect for a completely flexible or disordered 
region which would typically have very low or even negative NOE values.  Additionally, 
both domains have elevated rotational correlation times relative to their isolated 
counterparts.  Therefore, it is likely that the linker region is not completely unrestricted 
and that C1B-C2 may adopt preferred orientations in solution.  To investigate this, an 
approach was developed with paramagnetic lanthanides to characterize the 
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conformational space sampled by C1B-C2.  The ultimate goal is to assess the position of 
the membrane binding loops prior to membrane insertion. 
Table IV-2. Median R1, R2, and NOE values for C1B-C2 in the different metal-
ligated states.
R1 (s-1) R2 (s-1) NOE
Apo                  
C1B 0.89 17.4 0.73
C2 0.61 21.3 0.74
linker 0.83 14.5 0.58
Ca2+                   
C1B 0.87 20.3 0.73
C2 0.61 23.9 0.76
linker 0.89 20.1 0.56
Table IV-3. Rotational correlation times predicted from ROTDIF 3.1 (C1B-C2) and 
from ref 103 and 183 for isolated C1B and C2 respectively. *Predicted values from 
HYDRONMR and the crystal structure.
Apo (ns) Ca2+-bound (ns) Predicted* (ns) Isolated apo (ns) Isolated Ca2+(ns)
C1B 10.5±0.03 11.5±0.1 13.6 3.28 -
C2 13.7±0.2 14.9±0.1 13.6 9.0±0.1 9.3±0.1
Conformationally averaged restraints  
The high magnetic moment of unpaired electrons results in profound effects in an 
NMR spectra.  All paramagnetic substances give rise to paramagnetic relaxation 
enhancement (PRE) that results in broadening of the observed resonances in proximity 
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to the paramagnetic center.  In paramagnetic substances with anisotropic magnetic 
susceptibility tensors, meaning the magnitude of the magnetic susceptibility changes 
with direction, there are two additional effects:  pseudocontact shifts (PCSs) and residual 
dipolar couplings (RDCs).  PCS depend on the distance and orientation of the nuclei 
being observed with respect to the paramagnetic center.  RDCs are distance independent 
and depend on the orientation of the bond vector of the J-coupled nuclei with respect to 
the metal center.  The distance and orientation dependence of these effects can be 
exploited to gain structural information.  In the case of flexible, multidomain proteins, 
these restraints are conformationally averaged, with largely populated conformations 
making a larger contribution to the measured restraint.  Here the Maximum Occurrence 
method is used with PCS and small angle X-ray scattering (SAXS) as restraints to 
determine the maximum weight that sterically allowed conformations in solution can be 
and still be compatible with the experimental restraints.  This gives information on 
which conformations are the most likely to be sampled by C1B-C2 in solution as well as 
on which areas are less populated.  
Paramagnetic lanthanide ions are useful for gaining structural information for 
biological macromolecules due to their varied paramagnetic properties.  A single 
lanthanide ion can be bound in the loops of the C2 domain 59 and from this 162 
intramolecular PCS were collected on the C1B domain from three different 
paramagnetic lanthanide ions bound to the C2 domain: Tm3+, Tb3+, and Dy3+ (Figure 
IV.5).  All three metal ions have anisotropic magnetic susceptibility tensors.  La3+ was 
used as a diamagnetic reference.  
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Figure IV.5  Intramolecular PCS for C1B-C2 bound to Ln3+ at 800 MHz.
In order to gain structural information from PCS, the coordinates of the metal 
center, the magnitudes of the axial and rhombic components of the magnetic 
susceptibility tensors, and the Euler angles relating the tensor to the molecular frame of 
the protein must be determined.  These parameters were determined from the PCS on the 
isolated C2 domain. 59  Due to a transient self-association detected between neighboring 
molecules, the C1B intramolecular PCS had to be extracted according to the protocol 
outlined in the methods section above.  The calculated PCS from the best fit ensemble 
are in good agreement with the experimental PCS
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. The Maximum Occurrence value (MO value) was calculated for each randomly 
selected conformation using a target function set such that the q-factor at the given 
weight of any conformer taken with the rest of the possible conformations could not 
exceed 20% greater than the q-factor of the best fit ensemble. In addition to PCS, SAXS 
data were collected for both Ca2+-bound C1B-C2 and apo C1B-C2 (Figure IV.6).
  
Figure IV.6  SAXS data for C1B-C2 in the apo and Ca2+- bound forms. Lack of 
changes are observed in comparisons of the raw scattering curves (A), P(r) (B), and the 
dimensionless Kratky plot (C).  
The SAXS data were consistent with the NMR dynamics data.  The SAXS 
curves for both metal bound states were almost super-imposable, which indicates that 
there are no major Ca2+-dependent conformational changes (Figure IV.6).  Furthermore, 
the dimensionless Kratky plot displayed the characteristics of a flexible, multidomain 
protein:  a plateau-like region at larger qRg values and lack of a maximum of 1.1 at qRg 
= √3.  Since there were no metal dependent changes in the scattering data, the Ca2+-
bound C1B-C2 data was used.  The agreement between the experimental and calculated 
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scattering intensity and PCS are good for the best fit ensemble (Figure IV.7B).  Overall, 
the data were sufficient to determine the conformational preferences of C1B-C2. 
Figure IV.7  Comparison of the experimental PCS and SAXS curves with the 
averaged data from the best fit ensemble chosen by MaxOcc. (A) Comparison of 
experimental and calculated PCS. (C) Comparison of the full experimental SAXS data 
with calculated SAXS data.
C1B-C2 samples primarily open conformations 
The MO values were determined for 600 structures that were randomly selected 
from a pool of 50,000 conformations, representing the allowed conformational space of 
C1B-C2.  The distribution of MO values ranged from 0.03 to 0.68, and only 8% of the 
total structures had MO values greater than 0.4 (Figure IV.8A). 6% of the structures had 
MO values below 0.1, which indicated that a portion of the theoretically allowed 
conformational space cannot be appreciably populated and still be consistent with the 
data.  The conformation of C1B-C2 in solution isn’t random and the experimental 
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restraints are sufficient to distinguish between the areas that C1B-C2 can and cannot 
sample.  
To characterize the structures that were the most consistent with the experimental 
data and therefore the most representative of the conformations sampled by C1B-C2, a 
set of angles,  and , were defined to determine the relative position of the C1B loops 
to the C2 loops (Figure IV.8B).  The parameter, R, was defined as the distance between 
the C atom of L125 and T251 on the loop tips of C1B and C2, respectively (Figure 
IV.8B).    was defined as the angle between R and the Z-axis of the C2 inertia tensor 
and ranges from 0° to 180° (Figure IV.8B).   is defined as the angle between R and the 
X-axis of the C2 inertia tensor and ranges from -180° to 180°.
Figure IV.8  Conformational analysis of C1B-C2.  (A) Distribution of MO values for 
600 structures from MaxOcc analysis.  (B) Random C1B-C2 conformation from the 
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MaxOcc analysis with the parameters used to characterize the conformational space 
sampled by C1B-C2.
The distributions of R, , and  for the top-scoring structures with MO values 
above 0.4 as well as the bottom structures with MO values less than 0.1 (Figure IV.9) 
were evaluated.  The top-scoring structures are on average more extended than the low-
scoring structures, with smaller R values correlating with lower MO scores (Figure 
IV.9A). The distance between the tips of the C1B and C2 loops varies from 39 to 67 Å 
for the top structures. For the low-scoring structures, the distances are between 16 and 
41 Å, which indicates that these structures are more compact.  The ranges of both   and 
 are also slightly more narrow for the top-scoring structures versus the low-scoring 
structures (Figure IV.9B,C).  The conformations with high MO values have  values that 
range from 38 to 136° whereas the low-scoring conformations range from 16 to 134°.  
The range of  values is even narrower for the top-scoring conformations (Figure 
IV.9C).  Collectively, this indicates that the motion of C1B relative to C2 is somewhat 
restricted and that all conformations cannot be sampled equally.  This is consistent with 
C1B-C2 relaxation data that show that the linker region isn’t fully flexible.  
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Figure IV.9 C1B-C2 samples a narrow region of the allowed conformation space.  
Distributions of R (A),  (B), and  (C) for the top and bottom conformations from the 
MaxOcc analysis. 
C1B-C2 samples “open” conformations, poised for membrane insertion
The top and bottom structures from the MaxOcc analysis were inspected and 
overall, the low-scoring structures were more compact than top-scoring structures.  
There were 6 structures with MO values above 0.5 (Figure IV.10). 
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Figure IV.10  C1B-C2 samples mostly “open” conformations.  Top-scoring 
conformers from C1B-C2 MaxOcc analysis. The membrane-binding loops are indicated 
with grey circles. 
These structures can be more than 50% populated in solution and still be 
compatible with the experimental observables. In all structures in this category C1B-C2 
is in an “open” conformation, with both membrane binding sites exposed and C1B 
pushed away from C2.  While in the entire pool of conformations C1B can sample many 
orientations near the bottom and top of C2, in all of the top structures C1B is found to 
the left of the C2 loops. The membrane binding sites for C1B and C2 have varied 
relative orientations. However, in all structures both sites are free to bind their respective 
membrane-embedded ligands. Most of the top scoring conformations have loop positions 
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that would be compatible with the loops of both domains binding the membrane 
simultaneously.  However, for two of the six top scoring conformations, the C1B 
domain’s position relative to the C2 domain would need to change significantly in order 
for the simultaneous binding to membranes to take place.  
Compact conformations, like the conformation found in the crystal structure, 
scored consistently lower in the MaxOcc analysis, which indicates that they cannot be 
highly populated in solution. All but one of the low-scoring conformations have relative 
positions in the C1 and C2 membrane binding sites that would require significant 
rearrangements to allow for simultaneous membrane insertion (Figure IV.11). 
Furthermore, in some structures, the C2 loops are partially occluded. In all structures, 
C1B is packed up against C2 loops. This is true for the Pb-crosslinked crystal structure 
as well.
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Figure IV.11  Compact conformations score low in MaxOcc analysis.  Bottom 
scoring structures from MaxOcc analysis.  The membrane binding loops are indicated 
with grey circles.
Using Naccess with a probe size of 1.4 Å, the solvent accessibility of the top and 
bottom scoring conformers (Figure IV.12A-B) was calculated.  For the top-scoring 
conformation there was no change in the solvent accessibility relative to the isolated 
domains for the C1B or C2 loop regions.  However, the bottom-scoring conformation 
had a decreased solvent accessibility of CMBL1 and CMBL3 (sequestering 81.4 and 
98.9 Å2, respectively).  Collectively, this suggests that C1B-C2 samples states that are 
poised for the simultaneous membrane insertion of the C1 and C2 domains and that the 
C1B domain does not occlude the membrane binding of the C2 domain to membranes.  
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This is in sharp contrast to the C1B-C2 crystal structure that shows the C1B-C2 region in 
a compact conformation. 
Figure IV.12  C1B-C2 samples “open” conformation in solution.  (A) Top structure 
from MaxOcc analysis of C1B-C2 with , , and R indicated on heat maps.  (B) Bottom 
structure from MaxOcc analysis of C1B-C2 with , , and R indicated on heat maps.
C1B-C2 transiently self-associates
It was surprising to find that C1B-C2 gave rise to PCS on neighboring molecules 
through transient self-association.  The PCS detected on C1B-C2 were primarily in the 
C1B loops, which suggested that there was an interaction between neighboring C1B and 
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C2.  To determine if this was mediated by lanthanide ions, it was investigated if this 
dimer was detectable in the apo form of the protein.  To gain access to the apo form of 
C1B-C2, paramagnetic relaxation enhancement (PRE) was used.  PRE is an excellent 
tool for detecting transient protein-protein interactions. By attaching a paramagnetic tag 
to the C2 domain PRE in the apo state can be measured without the need for 
paramagnetic metal ions.  Two C1B-C2 cysteine variants (K181C and K268C on the C2 
domain) were constructed in order to measure intermolecular PRE in C1B-C2 and 
modified them with a PROXYL tag harboring a stable nitroxide group bearing an 
unpaired electron. PROXYL-tagged, natural abundance C1B-C2 cysteine mutant was 
mixed with U-15N C1B-C2wt with no paramagnetic tag (Figure IV.13B).  PRE was 
collected for backbone amide groups (Figure IV.13D) as described in the methods 
section and was observed again primarily on C1B loop residues.  There was a smaller 
elevation of PRE values for the C2 loop region and the interdomain linker region.   
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Figure IV.13  C1B-C2 has propensity to self-associate in a manner that is unique 
from the isolated C2 domain. (A-B) Experimental design for paramagnetic 
intermolecular experiments. (C)  Detected intermolecular PCS on C1B-C2 at 800 MHz.  
(D)  Intermolecular 1H Γ2 values plotted against the residue number in C1B-C2.  
Residues that were broadened beyond detection are assigned a 1H Γ2 rate of 100 s-1. 
Collectively, this indicates that a transient intermolecular interaction exists 
between neighboring C1B-C2 molecules, likely between the C1B and C2 domains.     
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Discussion
In the activation pathway, PKC starts out in a compact, latent form where the 
membrane binding sites of the regulatory region are masked by at least two proposed 
intermolecular interactions: C1A/C257,58 and C2/V5.59  Prior to membrane binding, the 
C1 domains must be unmasked in order to bind their respective ligands.  There is no 
structural information about the regulatory region during any of phase of the activation 
pathway.  The data presented in this chapter takes the first steps to understanding the 
structure and dynamics of this region during activation by characterizing the 
conformations sampled by the C1B-C2 domains.  By omitting the C1A domain that has 
been proposed to interact with the C2 domain in the full length enzyme, insight into the 
conformational preferences of the C1B-C2 region after unmasking of the C1 domains 
but prior to membrane insertion can be gained.  Despite the large area of allowed 
conformational space that can theoretically be sampled by C1B-C2, only a narrow range 
of space can be appreciably populated and still be consistent with the data.  This analysis 
found that C1B-C2 samples more extended, “open” conformations, with both sets of 
loops exposed.  In a majority of the top scoring conformers, the membrane binding loops 
of C1B and C2 face the same plane in orientations that would be compatible with 
simultaneous membrane binding.  While the flexible linker allows C1B-C2 to sample 
many conformations, this raises the possibility that membrane binding proceeds through 
conformational selection, where the membrane-bound conformation of C1-C2 pre-exists 
and facilitates ligand recognition.
124
It is proposed that Ca2+ binding serves multiple purposes in modulating C2 
affinity for membranes:  contributing to the change of electrostatic potential in C2, 
coordinating the head groups of anionic lipids such as phosphatidylserine (PS), and 
contributing to interdomain rearrangements in the regulatory region that primes the 
enzyme for membrane association.44  The former two have been studied extensively in 
the context of isolated C2 domains.184  Although Ca2+ binding does not have a profound 
effect on the structure of the C2 domain50, it has a large effect on the conformational 
dynamics of the loop regions and the dynamics and stability of the N- and C-termini. 183  
The latter is thought to give rise to the conformational rearrangements that lead to the 
solvent exposure and ligand recognition of the membrane binding sites of C1 and C2 
domains.  However, the impact of calcium binding on the structure and dynamics of the 
full regulatory region of PKC remains uncharacterized.  
Due to the changes in the N-terminus of C2 upon Ca2+ binding, the work in this 
chapter investigated if Ca2+-binding propagated these changes to the C1B domain due to 
their proximity in the primary structure of PKC.  No changes were observed in the sub-
nanosecond dynamics upon Ca2+ binding.  Furthermore, according to the SAXS data, 
there are no major perturbations in the conformations sampled by C1B-C2 upon Ca2+ 
binding.  Propagation of the Ca2+-binding event to the parent enzyme therefore likely 
requires the involvement of the C1A domain and the kinase domain185 or a change in 
dynamics on a different time scale.  Further studies on the full regulatory region are 
needed to understand the structural impact of Ca2+ binding.  
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One surprising finding of these studies is that C1B-C2 transiently self-associates 
through an interaction between C1B and C2.  Several studies have highlighted the ability 
of PKC to self-associate through interactions within the regulatory domains.57,58,186  
While there are no proposed interactions between C1B and C2 domains that have been 
shown to be important for function, several studies focus on the importance of C1A/C2 
interactions for maintaining the latent enzyme.  Despite this, there is no structural 
information about this interaction.  A high sequence identity between C1A and C1B 
domains raises the possibility that the C1A/C2 mode of interaction is being probed.  
C1A domains are notoriously instable and insoluble.  The intermolecular experiments 
with C1B and C2 could open the door to future studies to use C1B as a surrogate to gain 
structural information about the C1A/C2 interaction.  Mutations can then be designed on 
the C1A domain in the full length enzyme to study their impact on function and to 
validate the resulting structural model.
Collectively, the work presented in this chapter highlights the importance of 
flexibility in the structure and function of the PKC regulatory region and opens the door 
to new ways of targeting PKC, as well as study the intermolecular interactions that 
stabilize the latent enzyme.
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CHAPTER V 
MULTIVALENT INTERACTIONS OF THE C1B-C2 REGULATORY REGION 
WITH MEMBRANE MIMETICS AND FUTURE DIRECTIONS
Background
In this chapter, the objective is to elucidate how the PKC regulatory domains 
interact with membranes in the presence of their native ligands and how these 
interactions differ when C1B is bound to tumor-promoting phorbol esters.  Membrane 
binding of the C2 domain from the regulatory region of conventional PKCs and the 
subsequent membrane insertion of one or both C1 domains is required for full activation 
of conventional PKCs.167,187  This process is modulated by metal ions 3,188, anionic lipids 
189, and membrane-embedded diacylglycerol.  However, the mechanistic details of the 
membrane association process are poorly understood.  These studies focused on 
obtaining structural information about the interactions of the PKC regulatory domains 
with membrane mimetics and how these interactions modulate the Ca2+ requirements of 
membrane association.  
Conventional isoforms contain tandem C1 domains preceding a Ca2+-dependent 
C2 domain.  The C2 domain binds both phosphatidylserine (PS) and phosphatidyl-
inositol 4,5-bisphosphate (PIP2) in a Ca2+-dependent manner. The native agonist for C1 
domains is diacylglycerol, made available by the hydrolysis of PIP2.  Like 
diacylglycerol, plant-derived phorbol esters can also facilitate the membrane association 
process of PKC but C1 domains have a much higher affinity for phorbol esters compared 
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to diacylglycerol.  Activation of PKC by phorbol esters leads to prolonged activation, 
faster downregulation of PKC 190 and tumorigenesis.4,79,191  Researchers are limited in 
their design of potential PKC activators because of their phorbol ester-like tumor 
promoting activities.  Therefore, understanding the structural differences in phorbol 
ester- and diacylglycerol-induced activation of PKC is extremely important for 
designing better modulators of PKC that lack tumor-promoting activity.  Despite the 
importance of PKC activators, existing information about C1 domain/membrane 
interactions is limited.  This is, in part, largely due to the challenges of working with 
peripheral membrane binding proteins and selecting membrane mimetics that are both 
suitable for biophysical studies and physiologically relevant. 
Upon binding C1 ligands hydrophilic residues in the binding cleft are masked, 
increasing the hydrophobicity of the domain and facilitating membrane insertion. 30  The 
membrane interactions of C1B domain from PKC has been explored in micelles with 
and without a short chain diacylglycerol analog, DOG. 167  The addition of DOG was 
found to change the depth of insertion.  However, the lose packing and curvature of 
micelles does not always faithfully reproduce the conditions of a planar bilayer.  
Additional studies are needed in membrane mimetics containing a bilayer.  
This chapter describes efforts towards obtaining structural information of the 
regulatory domains in complex with isotropically-tumbling bicelles in the presence of 
different C1 domain targeting cofactors, specifically diacylglycerol and phorbol 12,13-
dibutyrate.  Bicelles are composed of long chain lipids that form a bilayer with 
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hydrophobic edges capped by short chain lipids.  Bicelles have the advantage of a 
physiologically relevant bilayer packaged in a small NMR-friendly form.
In addition, conventional and novel PKCs have complex, multivalent interactions 
with membranes that require coordination of multiple domains and multiple ligands. To 
examine the multivalent nature of PKC, the interplay between metal ions and lipid-
ligands in the membrane binding process will also be probed. 
Experimental Procedures
C1Bα Purification
C1Bα was purified according to Stewart et. al. 103  PKCα cDNA from Mus 
Musculus was purchased from Open Biosystems and residues S100-G152 were cloned 
into a pET-SUMO expression vector (Invitrogen) bearing kanamycin resistance as a C-
terminal fusion with histidine-tagged SUMO.  Plasmids were transformed into 
BL21(DE3) E. coli cells and colonies were inoculated into 5 mL Luria Bertani (LB) 
broth supplemented with 50 g/mL Kanamycin.  Cell cultures were grown to an optical 
density (OD) of 1 and used to inoculate 4- 1 L cultures of LB.    At OD 0.6, the cultures 
were spun down at 3,500 RPM for 25 minutes and washed with M9 salts.  The pellets 
were resuspended in 1 L of 85% D2O minimal media supplemented with 0.5 g of 13C, 
15N, D Isogro ® powdered growth medium (Sigma) with 2 g/L 13C-glucose (Cambridge 
Isotopes) and 1 g/L 15N-ammonium chloride (Cambridge Isotopes) as carbon and 
nitrogen sources, respectively.  Protein production was induced with 0.5 mM isopropyl 
β-D-1-thiogalactopyranoside (IPTG) at 15 ºC for 16 hours. 10 M ZnSO4 was added to 
the cultures just prior to induction to ensure proper folding.  Cells were harvested at 
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4,000 RPM for 30 minutes.    For NMR experiments, the proteins were concentrated to 
0.3–0.5 mM, and exchanged in the buffer containing 20 mM [2H-4]-imidazole at pH 6.5 
(Cambridge Isotopes), 50 mM KCl, 8% 2H2O, 1 mM tris(2-carboxyethyl)phosphine 
(TCEP), and 0.02% NaN3. 
C1B-C2 Purification and sample preparation
C1B-C2 linker variants were created using a QuikChange Site-directed 
mutagenesis kit (Stratagene).  C1B-C2 and its variants were purified as described in 
Chapter 4.  For NMR experiments, [U-15N, 75%-2H] C1B-C2 was concentrated to 0.3 
mM in 10 mM MES pH 6.0, 150 mM KCl, 1 mM TCEP, 8% 2H2O, and 0.02% NaN3. 
Preparation of bicelles
Isotropic tumbling bicelles with a q of 0.5 were used as membrane mimetics for 
C1B-C2 and isolated C1B experiments.  The composition of bicelles for C1B-C2 
experiments was:  6.7 mol % 1,2-dimyristoyl-sn-glycero-3-phospho-L-serine (DMPS), 
26 mol %, 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 60.0 mol % 1,2-
dihexanoyl-sn-glycero-3-phosphocholine (DHPC), 6.6 mol % 1,2-dihexanoyl-sn-
glycero-3-phospho-L-serine (DHPS), and 0.7 mol % L-α-phosphatidylinositol-4,5-
bisphosphate (PIP2) (Brain, Porcine).  This resulted in 17.2 DMPS and 1.7 molecules of 
PIP2 per bicelle.  For isolated C1B, bicelles were prepared with 33.3% DMPC and 
66.6% DHPC.  The short chain and long chain lipids dissolved in chloroform were 
measured out separately and dried under a stream of N2 (g).  The dried lipids were 
placed under vacuum for two hours.  The lipids were rehydrated with buffer, mixed, and 
subjected to freeze/thaw cycles with vortexing in between until the solution remained 
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clear at room temperature.  Phosphate quantification assay was used to measure the 
concentration of the bicelle stocks.  For diacylglycerol (DAG) experiments, the short 
chain diacylglycerol analogue, 1,2-dioctanoyl-sn-glycerol (DOG), was mixed with the 
long chain lipids before mixing to ensure that DOG was trafficked to the bilayer.
Measurement of 1H Paramagnetic Relaxation Enhancement
Transverse 1H paramagnetic relaxation enhancement (PRE) rates were collected 
for C1B in complex with bicelles on a Bruker AVANCE III instrument operating at a 
1H Larmor frequency of 800 MHz equipped with a cryogenically cooled probe.  D4-
methanol was used to calibrate temperature.  For paramagnetic samples, 1-palmitoyl-2-
stearoyl-(5-doxyl)-sn-glycero-3-phosphocholine (Avanti) was incorporated into the 
bicelles with two molecules per bicelle.  This was done by drying down the appropriate 
amount of paramagnetic lipids and incubating it with the diamagnetic sample.  PRE rates 
were measured and calculated as described in Chapter 4 with the exception that the pulse 
program was modified with a Transverse Relaxation-Optimized Spectroscopy (TROSY) 
192 selection scheme.
Measurement of PCSs and RDCs
Pseudocontact shifts (PCSs) for linker variants were collected as described in 
Chapter 4 on a Bruker AVANCE III instrument operating at a 1H Larmor frequency of 
600 MHz.  In addition, residual dipolar couplings (RDCs) were measured for native, 
Ln3+-bound C1B-C2 as well as the proline and glycine linker variants by measuring the 
JHN splitting for C1B-C2 bound to isotropic La3+ and anisotropic Tb3+ using in-phase and 
antiphase (IPAP) J-coupled HSQC spectra. 193 The splittings for La3+ bound C1B-C2 
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were subtracted from Tb3+ bound C1B-C2 to obtain RDCs.  Chemical shift perturbations 
were calculated as described in Chapter 3.
Assignment of C1B methyl region
For the assignment of the methyl region of C1B, U-15N, 13C-C1B was 
concentrated to 0.286 mM in 10 mM MES pH 6.0, 150 mM KCl, 1 mM TCEP, 0.02% 
NaN3, and 8% D2O.  The following experiments were collected on the apo protein, 13C 
CT-HSQC, H(CCO)NH 194,195, and CC(CO)NH 194at a field strength of 500 MHz.  13C-
HMQC was collected for C1B in the presence of 200 mM PS/PIP2-containing bicelles 
with 2 mol. Eq. PDBu.
Protein-to-membrane FRET
Protein and membrane interactions driven by Ca2+ were monitored by protein-
membrane-FRET between C1B-C2 variants labeled with an Alexa Fluor™ 488 C5 
Maleimide (ThermoFisher Scientific) fluorophore and Rhodamine-doped large 
unilamellar vesicles (LUVs). LUVs were prepared as previously described 50 using 1-
Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-
glycero-3-phospho-L-serine (POPS), and 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (Liss Rhod-PE), all from 
Avanti Polar Lipids.  The composition of LUVs was POPC:POPS:Rh-PE=79:20:1 molar 
% for “C1B-ligand-free” liposomes and experiments where phorbol 12,13-dibutyrate 
(PDBu) as a C1 ligand was added externally.  For experiments with native activator, 
diacyclglycerol, 10% 1-2-dioleoyl-sn-glycerol was added and the amount of POPC was 
reduced at the liposome preparation stage.  For PIP2 experiments, 2% L-α-
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phosphatidylinositol-4,5-bisphosphate (Brain, Porcine) was added and the concentration 
of POPC was adjusted accordingly.  To label C1B-C2 variants with the donor 
fluorophore, a cysteine was substituted for a lysine residue at position 181. The protein 
was reduced with 2 mM dithiothreitol (Sigma) for 2 hours prior to the labeling reaction.  
To remove reducing reagent, the protein was exchanged into extensively degassed 
reaction buffer ( 20 mM Tris HCl pH 8.0, 150 mM KCl) using two successive PD-10 
desalting columns (GE Healthcare).  The protein was immediately placed under a 
constant stream of N2(g). Four molar equivalents of Alexa Fluor™ 488 C5 Maleimide 
(ThermoFisher Scientific) fluorophore were added to the protein and the solution was 
incubated for the appropriate amount of time determined individually for each variant. 
The success of the reaction was verified by MALDI-TOF mass spectrometry and excess 
reagent was then removed using a PD-10 desalting column.  Any unlabeled protein was 
removed using a cation exchange column (SOURCE 15S) and the protein was buffer 
exchanged into MES buffer. 
All FRET experiments were carried out on an ISS PC1 fluorometer (ISS, 
Champaign, IL) at 25 °C by exciting at 484 nm and following the decrease in emission 
of the donor molecule at 517 nm upon addition of increasing amounts of Ca2+ from a 
concentrated stock solution added to 50 nM protein pre-incubated with 600 μM LUVs.  
Experiments were conducted in 20 mM HEPES pH 7.4 and 100 mM KCl (“FRET-
buffer”).  The fluorescence of a “blank” sample containing all components except for 
C1B-C2 was recorded and subtracted from the fluorescence of the sample cuvette.  The 
fluorescence was corrected for dilution where Ca2+ was added.  Buffering with 0.5 mM 
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ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA) was used to 
control trace amounts of residual Ca2+.  The amount of free Ca2+ in solution was 
calculated according to ref 196.  Three repeats were done for each experiment. To ensure 
that protein binding to LUVs and not the cuvette walls was being monitored, the cuvettes 
were coated overnight with a 1 mg/mL solution of IgG® (Sigma Aldrich) dissolved in 
FRET-buffer to prevent protein adsorption.  The cuvettes were rinsed with water and 
buffer and allowed to dry before use.  The donor emission was monitored over time with 
Ca2+ addition in the absence of LUVs to ensure that the decrease in emission was not due 
to protein sticking to the walls.  In all cases the decrease in Alexa fluorescence in the 
absence of LUVs was < 10% at the maximum concentration of Ca2+ added during the 
experiments. 
The change in Alexa fluorescence upon Ca2+-addition was normalized to the 
maximum change in fluorescence and plotted as a function of the free-Ca2+ 
concentration.  The resulting curves were then fit with the Hill Equation:
Equation 17
∆𝐹= ∆𝐹𝑚𝑎𝑥 ( )   [Ca2 + ]H[Ca2 + ]H12 + [Ca2 + ]H
Where Fmax is the maximum change in fluorescence observed, [Ca2+]1/2 amount of 
Ca2+ needed to reach half-maximal binding, and H is the Hill coefficient.
C1B binding to DAG probed by ultracentrifugation 
Large unilamellar vesicles (LUVs) were prepared containing sucrose according 
to the protocol outlined in Giorgione and Newton 197 with 10 mM HEPES pH 7.4, 100 
mM KCl, and 170 mM sucrose. The pelleting efficiency of the sucrose loaded LUVs 
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was determined to be >98% for all experiments by measuring phosphate concentration 
before and after centrifuging the samples.  The composition of LUVs was 
POPC/POPS/DAG 70:20:10 mol %.  50 nM native-linker C1B-C2 K181C Alexa 488 
was incubated with 0.6 mM LUVs for five minutes.  LUVs were centrifuged in an 
Optima MAX-XP tabletop ultracentrifuge for 30 min at 50 000 rpm and 25 °C. The 
amount of C1B-C2 in the supernatant was quantified using the fluorescence of Alexa 
488 normalized to the Alexa 488 fluorescence in the absence of LUVs. 0.5 mM EGTA 
was added to all samples to control trace amounts of Ca2+.  All experiments were 
conducted in FRET buffer.
Turbidity Assay
To assess tethering in C1B-C2 liposome samples, the absorbance at 405 nm was 
monitored using a SpectraMax Plus 384 microplate reader.  FRET-buffer with 0.5 mM 
EGTA was used for all samples.  The blank, which was subtracted from the absorbance 
of the samples, contained FRET-buffer and all components of the reaction except for 
liposomes.  The absorbance of solutions with all reactants except for protein were 
subtracted from each condition.  Each sample was 100 L.  Liposome concentration 
used was 0.9 mM.  Concentration of native C1B-C2 added was 2 M.  0.3 mM free Ca2+ 
was added from a concentrated stock solution.        
Diffusion-ordered spectroscopy
The translational diffusion coefficients, Dt, for bicelles were measured under 
different sample conditions using NMR. Bipolar-gradient based diffusion-ordered 
spectroscopy (DOSY) with convection compensation was carried out on an Avance III 
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Bruker instrument operating at the 1H Larmor frequency of 800 MHz and equipped with 
a cryogenically cooled probe for C1B-C2 samples and an Avance III Bruker instrument 
operating at the 1H Larmor frequency of 500 MHz for C1B samples. The diffusion time 
interval and gradient pulse lengths were optimized for each sample. Diffusion time 
intervals were set to 300 ms for all bicelle measurements, with gradient pulse durations 
being set to 1.0-1.5 ms. Water diffusion coefficient measurements were carried out for 
each condition using a 30 ms diffusion time and a 0.75 ms gradient pulse duration and 
used to estimate the solvent viscosity. The pulsed gradient field strength was 
incremented linearly from 2% to 95% in 16 steps.  The well resolved DMPC methyl 
peak was chosen for Dt determination due to the low solubility of free DMPC in 
solution.  Temperatures were calibrated with [2H4]-methanol.  The data were analyzed 
using the TopSpin3.2 software (Bruker Biospin).  Shigemi tubes were used to minimize 
the contribution of convection to the diffusion measurements for all C1B-C2 samples.  
Shigemi tubes and convection compensation were not needed for C1B samples as they 
were all done at 298 K and convection was minimal.   
Results
Ligands do not perturb isotropic bicelles
Isotropically tumbling DMPC/DHPC bicelles with a q of 0.5 were employed as a 
membrane mimetic to gain structural information on C1B membrane interactions. Prior 
to characterizing C1B interactions with ligands in bicelles, the bicelles were 
characterized to ensure that their morphology was not disturbed by the ligands or by 
protein binding.  Diffusion ordered spectroscopy (DOSY) was used to measure the 
136
translational diffusion coefficients of the bicelles in the presence of different 
ligands/protein (Table V-1).  A population of DHPC exists as free monomer in solution. 
198 Therefore, to avoid underestimation, the diffusion coefficient was determined using 
the acyl-CH3 moiety of DMPC, which exists primarily in the bilayer. 198 The 
translational diffusion coefficient for water was also determined for each sample and the 
ratios, Dt,bicelle/Dt,water, were considered as part of the changes in viscosity.  
The translational diffusion coefficient (Dt) of bicelles in the absence of protein 
and externally added ligands is 6.14 x 10-11 m2s-1 (Table V-1).  This is close to the 
published value for q = 0.5 DMPC/DHPC bicelles with 100 mM total lipid concentration 
(5.6 ± 0.01 x 10-11 m2s-1). 198  The addition of protein and ligand does not significantly 
decrease the diffusion coefficients or ratios.  This indicates that protein binding and 
ligand incorporation doesn’t perturb bicellar morphology or significantly increase the 
size.
Table V-1. Ligands do not perturb bicelle morphology.  Translational diffusion 
coefficients (Dt) determined from DOSY experiments at 500 MHz.
Conditions Dt DMPC m2/s Dt water  m2/s Dt DMPC/Dt 
water
100 mM Bicelles 6.14 x 10-11 2.13 x 10-9 2.88 x 10-2
+0.4 mM C1B + 0.8 mM PDBu 5.97 x 10-11 2.07 x10-9 2.89 x 10-2
+0.4 mM C1B + 8 mM DOG 5.71 x 10-11 2.16 x 10-9 2.64 x 10-2
+0.4 mM C1B + 0.8 mM PMA 6.31 x 10-11 2.08 x 10-9 3.04 x 10-2
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PKC has also been shown to interact with PS 81,143,199 and PIP2. 200,201  To study 
these interactions and eventually extend these studies to the entire regulatory region of 
PKC, bicelles were designed with PS and PIP2.  A stable bicelle was created with all of 
the components necessary for both C1 and C2 domains to bind. DHPS and DMPS were 
added at 10% and 20%, respectively as well as 2% brain PIP2.  DOSY was again used to 
measure the diffusion coefficients of the bicelles by themselves and in the presence of 
externally added ligands (Table V-2).  The Dt,bicelle/Dt,water for bicelles only (Table V-2) 
was comparable to that of DMPC/DHPC bicelles (Table V-1), which indicates that 
incorporating anionic components did not change the bicellar morphology.  In addition, 
both C1 and C2 ligands were added and the temperature of the experiments was varied.  
In all cases, the Dt,bicelle/Dt,water doesn’t change.  It was concluded that the bicelles are 
stable and suitable for the experiments.
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Table V-2.  Ligands do not perturb bicelle morphology. Translational diffusion 
coefficients (Dt) determined from DOSY experiments at 800 MHz.    
Condition Temperature 
(K)
Dt DMPC 
(m2/s)
Dt water  
(m2/s)
Dt DMPC/Dt 
water
200 mM Bicelles 298.15 4.97E-11 1.72E-09 2.81E-02
200 mM Bicelles 303.15 5.49E-11 1.94E-09 2.84E-02
200 mM Bicelles 308.15 6.08E-11 2.14E-09 2.87E-02
200 mM Bicelles 313.15 6.78E-11 2.40E-09 2.91E-02
200 mM Bicelles 318.15 8.17E-11 2.69E-09 2.85E-02
+ 1.2 mM Ca2+ 298.15 4.85E-11 1.69E-09 2.89E-02
+ 1.2 mM Ca2+ 303.15 5.51E-11 1.91E-09 2.92E-02
+ 1.2 mM Ca2+ 308.15 6.38E-11 2.15E-09 2.95E-02
+ 1.2 mM Ca2+ 313.15 7.21E-11 2.41E-09 2.98E-02
+ 1.2 mM Ca2+ 318.15 9.32E-11 2.77E-09 2.94E-02
+ 0.6 mM PDBu 298.15 4.51E-11 1.58E-09 2.84E-02
+ 0.6 mM PDBu 303.15 5.20E-11 1.79E-09 2.86E-02
+ 0.6 mM PDBu 308.15 5.91E-11 2.01E-09 2.89E-02
+ 0.6 mM PDBu 313.15 6.58E-11 2.26E-09 2.90E-02
+ 0.6 mM PDBu 318.15 7.34E-11 2.52E-09 2.92E-02
+ 1.2 mM Ca2+/0.6 mM PDBu 298.15 4.52E-11 1.58E-09 2.83E-02
+ 1.2 mM Ca2+/0.6 mM PDBu 313.15 6.80E-11 2.26E-09 2.95E-02
C1B transiently associates with bicelles in the absence of ligands
It has been proposed that C1 domains pre-associate with bilayers in the absence 
of ligands. 81 C1B has also been shown to have a propensity to associate with detergent 
micelles, even in the absence of C1 ligands.103,167  However, their loose packing and 
curvature renders experiments with micelles prone to artifacts and the molecular details 
of membrane interactions in the absence of ligands are uncharacterized.  As a first step 
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to characterizing interactions of C1B with membranes, isotropic tumbling, q = 0.5 
DMPC/DHPC bicelles were added in the absence of C1 ligands. Upon the addition of 
bicelles to C1B, the backbone chemical shifts of residues in both C1B loops are 
perturbed (Figure V.1) while Y123, L125, and G129 in the 34 loop are broadened due 
to the chemical exchange.   This is consistent with C1B pre-associating with bicelles in 
the absence of ligands and suggests that both loops participate in this association.
Figure V.1 C1B transiently associates with isotropically tumbling bicelles. (A) 
Chemical shift perturbations upon addition of 100 mM bicelles to C1B.   1H 2 rates 
for 0.4 mM C1B in the presence of 100 mM bicelles. Rates were determined by 
subtracting 1H R2 values for the diamagnetic sample from 1H R2 values from samples 
with 2 molecules of 16:0-5 Doxyl PC per bicelle.   Residues that are broadened due to 
chemical exchange are indicated with a “B”.  Prolines are indicated with a “P”.   
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While CSPs are a useful tool in detecting protein interactions, they cannot by 
themselves unambiguously identify the interaction interface.  This is because changes in 
structure or dynamics upon binding can give rise to CSPs away from the binding site.  
Therefore, paramagnetic relaxation enhancement (PRE) rates were collected for C1B in 
the presence of bicelles. Transverse 1H PRE rates were obtained by incorporating 16:0-
5-doxyl PC, bearing a stable nitroxide at position 5 on the acyl chain.  The magnitude of 
the observed PRE observed depends on the distance with respect to the paramagnetic 
center.  Despite the exchange broadening, elevated PRE rates were observed for three 
reporters in the loops--S111 and T113 in the 12 loop and I126 in the 34 loop. This is 
direct evidence that both loops are inserted into the bilayer.  In addition to loop residues, 
PRE was observed for L121 preceding the 34 loop.  This indicates that this residue was 
inserted deeply into the bilayer and in closer proximity to the doxyl group.
34 loop of C1B partitions deeper into the bilayer in the presence of phorbol esters
Two molar equivalents of phorbol 12,13 dibutyrate (PDBu) added to the 
C1B/bicelle mixture was enough to saturate C1B.  Residues broadened beyond detection 
in the presence of bicelles could only be recovered upon PDBu addition.  CSPs were 
again only observed for residues in both ligand binding loops (Figure V.2). 
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Figure V.2 PDBu binding recovers exchange broadened C1B residues in the 
presence of bicelles.  Chemical shift perturbations upon addition of 2-fold phorbol 
12,13-dibutyrate (PDBu) and 100 mM bicelles to C1B.  Prolines are indicated with a 
“P”.  G110 is exchange broadened in the apo spectra but is recovered upon addition of 
PDBu.
Upon addition of bicelles and then PDBu, the 1H R2 rates for the diamagnetic 
samples increase relative to the apo protein, due to the larger apparent molecular weight 
when associated with bicelles (Figure V.3).  Two-fold PDBu saturates C1B.  The 
assumption is made that 100% of C1B is bound to bicelles in the presence of PDBu and 
used the average 1H R2 rates to estimate the population of C1B bound to bicelles in the 
absence of ligands to be ~27%.
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Figure V.3 1H R2 increases upon bicelle and PDBu addition.  Rates are shown for 0.4 
mM C1B in different ligand complexed states (diamagnetic sample).  The average R2 
values for each state are indicated.  From these values the population of bound species 
was estimated to be 26.5% in the presence of bicelles only. 
 Transverse 1H PRE for C1B backbone N-H groups in the presence of PDBu 
and bicelles were then collected.  This revealed that the 34 loop penetrates deeper into 
the bilayer. PRE values were larger for residues in the 34 loop than in the 12 loop 
(Figure V.4).  L121 also has a large PRE indicating that this residue penetrates deeper 
into the bilayer.
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Figure V.4  The 34 loop of C1B is inserted deeper into the membrane with PDBu.
1H 2 rates for 0.4 mM C1B in the presence of 2-fold PDBu and 100 mM 16:0-5-
Doxyl PC doped bicelles.  Prolines are indicated with a “P”.
Although there are not enough reporters on the loops in the absence of ligands 
due to exchange broadening, PRE is only observed in the loop regions in the presence 
and absence of ligands, which indicates that the same regions of the protein are 
responsible for binding in both cases.  To see if PDBu is incorporating into the bilayer 
and not into the less densely packed short chain lipids that cap the bilayer, since PDBu is 
added externally, bicelles with phorbol 12-myristate 13-acetate (PMA) were made.  The 
PRE pattern, 1H R2 of the diamagnetic sample, and the chemical shift perturbations were 
compared and found to be virtually identical (Figure V.5) to that of PDBu.  This is 
consistent with C1B inserting into the bilayer in the presence of PDBu.
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Figure V.5 PDBu and PMA generate identical PRE profiles on C1B.  Chemical shift 
perturbations, 1H R2 rates, and 1H 2 rates for C1B in the presence of 100 mM 
DMPC/DHPC bicelles with either phorbol 12-myristate 13-acetate (PMA) or the short 
chain phorbol, PDBu.
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Next, interactions of C1B with bilayers in the presence of its native ligand, 
diacylglycerol, were investigated.  Bicelles were made with a short-chain diacylglycerol, 
1,2-dioctanoyl-sn-glycerol (DOG) incorporated into the bilayer.  The final concentration 
of DOG in the samples was 8 mM for a 20-fold excess of DOG:C1B.  Elevated 1H R2 
and chemical shift perturbations indicate that C1B is bound to the bicelles under these 
conditions (Figure V.6). The magnitude and pattern of the diamagnetic 1H R2 rates for 
DOG-bound C1B are comparable to PDBu-bound C1B.  There is a slight elevation in 
the rates for DOG compared with PDBu that suggests that the ternary complex is larger.  
This can be attributed to the high concentration of DOG incorporated into the bilayer 
and increasing the effective size. DOG was not considered in the calculations for the q of 
the bicelle because the chain length of 8 carbons is between the chain lengths of DMPC 
(14:0) and DHPC (06:0).  Although the bicelles were made by mixing DOG with DMPC 
to “trap” DOG in the bilayer, some DOG could be incorporated into the sides of the 
bicelle.  The exchange behavior in the loops, observed in the absence of ligands with 
bicelles (Figure V.3), is presented as elevated 1H R2 rates for loop residues and was not 
observed with DOG-bound C1B  From this it is concluded that all of C1B is bound 
to the bicelles.  G110 is the only residue in the loop region with elevated 1H R2 rates.  
G110 is a dynamic residue, completely broadened beyond detection in the apo protein.  
The dynamics of this residue are quenched upon PDBu binding but not upon DOG 
binding (Figure V.6).  The PRE for DOG was larger in the loop regions than with the 
PDBu with three residues (L121, G124, and L125) completely broadened by doxyl 
(Figure V.6).  While docking and restrained molecular dynamics studies need to be 
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completed to understand the membrane binding geometry, this suggests that C1B 
penetrates deeper into the bilayer in the presence of DOG than with PDBu. 
 
Figure V.6 DOG drives C1B deeper into the membrane.  1H R2 rates, and 1H 2 
rates for C1B in the presence of 100 mM DMPC/DHPC bicelles with either PDBu or 
DOG.  Residues broadened beyond detection were assigned a 1H 2 rate of 200 s-1. 
Proline-linker variant decreases conformational variability of C1B-C2
Having characterized the interactions of C1B with bicelles in the presence of 
different ligands, experiments were conducted to determine how different C1 ligands 
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affected the coupling between C1 and C2 domain membrane insertion.  Additionally, in 
Chapter 4 it was shown that C1B-C2 has a great deal of conformational variability 
mediated by its flexible linker. The objective was to determine how changing the 
conformational entropy of C1B-C2 by changing the flexibility of the linker region 
changes the interplay between C1 and C2 in their interactions with membranes.  
Figure V.7 Proline-linker rigidifies C1B-C2.  (A) Distribution of residual dipolar 
couplings (RDCs) for C1B and C2 from C1B-C2 complexed to Tb3+ at 600 MHz. (B) 
Comparison of 1H pseudocontact shifts (PCS) from backbone N-H groups for native-
linker and glycine/proline linker variants separated by domain. 
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Two inter-domain linker variants for C1B-C2 were designed, replacing six 
residues between the folded cores with glycines or prolines to create a more flexible and 
more rigid interdomain linker, respectively (Figure V.7A).  As a control, to evaluate if 
these modifications had the desired effects on C1B-C2, pseudocontact shifts (PCS) and 
residual dipolar couplings (RDCs) were collected for all variants from the paramagnetic 
Tb3+ bound in the C2 domain.  These report on the structural ensemble (RDCs and PCS) 
and flexibility (RDCs) of C1B-C2 (Figure V.7).  By evaluating the RDC distributions of 
C1B and C2 (aligned domain) information can be gained on the extent of conformational 
averaging of C1B relative to C2 which qualitatively reports on the flexibility of the 
linker.  
For the native-linker, the aligned domain (C2) has a larger distribution of RDCs 
compared to the unaligned domain C1B (Figure V.7D-F).  The distribution of RDCs is 
similar for C2 complexed to Tb3+ in all variants which is a good indication that the 
structure of C2 with the linker variants is not perturbed.  The distribution of RDCs for 
C1B was much like the glycine-linker variant and native-linker, consistent with 
maintaining the flexibility of the linker while changing the identity (Figure V.7E-F). 
However, the proline-linker variant had a larger distribution of RDCs for C1B than the 
native-linker or glycine linker, consistent with the restriction of C1B and with less 
conformational averaging (Figure V.7D).  These findings were echoed by the PCSs 
(Figure V.7B,C).  Thus, good agreement was found between the PCS for C2 from the 
native-linker with both linker variants (Figure V.7C). The C1B PCSs for the glycine-
linker variant were smaller than that of the native C1B-C2 linker variant (Figure V.7B).  
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The magnitude of PCSs on the C1B domain depend on the distance and orientation of 
the C1B relative to C2 as well as the extent of conformational averaging. Therefore, the 
smaller PCS observed in the glycine-linker variant were most likely due to an increase in 
flexibility relative to the native C1B-C2 linker and more extensive conformational 
averaging.  It could also be due to C1B-C2 adopting more extended conformations.  On 
the other hand, the proline linker variant on the other hand had larger C1B PCSs and a 
worse correlation with the native linker variant.  This is consistent with a more rigid 
protein and a perturbation of the native conformational ensemble.  From these 
experiments it can be concluded that substituting the linker region for prolines decreased 
the conformational variability of C1B-C2 while substituting for glycines maintained the 
variability while serving as a control for changing the identity of the linker.
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Figure V.8 The C1B-C2 linker region tunes avidity.  A) Linker variants used in this 
study.  Residues 153-158 (native linker in blue) were replaced with glycines or prolines 
to make the linker more flexible or more rigid, respectively. B) Experimental design for 
protein-to-membrane FRET experiments.  Ca2+ drives C1B-C2 Alexa 488 to Rhodamine 
PE and PS/PIP2 doped liposomes resulting in FRET between Alexa 488 and Rh. PE.  C)  
Normalized protein-to-membrane FRET as a function of Ca2+ concentration in the 
presence (red) or absence (black) of PDBu. The fold-decrease in Ca2+ needed to achieve 
half-maximal membrane binding as indicated on the graph.
PIP2 is required to achieve maximum coupling between C1 and C2 ligands
Next, how these variants altered the Ca2+ concentrations needed to drive the C2 
domain to the membrane in the presence of C1 ligands was probed.  For the assay 
rhodamine-PE doped liposomes (acceptor) and C1B-C2 linker variants tagged with an 
Alexa 488 fluorophore (donor) at position 181 on the C2 domain (Figure V.8A) were 
used.  When Ca2+ is added, C1B-C2 is trafficked to anionic liposomes and Alexa 488 
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fluorescence is quenched by rhodamine.  There is only FRET when binding of C2 
domain to the membrane with the addition of Ca2+.  As a measure of the “coupling” 
between C1 and C2 ligands, the Ca2+ concentrations needed to drive membrane binding 
in the presence and absence of C1 ligands for each variant (Figure V.8B-G; Table V-3) 
were compared.
Table V-3. PIP2 is required to maximize interactions of C1B-C2 with membranes.  
[Ca2+]1/2 values from protein-to-membrane FRET experiments with C1B-C2.
[Ca2+]1/2
+PtdIns(4,5)P2
[Ca2+]1/2
-PtdIns(4,5)P2
Linker Ligand-free DAG PDBu Ligand-free DAG PDBu
Glycine 0.34±0.01 0.17±0.01 0.11±0.01 25.6±0.5 27.0±0.5 10.3±0.1
Native 0.43±0.04 0.2±0.01 0.11±0.01 27.4±0.6 26.6±0.2 9.3±0.2
Proline 0.56±0.02 0.23±0.01 0.07±0.01 31.0±0.2 32.5±2.0 10.3±0.2
First, liposomes bearing both phosphatidylserine and phosphatidylinositol 4,5-
bisphosphate were used.  The high local concentration created by tethering C1B-C2 to 
the membrane through C1/ligand interactions decreases the amount of Ca2+ needed for 
C2 to bind to the membrane (Figure V.8B-D). For wild-type C1B-C2 with the native 
linker, the [Ca2+] needed to achieve half-maximal binding ([Ca2+]1/2) was 0.43±0.04 M.  
Upon incorporation of 10% DAG into the liposomes, the [Ca2+]1/2 was lowered 2.2-fold.  
External addition of PDBu lowered the [Ca2+]1/2 even more by 3.9-fold relative to C1B 
ligand-free.   
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Omitting PIP2 from the membrane attenuated this effect, suggesting a synergy 
between PIP2 and C1 ligands.  Omitting PIP2 significantly increased the concentration of 
Ca2+ needed to drive membrane binding.  For the native-linker variant, this resulted in a 
64-fold increase in the [Ca2+]1/2.  In the absence of PIP2 the overall avidity from 
incorporating PDBu was decreased for all variants (Figure V.8E-G).  Furthermore, the 
effect of rigidifying the linker disappears with similar avidities for all variants (Figure 
V.8E-G).  
The most striking finding is that while in the absence of PIP2 there is only a 20% 
decrease in avidity for native C1B-C2 and there is no avidity upon incorporation of 
DAG for any of the variants. One possible explanation for this is that C1B-C2 is not 
binding to DAG in the absence of PIP2.  To test this, ultracentrifugation assays were 
conducted with sucrose-loaded vesicles containing 20% PtdSer and 10% DAG under the 
same conditions set forth in the fluorescence experiments.  For all experiments, >98% of 
the vesicles were pelleted.  The emission of 50 nM Alexa 488 labeled C1B-C2 in the 
presence and absence of 0.6 mM vesicles was measured.  In the absence of Ca2+, ~35% 
of the total protein was pelleted with the liposomes (Figure V.9A).  In the absence of 
Ca2+, this can only be due to C1B binding to the membrane.  As a control to make sure 
that all of the protein could be pulled down saturating Ca2+ was added and ~90% of the 
protein was pelleted.  This indicates that despite the lack of avidity, C1B-C2 is still able 
to bind to DAG in the absence of PIP2.  
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Figure V.9 C1B-C2 binds DAG and has the potential to tether liposomes.  (A)  
Fluorescence of C1B-C2 K181C conjugated to Alexa 488 in the presence of sucrose-
loaded vesicles containing 20% PS and 10% DAG normalized to the fluorescence in the 
absence of vesicles.  (B)  Schematic showing the two possible binding modes when both 
C1B and C2 interact with liposomes.  (C)  Absorbance of liposome solutions at 405 nm.  
Increases are caused by tethering of liposomes due to “trans” binding.
Another possibility is that in the absence of PIP2, C1B and C2 are not binding to 
the same liposome (“cis-binding”) and are instead binding to neighboring liposomes 
(“trans-binding”) as shown in Figure V.9B.  The trans-binding mechanism causes 
turbidity in the samples due to the increase in apparent size of the liposomes.  To 
distinguish between these two binding modes, the absorbance of the samples at 405 
nm202 (assay used by Liu et. al.203) was monitored, which increases when the solution 
becomes turbid.  The addition of 0.3 mM free Ca2+ did not increase the turbidity of the 
sample (Figure V.9C).  However, the addition of C1B-C2 in the presence of Ca2+ 
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doubled the absorbance, consistent with the trans-binding mechanism bridging the 
liposomes together.  This was reversed upon addition of a 4-fold excess of PDBu (Figure 
V.9C).  This is consistent with PDBu driving cis-binding and reversing the tethering.  A 
higher concentration of protein (2 M) was needed to achieve a measureable turbidity, 
leading to the possibility that trans binding is due to saturation of the available “cis” 
binding sites on the surface of the liposome.  However, the decrease in absorbance upon 
the addition of PDBu suggests that the trans binding was disrupted, most likely through a 
switch to cis binding, consistent with the presence of enough space on the liposomes to 
bind in cis. Collectively, these experiments show that the lack of avidity with PS 
liposomes is not due to a lack of DAG binding and could be due to an inability of C1B 
and C2 to bind to the same bilayer surface.  This also indicates that PIP2 in the 
membrane is essential for achieving the maximum coupling between C1 and C2 ligands.
Discussion and future directions  
This work showed that C1B transiently pre-associates with bicelles in the 
absence of C1 ligands, and this occurs through the ligand-binding loops.  This has been 
observed previously for C1 domains in micelles 103,204, but the details of the interaction 
have not been characterized for the C1B domain in a bilayer.  The chemical shift 
perturbations and PRE patterns for C1B with bicelles were similar to those in the 
presence of ligands.  This suggests that the insertion and membrane binding geometry of 
C1B is largely driven by the interactions with the membrane and are not fully dependent 
on the ligands.  The bilayer interaction is weak in the absence of ligands, although it is 
likely to be stronger in the context of the full regulatory region due to membrane 
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interactions with C1A and C2 when Ca2+ is present.  Residues in the loops 34 loop 
(L125, H127, Q128) had elevated 1H R2 values in the apo protein that are quenched upon 
ligand binding.  G110 in the 12 loop was completely broadened due to exchange.  
These dynamics are quenched upon binding ligands although G110 has elevated R2 
values when C1B is bound to DOG.  
There were subtle differences in the NMR signatures of C1B ligand binding.  
The PRE values were larger for C1B in the presence of DOG, which suggests that C1B 
inserts deeper into the membrane in the presence of DOG compared to PDBu.  This is 
likely due to the bulkier head group of PDBu (Figure V.6).  The shallower insertion in 
the presence of PDBu leaves the C1 domains more exposed and could contribute to this 
instability.  Although PDBu is a higher affinity ligand for C1Ba, the membrane insertion 
is shallower.  This indicates that the membrane insertion depth does not correlate with 
affinity. 
Future directions with these data involve using restrained molecular dynamics 
simulations to obtain a structural model of C1B in complex with membranes.  With the 
model for the C1B membrane complex in mind, backbone PRE and CSP that have 
already been collected as well as additional restraints collected for methyl groups will be 
used.  There are several methyl groups in the membrane binding region.  Triple 
resonance assignment experiments have already been collected and methyl groups for 
the C1B domain (Figure V.10) have been assigned.  Several residues shift in response 
to PDBu/bicelle binding (Figure V.10).
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Figure V.10 Assigned methyl spectra of C1B.  Overlay of 13C-HMQC of apo U-15N, 
13C C1B (green) and bound to PDBu in the presence of bicelles containing a PS and 
PIP2 component (black).
Additional work involves extending these studies to multi-domain regulatory 
regions from PKC.  Towards this goal, the feasibility of collecting restraints for C1B-
C2 in complex with bicelles and PDBu has already been established. C1B-C2 bound to 
bicelles containing PS, PIP2 and PDBu. Notably, despite the large apparent molecular 
weight of the complex (~150 kDa), high quality spectra were obtained as shown in 
Figure V.11.  Furthermore, chemical shift perturbations show that both C1 and C2 bind 
to the bicelle (Figure V.11). 
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Figure V.11 Multi-component isotropic bicelle enables acquisition of high quality 
NMR spectra in the presence of Ca2+ and PDBu. (A) 15N –TROSY spectra of C1B-C2 
bound to bicelles. (B) Chemical shift perturbation analysis of C1B-C2 bound to isotropic 
bicelles indicates that both domains bind the bicelle in the presence of their ligands.
Our functional studies identify the linker region between C1 and C2 domains as a 
potential target to modulate the Ca2+ dependence of PKC in the presence of C1 ligands.  
By rigidifying the linker region with prolines a factor of 2-fold greater avidity was 
achieved between C1 and C2 ligands.  The most plausible explanation for this is that by 
rigidifying the linker, the conformational space sampled by C1B and C2 decreased, 
lowering the entropic penalty for simultaneous membrane binding.  In contrast, by 
maintaining the flexibility of the linker but changing its identity by substituting it with 
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glycines, the native coupling between the C1 and C2 membrane binding was preserved.  
This highlights the importance of the conformational heterogeneity and linker region in 
maintaining the balance in the activating power between C1 and C2 ligands.
Many of the existing drugs target C1 domains of PKC. 205,206  Modulating the 
flexibility of the linker could serve as a way to tune the activity of PKC in the presence 
of C1 activators.  Furthermore, dynamic and transient interactions are crucial for cell 
signaling cascades.  These data suggest that the flexible nature of the linker plays a role 
in maintaining the right balance of the PKC response to Ca2+ in the presence of PDBu.  
The Ca2+ response of C1B-C2 in the presence of diacylglycerol was less dependent on 
the flexibility of the linker region.  This could be due to the fact that C1B/DAG’s much 
weaker interactions than those of C1B/PDBu; conversely, independence gained could 
also be due to a difference in the membrane binding geometry.  
Additionally, these studies revealed an additional role for PIP2 in regulating 
PKC.  PIP2 was essential to the enhancement of membrane interactions of C1B-C2 with 
DAG.  Upon sensing Ca2+, the C2 domain of conventional isoforms associates with PS 
molecules in the plasma membrane.  One PS molecule is replaced by PIP2.  Due to the 
bulky head group of PIP2, there is a change in the membrane binding geometry of the 
C2 domain.52  These results suggest that the orientation change upon binding PIP2 may 
mediate simultaneous DAG binding to the C1B domain and to achieve full activation.
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In this chapter, the objective is to elucidate how the PKC regulatory domains 
interact with membranes in the presence of their native ligands and how these 
interactions differ when C1B is bound to tumor-promoting phorbol esters.  Membrane 
binding of the C2 domain from the regulatory region of conventional PKCs and the 
subsequent membrane insertion of one or both C1 domains is required for full activation 
of conventional PKCs.167,187  This process is modulated by metal ions 3,188, anionic lipids 
189, and membrane-embedded diacylglycerol.  However, the mechanistic details of the 
membrane association process are poorly understood.  These studies focused on 
obtaining structural information about the interactions of the PKC regulatory domains 
with membrane mimetics and how these interactions modulate the Ca2+ requirements of 
membrane association.  
Conventional isoforms contain tandem C1 domains preceding a Ca2+-dependent 
C2 domain.  The C2 domain binds both phosphatidylserine (PS) and phosphatidyl-
inositol 4,5-bisphosphate (PIP2) in a Ca2+-dependent manner. The native agonist for C1 
domains is diacylglycerol, made available by the hydrolysis of PIP2.  Like 
diacylglycerol, plant-derived phorbol esters can also facilitate the membrane association 
process of PKC but C1 domains have a much higher affinity for phorbol esters compared 
to diacylglycerol.  Activation of PKC by phorbol esters leads to prolonged activation, 
faster downregulation of PKC 190 and tumorigenesis.4,79,191  Researchers are limited in 
their design of potential PKC activators because of their phorbol ester-like tumor 
promoting activities.  Therefore, understanding the structural differences in phorbol 
ester- and diacylglycerol-induced activation of PKC is extremely important for 
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designing better modulators of PKC that lack tumor-promoting activity.  Despite the 
importance of PKC activators, existing information about C1 domain/membrane 
interactions is limited.  This is, in part, largely due to the challenges of working with 
peripheral membrane binding proteins and selecting membrane mimetics that are both 
suitable for biophysical studies and physiologically relevant. 
Upon binding C1 ligands hydrophilic residues in the binding cleft are masked, 
increasing the hydrophobicity of the domain and facilitating membrane insertion. 30  The 
membrane interactions of C1B domain from PKC has been explored in micelles with 
and without a short chain diacylglycerol analog, DOG. 167  The addition of DOG was 
found to change the depth of insertion.  However, the lose packing and curvature of 
micelles does not always faithfully reproduce the conditions of a planar bilayer.  
Additional studies are needed in membrane mimetics containing a bilayer.  
This chapter describes efforts towards obtaining structural information of the 
regulatory domains in complex with isotropically-tumbling bicelles in the presence of 
different C1 domain targeting cofactors, specifically diacylglycerol and phorbol 12,13-
dibutyrate.  Bicelles are composed of long chain lipids that form a bilayer with 
hydrophobic edges capped by short chain lipids.  Bicelles have the advantage of a 
physiologically relevant bilayer packaged in a small NMR-friendly form.
In addition, conventional and novel PKCs have complex, multivalent interactions 
with membranes that require coordination of multiple domains and multiple ligands. To 
examine the multivalent nature of PKC, the interplay between metal ions and lipid-
ligands in the membrane binding process will also be probed. 
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In this chapter, the objective is to elucidate how the PKC regulatory domains 
interact with membranes in the presence of their native ligands and how these 
interactions differ when C1B is bound to tumor-promoting phorbol esters.  Membrane 
binding of the C2 domain from the regulatory region of conventional PKCs and the 
subsequent membrane insertion of one or both C1 domains is required for full activation 
of conventional PKCs.167,187  This process is modulated by metal ions 3,188, anionic lipids 
189, and membrane-embedded diacylglycerol.  However, the mechanistic details of the 
membrane association process are poorly understood.  These studies focused on 
obtaining structural information about the interactions of the PKC regulatory domains 
with membrane mimetics and how these interactions modulate the Ca2+ requirements of 
membrane association.  
Conventional isoforms contain tandem C1 domains preceding a Ca2+-dependent 
C2 domain.  The C2 domain binds both phosphatidylserine (PS) and phosphatidyl-
inositol 4,5-bisphosphate (PIP2) in a Ca2+-dependent manner. The native agonist for C1 
domains is diacylglycerol, made available by the hydrolysis of PIP2.  Like 
diacylglycerol, plant-derived phorbol esters can also facilitate the membrane association 
process of PKC but C1 domains have a much higher affinity for phorbol esters compared 
to diacylglycerol.  Activation of PKC by phorbol esters leads to prolonged activation, 
faster downregulation of PKC 190 and tumorigenesis.4,79,191  Researchers are limited in 
their design of potential PKC activators because of their phorbol ester-like tumor 
promoting activities.  Therefore, understanding the structural differences in phorbol 
ester- and diacylglycerol-induced activation of PKC is extremely important for 
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designing better modulators of PKC that lack tumor-promoting activity.  Despite the 
importance of PKC activators, existing information about C1 domain/membrane 
interactions is limited.  This is, in part, largely due to the challenges of working with 
peripheral membrane binding proteins and selecting membrane mimetics that are both 
suitable for biophysical studies and physiologically relevant. 
Upon binding C1 ligands hydrophilic residues in the binding cleft are masked, 
increasing the hydrophobicity of the domain and facilitating membrane insertion. 30  The 
membrane interactions of C1B domain from PKC has been explored in micelles with 
and without a short chain diacylglycerol analog, DOG. 167  The addition of DOG was 
found to change the depth of insertion.  However, the lose packing and curvature of 
micelles does not always faithfully reproduce the conditions of a planar bilayer.  
Additional studies are needed in membrane mimetics containing a bilayer.  
This chapter describes efforts towards obtaining structural information of the 
regulatory domains in complex with isotropically-tumbling bicelles in the presence of 
different C1 domain targeting cofactors, specifically diacylglycerol and phorbol 12,13-
dibutyrate.  Bicelles are composed of long chain lipids that form a bilayer with 
hydrophobic edges capped by short chain lipids.  Bicelles have the advantage of a 
physiologically relevant bilayer packaged in a small NMR-friendly form.
In addition, conventional and novel PKCs have complex, multivalent interactions 
with membranes that require coordination of multiple domains and multiple ligands. To 
examine the multivalent nature of PKC, the interplay between metal ions and lipid-
ligands in the membrane binding process will also be probed. 
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CHAPTER VI
SUMMARY AND FUTURE DIRECTIONS 
The findings presented in this dissertation take the first steps towards assembling 
the trajectory of the full regulatory region of PKC during activation, by focusing on a 
multidomain construct containing both C1 and C2 domains.
Chapters II and IV provide methods to overcome the challenges associated with 
studying flexible, membrane-associated proteins.  In Chapter II, the groundwork was 
laid for experiments for structural studies on the regulatory region of PKC by producing 
full-length regulatory regions from PKC and PKC free of large, bulky solubility tags.  
The key findings of this chapter are (1) the development of robust expression and 
purification protocols that enables the production of both regulatory regions in quantities 
sufficient for biophysical studies and (2) design of mutants and incorporation of 
osmolytes that stabilize the fold and decrease the aggregation behavior of the regulatory 
regions.  These optimizations facilitated the collected of the first, high-quality NMR 
spectra of each region, demonstrating the feasibility of structural studies on these 
regions. 
In Chapter IV the challenges associated with the flexibility of the regulatory 
region of PKC are overcome by using paramagnetic lanthanides to characterize the 
conformational space sampled by C1B-C2.  This was made possible by the development 
of a protocol to separate the contributions from a transient intermolecular interaction to 
structural restraints.  The use of the C1B-C2 regulatory region allowed access to the 
structure of the untethered state of the regulatory region prior to membrane insertion, 
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free from the intramolecular interaction between C1A and C2.  There was a clear 
distinction between conformations that could and could not be sampled by C1B-C2.  
This study suggests that C1B-C2 samples orientations that are highly compatible with 
simultaneous membrane insertion. These findings add to the existing knowledge about 
the activation pathway of PKC.  Despite its importance and despite the fact that PKC 
was discovered over 40 years ago, there is no structural information about this region 
during any stage of activation.  This is important because understanding the structure is 
essential for understanding its function and how to modulate it.  Gaps in our 
understanding are largely due to the ill behavior of the regulatory domains.  They are 
amphiphilic, aggregation prone, and the flexibility of this region that is essential for its 
function, poses a challenge to structural biologists.  This work overcomes these 
challenges to provide one of the first missing pieces to this puzzle.  In the context of the 
activation pathway, it is shown that when autoinhibitory interactions of the parent 
enzyme are relieved, C1 and C2 domains adopt orientations with both membrane 
binding sites in the same plane in the absence of any activating ligands.  This provides 
mechanistic information of how C1 and C2 domains coordinate interactions with 
membranes, through a preorganized membrane binding site.  Functional studies using 
protein-to-membrane FRET were consistent with this.  C1 ligands lowered the 
concentration of Ca2+ needed to drive C1B-C2 to PIP2 and PS doped LUVs.  
An intermolecular association between neighboring C1B-C2 molecules was 
identified.  Data indicates that the interface is between the C1B and C2 domains.  
Although there are no functional studies that indicate interactions between the C1B and 
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C2 domains, the high sequence identity with C1A (54% sequence similarity) and 
similarity in structure opens the possibility that the C1A-C2 mode of interaction is being 
probed.  The C1A-C2 interaction is proposed to be one of the most important 
interactions for maintaining the latent for of the enzyme but the details are still unknown 
due to the notoriously ill behavior of C1A.  However, the C1B domain is well behaved.  
The C1B and C2 interaction could be a means to probe the C1A/C2 interaction by using 
C1B as a surrogate.  The feasibility of such studies has already been outlined in this 
dissertation.  Both paramagnetic lanthanides bound to the C2 domain and PRE from tags 
bearing an unpaired electron can be used to get complementary structural information.  
Future studies should be aimed at obtaining a structural model of the C1B/C2 complex 
using paramagnetic agents and the knowledge from this can be applied to the C1A/C2 
interaction.  While the details remain elusive, Ca2+-binding to the C2 domain is proposed 
to propagate to other regions of the protein through a change in the dynamics at the N- 
and C-termini to facilitate activation.183  We did not observe any effect of Ca2+ binding 
on the sub-nanosecond dynamics of C1B-C2.  However, an experiment reported here 
suggests a different possible mechanism for the propagation of the Ca2+ binding event.  
When U-15N labeled C1B “NMR-visible” was mixed with 14N-C2 K181C-MTSL 
“NMR-invisible”, PRE was observed on C1B (Figure VI.1).  This is consistent with an 
intermolecular interaction between C1B and C2.  Interestingly, Ca2+ addition decreased 
the PRE observed on C1B.  This suggests two things: (1) the site for C1B and C2 
interaction is near the loop region of C2 and (2) Ca2+ binding to the loops of C2 breaks 
up the interaction.  It is assumed that these experiments are probing the C1A-C2 
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interaction due to the similarities between C1B and C1A.  Therefore, it is likely that Ca2+ 
binding to the loops provides electrostatic repulsion necessary to relieve this 
autoinhibitory interaction, leading to activation.   
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Figure VI.12 Ca2+ breaks up an intermolecular interaction between C1B and C2.    
Intermolecular 1H Γ2 values plotted against the residue number for 15N-C1B mixed with 
14N C2 K181C labeled with MTSL in the presence of increasing amounts of Ca2+.  
Chapter V details preliminary work on interactions of the regulatory domains 
with membrane mimics.  Although it is known that C1 domains associate with 
membrane mimics in the absence of ligands, this work found that this interaction 
proceeds through the ligand binding loops in the presence of a bilayer and the interaction 
mode is similar in the presence of ligands.  Although a structural model has not been 
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obtained yet, PRE data is consistent with the C1B domain being tilted with respect to the 
membrane, with the 34 loop penetrating deeper into the bilayer.  Ligand identity did 
not change the overall PRE patterns, although in the presence of 1,2-dioctanoyl sn-
glycerol (DOG), a short chain diacylglycerol (DAG) analogue, the magnitude of the 
PRE was larger, which indicates that DOG causes deeper penetration.  The deeper 
penetration of C1B in the presence of DOG versus PDBu could potentially explain the 
increased down regulation of PKC mediated by PDBu.  The large headgroup of PDBu 
could push C1B out, leaving its reactive cysteine more exposed and therefore PKC more 
vulnerable to reactive oxygen species.  As a future direction, this can be tested by 
investigating the reactivity of this cysteine in the presence of PDBu/DOG doped 
membrane mimics.  Future directions involve combining the restraints gathered and 
presented in this thesis with molecular dynamics simulations to obtain a structural model 
of the interactions of C1B with bilayers.  This will shed light on the molecular 
mechanism of membrane interactions and the differences between PDBu and DOG.
Membrane studies were also extended to the C1B-C2 region.  An NMR-friendly 
bicelle with all ligands necessary to bind both C1B and C2 domains was developed and 
characterized.  These bicelles enabled high-quality 1H,15N-TROSY spectra to be 
obtained and will facilitate the extension of structural studies to the C1-C2 membrane 
binding region.  Finally, functional studies in this chapter found that the flexibility of the 
inter-domain linker region tunes the coordination between C1 and C2 membrane 
interactions in the presence of a strong C1 ligand.  This could be an important tool for 
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designing drugs to target the regulatory region.  The potency can be tuned by altering the 
rigidity of the linker region.  
Membrane insertion of both C1 and C2 domains is required for full activation of 
conventional PKCs.  Studies from Chapter V found that the low-abundance lipid, 
phosphatidylinositol 4,5-bisphosphate (PIP2), was absolutely essential for achieving the 
maximum thermodynamic benefits of bivalent binding in the presence of DAG. This is 
despite the finding that C1B-C2 is bound to DAG in the absence of PIP2 under the 
conditions in these experiments.  Experiments show tethering of large unilamellar 
vesicles, which indicates that C1B-C2 can bind to neighboring liposomes.  Therefore, 
the lack of avidity could be the result of simultaneous membrane insertion of C1B and 
C2 being disfavored.  PIP2 is known to cause a change in the membrane binding of the 
C2 domain.  These results suggest that this change in orientation could facilitate the 
ability of both domains to insert into the membrane.  The small differences in the 
magnitude of PRE patterns with C1B in the presence of bicelles and C1 ligands could 
explain why.  The deeper insertion of the C1 domain into the membrane in the presence 
of DAG could cause conformational strain relieved by tilting the C2 domain more 
perpendicular to the bilayer surface.  PDBu abolished the need for PIP2 to achieve 
bivalency in membrane interactions.  Another study hinted at the PIP2-dependence of 
combined C1-C2 membrane interactions.81  In this study, the diffusion of the regulatory 
region was only decreased in the presence of PIP2/DAG containing membranes.  
DAG/PS/Ca2+ alone was insufficient to increase the drag afforded by two membrane 
interacting modules.  However, the constructs used in this study had bulky MBP tags on 
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the proteins that complicate the analysis.  Consistent with their findings, this work shows 
that PIP2 is essential for the multivalent interactions of C1 and C2 domains with 
membrane mimics and provides a direct measurement of avidity using tag-free proteins.  
Furthermore, while it is known that both C1 and C2 domain interactions with 
membranes are absolutely essential to achieving full activation, it is currently unknown 
if both domains, C1A, or C1B bind to the membranes in addition to C2.  Collectively, 
our work suggests that at least in the case of the native ligand, DAG, C1B cannot be the 
sole C1 domain responsible for inserting into the membrane to facilitate interaction, 
unless PIP2 is available.  One potential model is that in the absence of PIP2, C1A is the 
primary C1 domain responsible for membrane insertion.  However, in the presence of 
PIP2 either the C1B domain or both the C1A and C1B domain insert into the membrane.  
This presents a previously unexplored, additional layer of regulation afforded by PIP2.
Finally, Chapter III details interactions of the regulatory region with xenobiotic 
metal ions, Pb2+ and Cd2+.  Two divalent ions are essential for the fold and function of 
the regulatory region of PKCs.  C1 domains cannot fold properly without two Zn(II) 
ions.  While the C2 domain does not need Ca2+ to fold properly, Ca2+ is essential to its 
function.   This work finds that toxic metal ions interact with the regulatory region using 
two different modes:  ionic mimicry and opportunistic binding.  It was already known 
that both Pb2+ and Cd2+ can bind to the loops of the C2 domain.  Here another mode of 
ionic mimicry is presented for Cd2+:  spontaneously replacing Zn2+ in the C1B domain.  
Solution NMR showed that Cd2+ was able to support the fold and function of isolated 
C1B.  Furthermore, replacement started before the high-affinity sites on the C2 loops 
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were completely populated, indicating that the structural Zn-sites on C1B can compete 
with the C2 domain for Cd2+.  Pb2+, in contrast, was not able to replace Zn2+ due to 
geometry preferences with an all sulfur coordination sphere.  A unique property of the 
C1B domain in PKC is the presence of a reactive cysteine in the second Zn-site.31  This 
is proposed to be the entry point for reactive oxygen species that activate PKC.  Cd2+ has 
a larger ionic radius and is more polarizable than Zn2+.  Therefore, in proteins this often 
results in stronger bonds.  Consistent with this, both sites had higher affinities to Cd2+ 
than to Zn2+.  The broad implication for replacement at this site is that Cd2+ could 
potentially protect C1B and, therefore, the parent enzyme from activation by reactive 
oxygen species.  A future direction is to test this by comparing the reactivity of the C1B 
domain as a Cd-finger and a Zn-finger. This can be achieved by refolding C1B in the 
presence of Cd2+ and monitoring the reaction of the domain with a cysteine reactive tag.  
Opportunistic binding of both Pb2+ and Cd2+ was found to mediate self-association of 
C1B-C2.  The regions identified, the interdomain linker and C-terminal helix of C2 have 
not been shown to bind Ca2+.  These regions of the protein are highly conserved in 
conventional enzymes.  Therefore, it is plausible that other conventional enzymes could 
self-associate in the presence of Cd2+ and Pb2+.  In particular, PKC has been shown to 
have unmasked regulatory domains in the latent form and therefore would be the most 
susceptible to self-association driven by toxic metal ions.  Very interestingly, there were 
no single nucleotide polymorphisms (SNPs) within these regions.  Along with the high 
conservation of these regions, this indicates that these regions are likely extremely 
important for PKC function.  
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The most surprising finding of this study was that self-association enhanced 
interactions of the regulatory region with membranes. While previous studies showed 
that Cd2+ is unable to support binding of the isolated C2 domain to anionic membranes, 
both Pb2+ and Cd2+ supported the membrane binding of C1B-C2.  This was attributed to 
the avidity of multiple weak interactions of C1B-C2 with membranes.  Self-association, 
like Zn-replacement, starts to occur before the loops are fully populated with either 
metal ion, which indicates that both opportunistic binding and ionic mimicry are 
important for interactions of PKC with Pb2+ and Cd2+.  Several studies have shown that 
the self-association through the regulatory region is another mode of PKC 
regulation.58,62-64  This has been shown to be mediated primarily by Ca2+, the C1A 
domain, and the C2 domain.  One proposed mechanism for regulation is sequestration of 
intramolecular interaction sites by intermolecular interactions.57  Our studies show that 
self-association increases the affinity of the regulatory domains for membranes, 
suggesting an additional role for self-association in regulation. The exact mechanism of 
Ca2+ in driving self-association is unknown.  Although we did not observe Ca2+ binding 
to the linker and the C-terminal helix, it is interesting to speculate that in the full length 
enzyme where both C1A and C2 are present to strengthen the intermolecular 
interactions, Ca2+ binding to these regions could stabilize the multimers.  Support for this 
comes from two pieces of evidence: (1) there were minor chemical shift perturbations 
observed in the linker region between C1B-C2 upon Ca2+ addition (data not shown), (2) 
Ca2+ addition to isolated C2 gave rise to intermolecular PRE, indicating a transient 
intermolecular interaction mediated by Ca2+.183  The PRE pattern observed in the 
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isolated C2 domain resembles the predicted PRE from the conformation found in the 
PKC II crystal structure.61  In this structure, ligands from both the linker and the C-
terminal helix mediate the dimerization of C2.  Pb2+ and Cd2+ bind with much higher 
affinities to this region as the same concentrations of Ca2+ in our studies could not drive 
self-assembly.  However, Ca2+ could be using a similar mechanism to mediate self-
association but the C1A-C2 interaction is additionally needed because of the relatively 
weaker ability of Ca2+ to drive self-association.  This can be explored using the 
conventional, full length regulatory domain construct from Chapter II.    
The work presented in this dissertation sheds light on the interactions of 
xenobiotic metal ions with the regulatory region, but these ions can also potentially exert 
their toxic effects by acting on the kinase domain.  The function of the kinase domain 
relies on the divalent metal ion, Mg2+, to aid in catalysis.  Other studies have 
investigated the ability of toxic metal ions to substitute for Mg2+ in kinase domains.  One 
study was done on PKA, which is also a member of the AGC family of kinases and very 
similar to PKC.  Cd2+ was found to bind to the kinase domain but was unable to fully 
support the function.207  Cd2+ was able to support phosphoryl transfer to substrates but 
was unable to support substrate turnover.  Additionally, functional studies have shown 
that both Cd2+ and Pb2+ can activate PKC at low concentrations and Pb2+ inhibits PKC at 
higher concentrations, revealing the complexity of PKC interactions with toxic metal 
ions.17,18,118,121  Murakami et. al. found that high concentrations of Pb2+ inhibited both 
PKC and PKM, a proteolytically generated kinase domain fragment.71  This effect was 
found to be reversible upon chelation of Pb2+ and suggests that the ability of Pb2+ to 
173
inhibit PKC is, at least in part, a result of interactions with the kinase domain as Pb2+ 
was able to inhibit the isolated kinase domain.  Mg2+ is present in the cell in millimolar 
quantities and therefore both Pb2+ and Cd2+ would both need to bind with high affinity to 
the kinase domain in order to substitute for Mg2+.   Currently, there is no information on 
the affinities of Cd2+ nor Pb2+ to the kinase domain.  Binding affinities for the isolated 
kinase domain and structural studies on full length PKC in the presence of Pb2+ and Cd2+ 
are needed to understand the interplay between the interactions of Pb2+ and Cd2+ with 
kinase domain and the regulatory domain to understand which interactions are important 
for modulating activity. Collectively, the work outlined in this dissertation adds a 
mechanistic understanding of the behavior of the regulatory region before and after 
membrane insertion.  Furthermore, it lays the foundation for structural studies extending 
to full-length regulatory regions.  Finally, this work changes our understanding of the 
way that PKC interacts with toxic metal ions. 
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